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Abstract 
Multiple sclerosis (MS) is a disease of the central nervous system, which is characterized 
by neuroinflammation and demyelination that mainly affects the white matter (WM) 
structures. MS is one of the major causes of neurological disability worldwide, with patient 
symptoms vary according to the disease stage and treatment outcomes (Trapp & Nave 
2008). The major hallmarks of MS include neurodegeneration, demyelination, axonal 
damage and nerve injury (Lassmann, H. 2013).  
Recently, diffuse pathological changes have been documented in the gray matter (GM) 
and cortical areas in patients with MS, as well as in certain animal models (Calabrese, M. 
et al. 2011; Pirko et al. 2009). Various rodent models of MS have been developed to 
investigate specific aspects of this disease and explore the underlying mechanisms. 
Experimental autoimmune encephalomyelitis (EAE) is a classical animal model for MS, 
which is characterized by the development of CNS neuroinflammation that leads to 
demyelination and neurodegeneration. EAE disease severity in mice varies according to 
the mouse strain and the immunization protocols utilized (Lassmann, H. 2008; Robinson et 
al. 2014). In order to assess sensory deficits in EAE-mice, the immunization protocol was 
optimized (in the laboratory of Prof. M. Smith, the School of Pharmacy, UQ) to produce 
mild relapsing remitting MS clinical symptoms with partial recovery between relapses 
(Khan, Woodruff & Smith 2014; Peiris et al. 2007). Using this EAE model, we assessed the 
correlations between clinical scores and pain behaviour with changes in the motor and 
sensory areas of the brain by magnetic resonance imaging (MRI). The aim of this PhD 
project is to develop MRI diffusion weighted imaging (DWI) at 16.4 T to detect sensory and 
motor deficits in a mild EAE model of relapsing and remitting MS. 
In rodent MRI, a high magnetic field is desirable feature, because it provides a high spatial 
resolution and a high signal-to-noise (SNR) ratio (Moldrich et al. 2010). Spin echo high-
spatial and high-angular resolution diffusion-weighted imaging (HARDI) has been used for 
many ex vivo mouse brain studies using at 16.4T. Ex vivo imaging has some disadvantage 
as the diffusion parameters could be affected uniformly by tissue fixation (Zhang et al. 
2012). On the other hand, in vivo HARDI-DWI provides potential benefits in term of 
tracking longitudinal pathological changes during the disease cycle. However, in vivo ultra-
high field MRI has several physical challenges, including limited acquisition time, motion, 
magnetic susceptibility, lengthening of T1 and shortening of T2 relaxation times. In vivo 
HARDI acquisition using spin-echo DWI would result in long experiment time and 
increased sensitivity to motion (Aggarwal, Zhang & Mori 2012; Wu, D et al. 2014).  
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The first part of this project involved the optimization of two-dimensional (2D) HARDI echo 
planar imaging (EPI) sequence for in vivo MS imaging at 16.4T. This sequence was 
optimized to overcome the technical challenges above, including the incorporation of echo-
train length segmentation and partial Fourier acceleration in the phase direction. High-
quality HARDI data was acquired at b=3000 s/mm2, 64 diffusion-encoding directions, 125 x 
150µm2 in-plane resolution, 0.6 mm slice thickness, within a 2h acquisition time. The 
analyses of manually drawn regions of interest (ROIs) of DTI parameters (fractional 
anisotropy (FA), axial and radial diffusivity (AD) and mean diffusivity (MD) of the major WM 
structures, however, did not reveal significant changes between controls and MS animals. 
To study the MS disease model in more detail and to increase the possibility to detect 
subtle pathological changes unobserved in in vivo imaging, subsequent studies were 
performed with 3D-ex vivo MRI at 16.4T. Ex vivo imaging was done using 100µm3 
isotropic spin echo DWI with 30 directions at b = 3000 s/mm2. Comparison of DTI 
parametric maps of manually drawn ROIs in the major WM structures did not reveal 
significant changes between EAE, sham and control subjects in acute and chronic stages 
of the MS disease. However, whole brain analysis using VBM (Voxel Based Morphometry) 
revealed significant reductions of FA in chronic EAE-mice compared to naïve control 
animals in important gray matter (GM) brain areas including the primary and secondary 
motor areas, primary somatosensory area, anterior cingulate and rostral CA1 hippocampal 
regions, and a small portion of WM external capsule. These FA changes were not 
detected in the MS animals of the acute phase. Also, using ROI based analysis; there 
were significant increase of the T2 relaxation time in these areas exhibiting reduction in FA. 
Black and Gold II histology confirmed the presence of extensive demyelination in these 
gray matter and cortical areas.  
Our findings suggest that there is a correlation between histological changes in the brain 
motor and sensory areas, all which are consistent with the reductions of FA observed in 
these regions. The ability to detect mild EAE pathology in GM somatosensory cortex using 
MRI is highly important, providing better insight into neuropathological changes during the 
remitting-relapsing disease course.  
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1 Literature Review  
Animal models have been instrumental in understanding neuropathological aspects of 
various processes including inflammatory diseases (Kim, JH et al. 2006; Pirko et al. 2004), 
neuronal or axonal injury (Budde et al. 2008), neurodegenerative diseases (MacKenzie-
Graham, A. et al. 2009; Pirko et al. 2009) and neoplastic diseases (Phuong et al. 2003). In 
biomedical research, a reliable diagnostic tool is essential for tracking pathological 
changes or subtle abnormalities. Optical microscopy (Kim, JK, Choi & Yun 2013) and 
histology techniques (Schmued et al. 2008) can visualize tissue compartments or cellular 
interactions. However, they have two major limitations. Firstly, they are an invasive 
procedure, requiring the dissection of the animal and therefore only ex vivo tissues can be 
studied at a high resolution. Secondly, they may produce variable results based on the 
staining protocols used (von Elverfeldt, Reichardt & Harsan 2012). Magnetic Resonance 
Imaging (MRI) is a powerful investigative tool, because it allows tracking of pathological 
changes at multiple time points without sacrificing the animals (MacKenzie-Graham, A. et 
al. 2009). Since the first report of MR imaging of the rat (Hansen et al. 1980), MRI has 
become a significant diagnostic instrument in preclinical environments (Aggarwal, Zhang & 
Mori 2012).   
Recent developments in MRI modalities have been tailored to investigate specific aspects 
of multiple sclerosis (MS) using animal models and to enhance diagnostic accuracy in 
patients (Nathoo, N, Yong, V & Dunn, J 2014). Key aspects of MS that can be monitored 
by MRI include blood brain barrier (BBB) leakage, immune cell infiltration, inflammation, 
demyelination/remyelination, axonal injury, changes in brain connectivity and structural 
volumes (Lassmann, H. 2013; Qian et al. 2011).  
Conventional MRI techniques, such as T1 and T2-weighted imaging can provide an 
accurate representation of the brain macroscopic anatomical structures in addition to 
superb contrasts between the white and gray matter (Benveniste & Blackband 2002). 
However, neuronal tissues contain complex cellular arrangements and axonal wiring, such 
that conventional MRI techniques are not sufficient to provide detailed characterization at 
the level of microscopic structures, such as fibre architectures and connectivity between 
neuronal structures (Baloch et al. 2009; Chahboune et al. 2007).  
Diffusion weighted imaging (DWI) is a sensitive measure of the characteristic movement of 
the water molecules and is achieved by incorporating diffusion-weighted (DW) gradients to 
various pulse sequences (Le Bihan et al. 2001; Mori & Tournier 2014). As the number of 
applied DW gradients increases, the accuracy of the measurement of the diffusion 
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parameters will dramatically improve (Tournier, Mori & Leemans 2011), however, this also 
significantly increases the image acquisition time (Bammer et al. 2009).  
Diffusion Tensor Imaging (DTI) is the outcome matrix, which calculated from application of 
diffusion gradients in minimum of six directions in addition to one without application of 
diffusion gradients (Le Bihan 2014). DTI has been used in various studies of neurological 
disease models in rodent brains (Aharoni et al. 2013; Sun, S et al. 2007) and spinal cords 
(Budde et al. 2008; DeBoy et al. 2007). DTI parametric measurements mean diffusivity 
(MD), fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD) have 
become indispensable quantitative diagnostic tools for determining the quality of 
therapeutic approaches, specifically in white matter diseases (Harsan et al. 2008). DTI has 
also provided a better understanding of the intricate connectivity of the mouse brain (Wu, 
D et al. 2014) and normal brain development, such as the process of myelination in a 
neonatal brain (Baloch et al. 2009). 
This thesis starts with a literature review chapter, which covers the field of DWI experiment 
of the rodent brain and introduction to MS and discussion MRI studies of MS in patients 
and animal models. This work started with the optimization of a segmented EPI-DWI 
sequence to acquire in vivo HARDI data of adult C57BL/6 mice at 16.4 Tesla (T) at a high 
in-plane spatial resolution and within an acceptable experiment time. During optimization, 
technical challenges of DWI of the rodent brain in an ultra-high magnetic field, including 
the effect of relaxation times, magnetic susceptibility, motion and chemical shift artefacts 
were addressed. This is then followed by 2D in vivo and 3D ex vivo high resolution DTI 
study, to assess their sensitivity and to compare with conventional MRI, histology and 
behavioural data, for detecting neuropathological changes in relapsing remitting EAE (RR-
EAE) animal models.  
 
1.1 Introduction to Magnetic Resonance Diffusion-Weighted Imaging 
Magnetic resonance imaging (MRI) can be defined by a sequence of radiofrequency (RF) 
pulses and time varying gradient magnetic fields (Paschal & Morris 2004). When the 
subject placed inside the magnet, the atomic nuclei exposed to the electromagnetic 
energy. These nuclei contain protons and neutrons and both have nuclear spins 
(Westbrook & Roth 2013). MR active nuclei are those that have net spins because they 
are odd numbers or they don’t cancel each other. Hydrogen (1H) nuclei are the common 
MR active nuclei because it is abundance in the body which we are investigating in this 
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experiment (Hashemi, Bradley & Lisanti 2012). When the B0 (static magnetic field) 
magnetisation is applied, some of the MR active nuclei align parallel with the axis of the B0 
and others are antiparallel. They cancel each other and produce the net magnetic vector 
(Bitar et al. 2006; McGowan 2008)  
During application of the radiofrequency (RF) pulse, the net magnetisation vector will flip 
by a certain degree and this produces two components; longitudinal and transverse 
magnetisation. When all the spins are on the transvers axis and pointing on the same 
direction, it induces current in the receiver coil and consequently produces the maximum 
MR signals (Bitar et al. 2006). Imaging gradients are linear variation of the magnetic field 
strength in a selected direction. There are three basic imaging encoding gradients; 
including slice selection, frequency and phase. Their major purpose is spatial encoding of 
the MR signals (McGowan 2008). K-space is the domain where the time varying signals is 
stored from detection of precessing magnetization, which is subsequently the Fourier 
Transformed (FT) converts data into an image (Bernstein, King & Zhou 2004a). 
 
1.1.1 Molecular diffusion in biological tissue  
Diffusion can be defined as the movement of water molecules from one location to another 
through random molecular Brownian motions that can be quantified using a diffusion 
coefficient (D) (Hagmann et al. 2006; Le Bihan et al. 2001). Magnetic Resonance Imaging 
(MRI) can be sensitized to measure the diffusion process of water molecules using 
Diffusion-weighted Imaging (DWI). DWI estimates the mean square distance travelled by 
molecular spins in a given interval of time, called the apparent diffusion coefficient (ADC) 
(Basser, P. & Özarslan 2014; Mori & Zhang 2006).  
Molecular diffusion can be broadly classified as isotropic and anisotropic diffusions. 
Isotropic diffusion is defined as the non-restricted random distributions of water molecules 
(Le Bihan et al. 2001; Tournier, Mori & Leemans 2011). Anisotropic diffusion can be 
defined as the molecules have restricted and deterministic diffusion direction. In biological 
systems, the properties of molecular water diffusion vary according to tissue types 
(Hagmann et al. 2006). An example of isotropic diffusion in the brain is the cerebrospinal 
fluid (CSF) and, to a lesser extent, the gray matter (Mukherjee, Berman, et al. 2008). 
Some examples of tissues with anisotropic diffusion are the brain white matter and the 
skeletal muscle fibres (Basser, P. , Mattiello & LeBihan 1994; Mori & Tournier 2014). 
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The overall shape of the isotropic diffusion can be described as resembling a sphere. 
Therefore, the diffusion measurement in such structures can be sufficiently performed in 
one direction. For anisotropic diffusion structures such as the white matter, the 
directionality of the diffusion displacement can be described as a diffusion ellipsoid, in 
which the highly anisotropic structures will have a sharper ellipsoid (Mori & Zhang 2006). 
To characterize the diffusion coefficient (D) in anisotropic structures, the DWI experiments 
need to be acquired with at least six orthogonal diffusion-encoding directions. This 
technique is known as Diffusion Tensor Imaging (DTI) (Basser, P. , Mattiello & LeBihan 
1994). The diffusion measurement has the highest magnitude and accuracy when the 
diffusion-encoding gradient is parallel to the molecular diffusion direction and the least 
sensitive when the gradient is perpendicular to the major diffusion direction (Basser, P. & 
Özarslan 2014).   
Figure 1.1 shows the relationships between the molecular diffusion and the diffusion 
tensor. In this figure, the long axis of the ellipsoid depicts the major diffusion direction. The 
measurement of the diffusion coefficient will be most accurate when the diffusion-encoding 
gradient is parallel to the main direction (Mori & Zhang 2006; Mukherjee, Berman, et al. 
2008).  
The effect of the imaging gradients on the static and moving spins can be described by the 
following equation:  𝜙 𝑡 = 𝛾𝐵!𝑡 + 𝐺 𝑡! . 𝑥(𝑡!)𝑑𝑡′!!                (1) 
Where Φ (t) refers to the phase evolution as a function of time, γ is the nucleus specific 
gyromagnetic ratio, B0 is the static magnetic field, t’ is the duration of the change in the 
magnetic field, G (t’) and x (t’) are the gradient amplitude and position as a function of 
time, respectively (Bammer 2003). 
In equation 1, the first term expresses the relationship of the phase accumulation and 
static magnetic field and the second part describes the influences of the gradients and how 
they change the phase of the examined spins. In general, the phase accrual is proportional 
to the strength of the field gradients, how long the gradients have been applied and the 
position of the examined spins (Bammer 2003; Mukherjee, Berman, et al. 2008). Equation 
1 forms the basis of the diffusion imaging experiment, because the gradients can be used 
to track and determine the spatial location of the targeted spins according to the 
differences in their precession frequency (Bammer 2003).   
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Figure 1.1 Schematic diagram of the relation between diffusion pattern and diffusion tensor 
Reproduced from (Mukherjee, Berman, et al. 2008). 
 
1.1.2 Significance of diffusion-weighted imaging in neurological studies 
In the neurological tissues, the degree of anisotropy of molecular diffusion can be 
dependent on several characteristics of the nerve fibres including axon number, diameter 
and the level of myelination (Le Bihan 2014). For human clinical imaging, the DWI can 
achieve a reasonably high resolution within the level of millimetres (Mori & Tournier 2014; 
Tournier, Mori & Leemans 2011). The DWI is extremely useful as a diagnostic tool for 
visualization and staging various neurological diseases. Examples of the DWI clinical 
applications are in the imaging of stroke (Lai et al. 2014; Lansberg et al. 2000), 
schizophrenia (Whitford, Kubicki & Shenton 2011), dyslexia (Klingberg et al. 2000) brain 
development (Johnson et al. 2014) and multiple sclerosis (Aliotta et al. 2014; Koenig et al. 
2013).  
Alterations in the diffusion process are important biological markers for the change of the 
cellular stability or homeostasis. This phenomenon has been exploited for early detection 
of the acute ischemic stroke (Moseley et al. 1990) and it has become a standard for 
routine clinical diagnosis of stroke patients (Lansberg et al. 2000). The DWI can assess 
the morphological changes that may occur in the neural tissues. DWI can be used to 
assess morphological changes that may occur in neural tissues by measuring the 
 30 
microscopic random translational motion influenced by several biological factors such as 
cellular density, cell membranes, myelin and organelles (tissue compartments). It also 
provides extra diagnostic characterization of the focal or diffuse lesions that could be 
undetected by other conventional MRI techniques, such as the T1 or T2-weighted imaging 
(Rovaris, M. et al. 2005). This has provided tremendous information for the window of 
opportunity in planning treatments and reducing the extent of the disability because of the 
ischemic stroke lesions or other lesions (Lansberg et al. 2000). 
In addition to the alterations in the cellular homeostasis, other pathological processes that 
could be investigated with the DWI include degenerative and regenerative mechanisms of 
the cellular membrane, scarring, inflammation and neoplastic infiltration (Filippi & Agosta 
2010; Zhang, J, Aggarwal & Mori 2012). All these pathological mechanisms could affect 
the characteristics of the proton diffusion and can be tracked by the DW-MRI (Aliotta et al. 
2014; Bammer & Fazekas 2002; Filippi et al. 2001; Filippi et al. 2012). Multiple sclerosis is 
an example of where the DWI can be used to provide information about the sequence of 
degeneration and regeneration mechanisms of neural structures and how these processes 
cause disease progression. Several DTI derived parameters can be utilized as surrogate 
biomarkers for MS. For example, a decrease in FA values is well correlated with 
demyelination (Filippi, Absinta & Rocca 2013; Ge, Law & Grossman 2006).  
 
1.1.3 Diffusion-encoding gradients in DWI  
DWI sensitizes MRI for the displacement of water molecules using diffusion-encoding 
gradients. Gradient coils are built inside the MRI scanner and their primary role is to 
provide spatial encoding to generate the image (Mori & Tournier 2014; Tournier, Mori & 
Leemans 2011). Imaging gradients usually have weak amplitude and a short duration, and 
therefore they cannot be used for encoding to detect the diffusion of the nuclear spins (Le 
Bihan et al. 2001). In contrast, diffusion gradients are made strong enough to encode the 
diffusion of the molecules and to measure their spatial distributions. Diffusion-encoding 
gradients can be inserted in most MRI pulse sequences, so that a particular pulse 
sequence will become sensitive to the macroscopic and microscopic motion of the spins 
(Huston & Field 2013; Lerner et al. 2013).   
Most DWI pulse sequences are based on the Stejskal and Tanner gradient design 
(Stejskal & Tanner 1965, 2004). In general, the simple design involves two diffusion 
gradients pulses separated by a time delay. The first gradient provides a spatial phase 
encoding to the spins, where, after a certain time evolution delay, they are refocused using 
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the second gradient. Diffusing spins will not be recovered as fully as the static spins and 
will appear with reduced signal intensity. The performance of these gradients is influenced 
by the gradient pulse duration (δ) and the gradient separation (∆) (Mori & Tournier 2014; 
Mori & Zhang 2006). 
For neurological research, the encoded spins in the DWI experiment may be likened to 
endogenous tracers to provide brain axonal connectivity information similar to other 
approaches that use an exogenous tracer, such as Manganese (Canals et al. 2008; 
Pautler 2004), dye tracing (Köbbert et al. 2000) and neurotropic virus (Card 1998). Unlike 
the DWI, these exogenous tracers involve invasive injections of the substances into the 
targeted brain areas, whereby they are transported through the axons through the active 
calcium transporter (Manganese tracer) or passive-restricted diffusion (axonal dye tracing) 
or viral infection. Such fundamental differences can cause differences in determining the 
profiles of the brain connectivity (Canals et al. 2008; Köbbert et al. 2000).  
There are four basic categories of DWI measurement techniques, a constant diffusion 
gradient, a pulsed field gradient spin echo (PFGSE) sequence, a stimulated echo (STE) 
sequence and a bipolar gradient echo sequence. A constant diffusion gradient can be only 
applied with spin echo sequences and allows measuring long diffusion time (Le Bihan 
1995; Le Bihan et al. 2001). However, it is technically difficult because the diffusion 
gradients and 180 refocusing pulse cannot be applied simultaneously and these will 
significantly cause slice selection impairment (Le Bihan et al. 2001). Therefore, this will not 
be discussed further. Each technique offers certain advantages and has technical 
challenges, which will be discussed in the next sections.  
1.1.3.1 Pulsed field gradient spin echo (PFGSE) sequence  
The common approach for sensitizing the spins for diffusion is by a pulse field gradient 
spin echo (PFGSE) (Stejskal & Tanner 1965, 2004). The PFGSE sequence contains two 
identical polarity diffusion gradients applied before and after the 180° refocusing pulse 
(Figure 1.2). Both diffusion gradients act on the moving spins in the direction of the applied 
gradients (Bammer 2003). The phase of the spins can be determined by the following 
equation:  𝜙 𝑇𝐸 = 𝛾 𝐺 𝑡! . 𝑥 𝑡! 𝑑𝑡! − 𝛾 𝐺 𝑡! . 𝑥 𝑡! 𝑑𝑡′!!!!!!!!!!!!!!!!  (2) 
For static spins, the application of two identical gradients before and after the refocusing 
pulse will cancel out the phase shift. In contrast, in the case of the moving spins, they 
continue moving and acquire phase evolution (Le Bihan 2014). The diffusion spins are 
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randomly distributed, therefore they continue accumulating phase shift (dephased), and 
thus the resonance signal is attenuated (Mori & Tournier 2014). The amount of the echo 
signal attenuation caused by the diffusion is defined by the following equation: 
                                   𝑀 !,!" !" = 𝑀!𝑒(!!"!!)𝑒!!"          (3) 
The factors that determine the attenuation of the signals are the T2 (relaxation time), TE 
(echo time), diffusion coefficient (D) and gradient strength (b) (Bammer 2003; Rueda-
Lopes et al. 2014). In the PFGSE experiment, the b-value can be described in the 
following equation:  
                                           𝑏 = 𝛾!𝐺!𝛿!(∆− 𝛿 3)                    (4) 
Where γ refers to the gyromagnetic ratio, G is the strength of the gradients, Δ is the 
separation time between the two applications of diffusion-encoding gradients and δ refers 
to the duration of the application of the diffusion gradients (Mori & Tournier 2014; Mori & 
Zhang 2006). 
Figure 1.2 shows the relation between G, Δ and δ parameters and how they influence the 
attenuation of the final signal through diffusion weighting (Diffusion-w) and T2-weighting 
(T2-w). If G, Δ and δ are small, the degree of signal attenuation through Diffusion-w and 
T2-w is minimal (Figure 1.2A). With an increasing Δ, the signal attenuation through the 
Diffusion-w and T2-w will increase accordingly owing to the increased b-value and TE 
(Figure 1.2B). Increasing δ or G (Figure 1.2C and 1.2D), while keeping a reasonably short 
TE, will increase the accuracy of the measurement of the diffusion coefficient, while 
minimizing the signal loss due to the T2  (Mori 2007, 2014).  
1.1.3.2 Stimulated Echo (STE) Diffusion sequence 
The STE diffusion sequence provides an alternative solution to the lack of powerful 
gradient strength, which is common in low-field clinical scanners. In addition, the STE 
offers the possibility of increasing the diffusion time (Δ) without attenuating the signals 
because of the T2 decay. This sequence consists of three 90° radio-frequency pulses, 
divided by two time intervals, the τ1 and τ2. The diffusion gradients pulses are inserted 
after the first and third 90° RF pulses. The measured diffusion in the STE diffusion 
sequence is longer than the measured value in the PGSE sequence, because of the 
second τ2 period (Bammer 2003; Pipe 2009; Tanner 1970). 
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Figure 1.2 The impact of DWI sequence parameters G, Δ  and δ  on diffusion and T2 weightings.        
This diagram shows the PGSE sequences incorporated with two identical pulsed field gradients pre- and 
post- the 180° refocusing pulse. (A) The standard Stejskal tanner sequence, the effect of increasing (B) Δ, 
(C) δ, (D) G. Reproduced from (Mori 2007). 
 
The same Stejskal and Tanner spin echo equation 4 can be applied to calculate the b-
value for the STE diffusion sequence. The signal decaying through the T2 relaxation is 
minimized, because the magnetization is placed on the longitudinal axis by the second 90o 
pulse. Therefore, the STE provides the ability to carry out long diffusion encoding, which is 
beneficial for measuring the slow diffusion rate, especially for samples with a short T2 
(Basser, P. , Mattiello & LeBihan 1994; Frahm et al. 1985). In addition, the STE can 
minimize artefacts caused by the imperfect shimming of the magnet or the sample 
inhomogeneity, which would otherwise be magnified by the presence of the gradients. 
However, the STE sequence suffers from a reduction of the SNR by up to 50%, because 
of the loss of coherence from the multiple radiofrequency pulses (Frahm et al. 1985; 
Merboldt et al. 1992).  
1.1.3.3 Bipolar diffusion gradients  
Bipolar diffusion gradients are commonly used for gradient echo sequences, with a similar 
effect for encoding the spin diffusion as in the unipolar diffusion gradients in a PFGSE 
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sequence (Basser, P. , Mattiello & LeBihan 1994; Le Bihan 1991). The gradient echo 
sequence will not be able to recover signal loss due to time-independent (T2*) transverse 
coherence dephasing. Such a problem will be more pronounced on high magnetic field 
scanners. To encounter this, the echo time needs to be shortened to achieve a reasonable 
SNR, with an unfortunate consequence that only low b-values are possible. In this case, it 
is difficult to have a long diffusion time unless the scanner can produce large diffusion 
gradients (Mori & Tournier 2014). On the other hand, the major advantage of combination 
of the bipolar diffusion gradient with gradient echo sequence is their rapidity and they allow 
measuring short diffusion molecules and consequently the TE should be short. Bipolar 
gradient can be used with SE sequences but should be multiple to become effective 
(Freidlin et al. 2012). This will provide advantage in avoiding effects from restricted 
diffusion attenuation multiple times compared with single bipolar. However, it requires 
gradients switching (Freidlin et al. 2012; Le Bihan 1995).   
 
1.1.4 DWI acquisition sequences 
According to the trajectories of the evolving data in the k-space, the DWI acquisition can 
be broadly divided into Cartesian and non-Cartesian k-space acquisition sequences. The 
Cartesian k-space sequences include spin echo (SE) (Sun, S et al. 2007), echo planar 
imaging (EPI) (Harsan et al. 2010), and fast spin echo (FSE) (Pipe, Farthing & Forbes 
2002), stimulated echo (STE) (Boretius, S. et al. 2007) and steady state free precession 
(SSFP) sequences. The non-Cartesian k-space acquisition sequences include spiral 
(Truong & Guidon 2014), radial (Trouard et al. 1999) and line (Gudbjartsson, Maier & 
Jolesz 1997) diffusion acquisition. The DWI sequences used in this project are spin echo 
and segmented echo planar imaging sequences. Other development of DWI sequences 
will also be discussed within the scope of this literature review.  
1.1.4.1 Spin Echo Diffusion-weighted Imaging (SE-DWI) Sequence 
Most of preclinical in vivo DWI data has been acquired using the spin-echo sequence (SE-
DWI) (Sun, S et al. 2007; Sun, SW et al. 2006; Xie et al. 2010), due to its greater immunity 
to magnetic susceptibility and chemical shift artefacts at high magnetic field. However, a 
number of technical challenges have been described for in vivo DWI studies of rodent 
brains (Boretius, S et al. 2009; Boretius, S. et al. 2007; Harsan et al. 2010; Harsan et al. 
2006; Lin, C-Y et al. 2005; Muller et al. 2012; Wu, D et al. 2013), such as sensitivity to 
motion and the magnetic susceptibility artefact (von Elverfeldt, Reichardt & Harsan 2012). 
A schematic diagram of the SE-DWI sequence can be seen in Figure 1.3.  
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Figure 1.3 A schematic diagram of SE-DWI sequence. 
G slice (Slice selection gradient), G readout (Readout Gradient), G phase (Phase Gradient), and Gd 
(diffusion gradient), reproduced from (Bernstein, King & Zhou 2004b).  
 
SE-DWI is time-consuming and allows only a limited number of diffusion encoding 
directions (6–12 directions) within a reasonable experimental time (Harsan et al. 2010; 
Wu, QZ et al. 2007). Therefore, the in vivo SE-DWI data is only suitable for conventional 
DTI processing and fibre tracking (Mori & Tournier 2014). Other high angular resolution 
diffusion-weighted imaging (HARDI) techniques require at least 30 diffusion-encoding 
directions with reasonably high b-value (b> 3000s/mm2) for accurate detection of fibre 
orientation distribution (FOD) and fibre tracking (Tournier, Calamante & Connelly 2012; 
Tournier, Mori & Leemans 2011). 
SE-DWI is the preferred imaging technique for ex vivo mouse brains, because it boosts the 
high signal-to-noise ratio and high spatial resolution with no specific restraints to the 
experiment time (Moldrich et al. 2010; Mori et al. 1999; Mori et al. 2001). Where as, the 
time for in vivo DWI mouse brain imaging is limited, requiring anaesthesia and 
consideration of the health status of the animal. SE-DWI is also more susceptible to 
motion artefacts owing to the reduced possibility for scan averaging (NEX) and 
consequently a low SNR as well as accumulating of phase errors during echo acquisition 
(Mori & Zhang 2006). To compensate for the low SNR, images are usually acquired with 
thick slices such that they contain more significant partial volume effects (Mori et al. 2001; 
Zhang, J, Aggarwal & Mori 2012).With such limitations, it is often difficult to optimise the 
SE-DWI to achieve similar in-plane resolution, slice thickness and high number of diffusion 
encoding-directions as EPI-DWI. 
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The partial Fourier reconstruction in both the frequency and phase encoding directions has 
been used to reduce the total experiment time and to reduce the TE (Harsan et al. 2010).  
This will be advantageous, because the T2* and T2 relaxation times are shorter in a higher 
magnetic field. This technique has been previously applied in a 7T magnetic field with the 
STE DWI sequence (Boretius, S. et al. 2007), but produced a severe reduction in the 
signal-to-noise ratio because of the lengthening of the diffusion time Δ. Even with 
significant benefit of partial Fourier reconstruction, the total time for the DWI-SE 
experiment time is long and not tolerable for an in vivo mouse brain studies owing to a 
high specific absorption rate (SAR). Also, the spatial resolution is low and it is highly 
susceptible to a partial volume effect because of the requirement for thick slices.  
Figure 1.4 shows an example of the acquired relative anisotropy (RA) reconstructed from 
the in vivo SE-DWI at 4.7T (Sun et al. 2007).	  Tables 1-1 and 1-2 summarize the imaging 
parameters of the SE-DWI sequence previously used for the in vivo and ex vivo mouse 
brain studies.  
 
Figure 1.4 Relative Anisotropy map acquired and reconstructed from the SE-DWI sequence at 4.7T.  
From top left to bottom right ON (optic nerve), AC (anterior commissure), CC (corpus callosum), EC (external 
capsule), OT (optic tract), CP (cerebral peduncle), reproduced from (Sun, S et al. 2007). 
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Table 1-1 Examples of in vivo SE-DWI studies 
In vivo SE-DWI Imaging parameters 
1. 2D DWI (Song et al. 2003; 
Sun, S et al. 2007; Sun, SW 
et al. 2006; Xie et al. 2010). 
All have quite similar imaging 
parameters 
TR/TE=1500/50 ms, FOV=3×3 cm, slice 
thickness=0.5 mm, matrix= 256×256, zero-filled 
to 512×512, ∆/δ= 25/10 ms, 6 directions, 1 zero b-
value, b-value=768 s/mm2, NEX=4, experiment 
time=3 h 
2. 2D DWI of high resolution 
corpus callosum only at 4.7T 
(Wu, QZ et al. 2007). 
TR/TE= 2000/30 ms, FOV=15×15 mm slice 
thickness=1 mm, matrix = 128×128. 
Two direction diffusion encoding precisely 
selected to match parallel and perpendicular 
diffusivity of corpus callosum, b-value=700 
s/mm2, experiment time=12 minutes 
 
Table 1-2 Examples of ex vivo spin echo diffusion-weighted imaging studies 
Ex vivo SE-DWI Imaging parameters 
1. 3D DWI-study at 9.4 T 
(Mori et al. 1999) 
FOV= 32×16×16 mm, matrix size= 128×64×64 
zero filled to 256 ×128×128, TE=44 ms, 10 DW 
encoding directions, δ/∆=5/16 ms, experiment 
time=12 hours 
2. 3D DWI study at 16.4 T 
(Moldrich et al. 2010) 
TR/TE=400 ms/22.8 ms, NEX=1, 
Resolution=0.1×0.1×0.1 mm without interpolation, 
30 DW encoding directions, b-value=5000 s/mm2, 
δ/∆=2.5/14 ms, experiment time=32 h 
3. 3D-study at 9.4 T(Mori et 
al. 2001). 
TR/TE=1000/36 ms, matrix size= 128×64×64 
zero filled to 256×128×128, FOV 10×6×6 mm, 
Resolution=39×47×47µm, 6 DW encoding 
directions, b-value=1187 s/mm2 with low b- 
value=206 s/mm2 
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1.1.4.2 Echo Planar Diffusion-weighted Imaging EPI-DWI sequence 
The SE-EPI sequence consists of a single 90°excitation and a 180° refocusing pulse 
followed by an alternating frequency and phase-encoding gradients. The pulsed-field 
diffusion gradients are placed on either side of the 180o pulse. In Single-shot echo planar 
imaging diffusion weighted imaging (SS-EPI-DWI), the whole k-space data needs to be 
acquired within a reasonable TE to avoid signal decay through the T2* relaxation time. An 
example of single shot SE-EPI-DWI sequence can seen be in Figure 1.5. Alternatively, the 
k-space can be divided into sections to maintain the signal level. Such a method is known 
as the Multi-shots or Segmented EPI (Mukherjee, Chung, et al. 2008).  
1.1.4.2.1 Single-shot EPI-DWI 
SS-EPI-DWI is widely used in clinical environments (Le Bihan 1995; Le Bihan et al. 2001). 
It has several advantages: (1) it is less susceptible to bulk motion effects from the subject 
or physiological movements because the data can be acquired in fractions of a second 
(DeLaPaz 1994; Stehling, Turner & Mansfield 1991); (2) its short acquisition time allows 
HARDI acquisition with a large number of diffusion-encoding directions; (3) it can provide a 
high SNR per unit of scanning time, which is preferred for DWI, as it has an inherently low 
SNR (Mukherjee, Berman, et al. 2008; Pipe 2009). However, SS-EPI has its own 
challenges at high magnetic fields. These include a fast signal decay due to shorter T2 and 
T2* relaxation times (exacerbated by increased magnetic susceptibility inhomogeneity), 
distortion artefacts and increased chemical shift artefacts (de Figueiredo, Borgonovi & 
Doring 2011; Jones, D. K. & Cercignani 2010). 
1.1.4.2.2 Segmented EPI-DWI 
In this sequence, the k-space is divided into multiple interleaves instead of acquiring the 
data in a single shot. This approach can reduce the susceptibility to off-resonance 
artefacts and image blurring as a result of faster filling of the k-space and reducing the T2 
and T2* decay times (Pierpaoli et al. 1996). The segmented EPI is less demanding on the 
gradient performance compared with the single shot EPI; therefore it can be installed 
easily on the clinical scanners (Bammer et al. 1999; Pipe 2009). 
However, the segmented EPI is more sensitive to the bulk motion effects compared with 
the single shot EPI sequences. This because many interleaves are required to fill up the 
entire k-space and making it prone to phase errors. The incorporation of the navigator 
 39 
echoes into a segmented EPI sequence is recommended to correct the phase-induced 
error between interleaves. In addition, the segmented EPI-DWI can be acquired with a 
respiratory triggering to reduce the motion artefacts in non-corporative subjects such as 
mice (Figure 1.6).  
	  
Figure 1.5 A schematic diagram of single-shot EPI-DWI sequence.  
RF (radiofrequency pulse), G slice (slice selection gradient), G readout (readout gradient), G phase (phase-
encoding gradient) reproduced from (Bernstein, King & Zhou 2004b). 
 
Figure 1.6 FA directional colour maps was acquired using segmented EPI-DWI at 9.4T 
The following directional colour encoding is used: red = medial-lateral, green = rostral-caudal, blue =dorsal-
ventral. gcc (genu corpus callosum), aca (anterior commissure anterior part), acp (anterior commissure 
posterior part) f (fornix), ec (external capsule), fi (fimbria), scc (splenium corpus callosum). (Harsan et al. 
2010) 
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A combination of the segmented EPI-DWI sequence (Kim, SG et al. 1996) with a partial 
Fourier reconstruction (Frost et al. 2012) is preferred for imaging in a high magnetic field. 
Recently, such an approach has been optimized for high-resolution in vivo DWI of mouse 
brain at 9.4T (Harsan et al. 2010). This has provided high quality images, a short 
experiment time and minimal distortion artefacts. Examples of the fractional anisotropy 
colour map acquired from the segmented EPI-DWI sequence at 9.4T can be seen in 
Figure 1.6 (Harsan et al. 2010).  
1.1.4.3 Image artefacts and technical challenges of EPI-DWI 
In general, EPI is susceptible to a large number of artefacts, such as image blurring, 
Nyquist ghosting, chemical shift, magnetic field inhomogeneity and diffusion gradient eddy 
current artefacts (Le Bihan et al. 2006; Pipe 2009; Sotiropoulos et al. 2013).  
1.1.4.3.1 Geometric distortion artefacts  
Geometric distortion artefacts increase with the increasing length of the echo train and 
increased echo spacing, giving the spins more time to accumulate phase errors owing to 
the constraint of the T2* relaxation time (Andersson & Skare 2002). The major cause of 
image artefacts in a high magnetic field is the local magnetic field inhomogeneity (Zhou et 
al. 1998). This arises from the differences in the magnetic susceptibility between adjacent 
tissue structures (Le Bihan et al. 2006). This effect is worse in EPI compared to gradient-
echo and spin-echo sequences (Sotiropoulos et al. 2013). For in vivo mouse brain MRI, 
these problems appear as a pronounced signal loss and shape distortion around the air 
cavities of the jaw, ear canals and olfactory bulb, and to a lesser extent, the brain-skull 
interface (Ahrens et al. 2002). 
1.1.4.3.2 Nyquist ghosting artefacts  
Nyquist ghosting artefacts are caused by EPI gradient readout errors. To acquire echoes 
with an EPI readout, the frequency gradients alternate in polarity and these lead to 
transverse of the k-space forwards and backwards (Le Bihan et al. 2006). If the mismatch 
between the alternating gradients gives rise to phase errors, this causes ghosting in the 
phase-encoding direction to be superimposed on the original image (Fischer & Ladebeck 
1998). This problem may be improved with correction to gradient compensation. 
1.1.4.3.3 Chemical shift artefacts 
The Nyquist ghosting problem can be worsen in the presence of chemical shift artefacts. 
Chemical shift artefacts are problematic in a higher magnetic field, where the difference in 
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the resonance frequencies between fat and water increases. If the image voxel (pixel) 
resolution is smaller than the difference in the fat/water chemical shift, this results in 
misplacement of the fat and water signal (Fischer & Ladebeck 1998). This artefact can be 
minimized using EPI with high receiver bandwidth to reduce the sampling time and 
consequently the echo spacing. However, having a large bandwidth will reduce the SNR 
and this will require more averaging. The fat suppression (saturation) technique is strongly 
required with the EPI sequences (Zhou et al. 1998). 
1.1.4.3.4 Eddy currents  
Eddy currents are residual magnetic fields induced by gradient switching and can cause 
image distortion through scaling, shifting and shearing in image slices (Alexander, AL, 
Tsuruda & Parker 1997). They persist after the gradients are switched off, even in self-
shielded gradients. This residual magnetic field can be cancelled by using bipolar diffusion 
gradients that have positive and negative lobes (Le Bihan et al. 2001; Le Bihan et al. 
2006). However, this approach could be difficult to apply in a high magnetic field because 
of the requirement for high b-values and a long echo time (Mori 2007; Mukherjee, Chung, 
et al. 2008).  
1.1.4.3.5 Magnetic susceptibility artefacts  
The major cause of image artefacts in a higher magnetic field is the local magnetic field 
inhomogeneity. This arises from the differences in the magnetic susceptibility between the 
adjacent tissue structures (Yang, Smith & Wang 2006). This effect is worse in the EPI 
compared to the gradient-echo and spin-echo sequences. For the in vivo mouse brain 
MRI, these problems appear as a very pronounced signal loss and shape distortion around 
the air cavities of the jaw, ear canals and olfactory bulb, and to a lesser extent, the brain-
skull interface (Ahrens et al. 2002).  
1.1.4.3.6 Limited spatial resolution 
The attainable spatial resolution in a single-shot-EPI is limited due to signal decay through 
T2 or T2* processes (Ugurbil et al. 2013). As the magnetic field increases, the T2 and T2* 
relaxation times are reduced; therefore, the imaging sequence echo time (TE) must be 
reduced to prevent acquiring signals at the late stage of the echo when the signals would 
be significantly diminished and the image would be distorted (Rohde et al. 2004). To 
acquire higher resolution images, segmentation of the echo train length (Guilfoyle & Hrabe 
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2006) and partial Fourier reconstruction (Jesmanowicz, Bandettini & Hyde 1998) were 
shown to be useful as they shorten the imaging sequence echo time. 
 
1.1.5 Motion artefacts in diffusion-weighting imaging 
The DWI sequences are sensitive to any sort of motion, including bulk/body motions and 
molecular diffusion (Bammer et al. 2003; Bammer et al. 2009; Bammer et al. 2005; Mori & 
Zhang 2006). This is the result of adding diffusion field gradients to the pulse sequence to 
boost the sensitivity of the molecular motion at the micrometre level. This makes the 
elimination of macroscopic motion a challenging task (Mori 2007). Bulk motion may vary 
from one to the next echo, which means each echo will be affected differently as a result of 
the phase-shift. In general, subject motion during the diffusion experiment will produce a 
phase error and appear as ghosting in the resultant images (Anderson, AW & Gore 1994).  
Motion artefacts can originate from voluntary head motions (e.g. when the animal 
regaining consciousness due to low anaesthetic level), involuntary head motions (e.g. 
movement of the neck from breathing) and physiological brain motions such as systolic 
compression of the ventricles, caudal movement of the midline structures and brainstem 
and carotid artery pulsation (Greitz et al. 1992). 
Also, there are two sources of pulsation motion in the human brain that could contribute 
significantly to the quality of the acquired images that are the systolic compression of the 
ventricles and the caudal movement of the midline structures and brainstem. Carotid artery 
pulsation is another source of physiological motion that can be reduced by a 
radiofrequency saturation pulse (Greitz et al. 1992).  
The bulk motion is a significant problem when using multi-shot DWI sequences. It causes 
a phase shift that affects each interleaf differently, and results in incorrect positioning of 
each interleaf in the k-space. The phase shift in each echo in each particular interleaf will 
not be identical owing to bulk motion and the induction of diffusion effects. This will 
complicate the correction of the existing phase error (Anderson, AW & Gore 1994).   
Segmented EPI is more sensitive to bulk motion effects compared to single-shot EPI 
sequences (Brockstedt et al. 2000; Frost et al. 2012). The increasing number of 
interleaves required to fill up the entire k-space makes the sequence more prone to phase 
errors. The phase shift in each echo in each particular interleaf will not be identical owing 
to bulk motion and the induction of diffusion effects, complicating the correction of the 
existing phase error (Anderson, AW & Gore 1994).  
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Several techniques (Atkinson et al. 2000; Bammer et al. 2003; Le Bihan et al. 2006) have 
been developed to reduce the effect of bulk motion on the quality of the acquired data 
through multi-shot DWI sequences. These include navigator echoes; signal averaging and 
cardiac and respiratory triggering. The application of a pair of bipolar gradients before and 
after the 180° RF pulse was suggested to help by producing a gradient moment nulling to 
compensate for a high-order (high velocity) motion. 
Navigator echo is an efficient correction method for reducing macroscopic motion artefacts 
(Ordidge et al. 1994). The navigator sequence acquires the non-phase encoding echoes 
before or after the imaging echo to correct phase variations of the acquired imaging 
echoes (Atkinson et al. 2000; Bammer et al. 1999; Butts et al. 1996; De Crespigny et al. 
1995). In general, a variety of navigator schemes have been developed. These include the 
zeroth order phase-correction, the zeroth and first-order phase-correction in the readout 
direction, the zeroth and first-order phase-correction in both read-out and phase-encoding 
direction, and navigator imaging. The last correction technique has provided an accurate 
result, because it oversamples the centre of the k-space and works as a navigator image. 
This information is used to determine the k-space shifts so that the original image in the k-
space data is re-gridded accordingly (Atkinson et al. 2000; Bammer et al. 1999; Butts et al. 
1996; De Crespigny et al. 1995). 
Immobilizing imaging participant within a customized holder inside the radiofrequency coil 
is the first step for successful imaging. To achieve this goal for imaging mice, a general 
anaesthesia, such as Isoflurane delivered in oxygen, is administrated by inhalation. This is 
the preferred method, because it allows for continuous calibration according to the 
condition of the examined subject and the length of the experiment (Denic, Macura, et al. 
2011; Ferris, Febo & Kulkarni 2013).  
Respiratory triggering during acquisition, this serves two purposes: it is paramount to 
monitor the wellbeing of the animal in addition to reducing the propagation of motion 
artefacts in the acquired images. Sharp inhalation or exhalation or irregular patterns must 
be avoided; once the animal breathing has reached a plateau, then the MRI acquisition 
can be initiated. However, the experimental time increases by factor of approximately two 
(Anderson, SA & Frank 2007; Denic, Macura, et al. 2011; Marzola, Osculati & Sbarbati 
2003). 
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1.1.6 Non-Cartesian diffusion weighted imaging  
An alternative imaging approach to minimize the susceptibility of the diffusion imaging for 
motion artefact is a line scan, which acquire echoes without the phase-encoding step 
(Gudbjartsson, Maier & Jolesz 1997; Gudbjartsson et al. 1996). Radial (Trouard et al. 
1999) and spiral image acquiring techniques (Li et al. 1999) are the other types of imaging 
non-Cartesian k-space trajectories, which are less sensitive to motion and can be used 
with in conjunction with the DWI. They are different in the way they collect data in the k-
space. The spiral acquisition continues filling the k-space in the form of spiral trajectory 
(Bammer, Glover & Moseley 2002). On the other hand, the radial acquisition collects the 
data in radial projections as blades and each one contains echoes per repetition time (TR); 
these blades are rotating at certain angles to cover the whole k-space (Pipe, Farthing & 
Forbes 2002).  
The spiral imaging acquisition is a fast imaging technique and is broadly categorized into 
single and interleaved spirals. It has been used for various MRI applications such as 
cardiac and functional imaging (Liao et al. 1997; Meyer et al. 1992). Also, it is potentially 
useful in diffusion-weighted imaging because it provides a self-navigation approach, 
because it fills the centre of the k-space at the beginning of the scan and oversamples the 
centre origin of the k-space. Additionally, the interleaved spiral could boost the navigation 
capabilities. Indeed, spiral imaging has been competitive to other fast imaging techniques, 
because it does not require a high gradient performance system, as does the EPI (Truong 
& Guidon 2014). In the spiral, both read and phase gradients continue to change slowly 
from one gradient amplifier to another to fill the trajectory throughout the k-space. This is 
completely different to the conventional filling of the Cartesian k-space acquisition (Liu et 
al. 2004).  
Another advantage of the spiral imaging is that the T2 or T2* decaying artefacts appear as 
a symmetric blurring, instead of a blurring along a particular direction. This could be 
related to the velocity of the filling of the k-space trajectory, which is faster in spiral imaging 
compared to other techniques. On the other hand, spiral imaging is widely used as a 
research approach, because it requires gradient waveform capabilities and specific image 
reconstruction. The variable density spiral imaging is currently being developed because it 
allows oversampling the centre of the k-space (Truong & Guidon 2014; Truong, Guidon & 
Song 2014).  
Line Scan-DWI is another attractive choice for reducing phase error owing to bulk motion 
(Gudbjartsson, Maier & Jolesz 1997; Gudbjartsson et al. 1996). It is also useful in 
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examining the small field of view structures (Murphy et al. 2001). In addition, it is less 
demanding in terms of the gradient performance (Gudbjartsson, Maier & Jolesz 1997). 
However, it is limited in terms of the SNR compared with 2D imaging (Norris 2001), in 
addition it provides low-resolution images (Gudbjartsson et al. 1996). 
Radial acquisition with fast spin echo (FSE) has been recently introduced (Pipe, Farthing & 
Forbes 2002); it is less sensitive to bulk motion because of its navigation capabilities. Also, 
the incorporation of FSE with radial acquisition yields images with less distortion and 
speeds up the acquisition of the data. However, the FSE-DWI is highly susceptible to 
signal instabilities and the radial acquisitions require the re-gridding of the acquired data 
before performing a Fourier reconstruction (Trouard et al. 1999).  
 
1.1.7 Optimisation of diffusion-weighted imaging acquisition parameters  
1.1.7.1 Selection of the appropriate b-value  
This is still a controversial issue; if the b-value is too small, this will result in too small a 
signal attenuation, because detecting small displacements of the diffusion molecules and 
the consequently signal decay is not accurate. In general, the b-value is directly 
proportional to the signal attenuation (Mori 2007, 2014). Optimizing the b-value is critical, 
because it depends on the diffusion constants of the sample and the amount of the 
acquired signal-to-noise ratio; for example, in clinical practice, the b-value is in the range 
of 600–1200 s/mm2 selected according to the diffusion constant of the brain tissues. 
Indeed, the b-value is controlled by the diffusion gradient duration (δ) and the separation 
(Δ) in addition to the gradient strength. As described in Section 1.1.3 Figure 1.2, to 
increase the b-value, either δ or Δ should lengthen, which means increasing the echo time 
(TE). However, the signals decay through T2 relaxation time due to lengthening of TE. 
Therefore the optimization of δ/Δ is constrained by the echo time in which the minimum 
echo time should be used to accommodate the diffusion gradients (Mori 2007, 2014).  
Another way of obtaining a high b-value is by increasing the gradient strength. However, 
this will increase the demands on the gradient’s performance and may result in inducing 
an eddy current, which can degrade the image quality. Nevertheless, it is the preferred 
choice in a high magnetic field and this problem has reduced significantly with the 
development of new gradients systems (Tournier, Mori & Leemans 2011).  
Most in vivo diffusion tensor micro-imaging studies have used the b-value in range of 700 
to 1000 s/mm2 to image the mature mouse brain and spinal cord (Wu, D et al. 2013; Wu, 
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QZ et al. 2007; Xie et al. 2010), whereas for the ex vivo mouse brain studies, they used 
the b-value in the range of 1500–2000 s/mm2 (Mori et al. 2001; Zhang, J et al. 2012; 
Zhang, J et al. 2005). The higher b-value is recommended when performing the DWI 
experiment on an ex vivo sample. This assists in overcoming the reduction of the diffusivity 
owing to the formalin fixation sample temperature alterations (Kim, JH et al. 2007; Sun, S, 
Liang, HF, et al. 2006).  
The diffusion compartments can be divided into two categories, fast and slow diffusion 
compartments. The fast diffusion compartments are usually located in the extracellular 
space, such as the extra-axonal structures, and exhibit Gaussian diffusion decay. The 
slow diffusion compartments are expected to be in the intracellular space, such as the 
intra-axonal structures, whereby the diffusion is highly restricted (Le Bihan 2014; Tournier, 
Mori & Leemans 2011). To resolve these two compartments, a high b-value is 
recommended. For high-angular resolution-diffusion imaging (HARDI) approaches, high b-
values are required in the range of 2000–4000 s/mm2 (Sotiropoulos et al. 2013). However, 
there is still no fixed consensus in the literature for the optimum b-value. More importantly, 
in addition to resolving the deviations in the Gaussian diffusion, the HARDI acquisition with 
a high b-value is useful for defining multiple-fibre populations and orientations, such as 
crossing fibres (Calamante, Fernando et al. 2012; Wu, D et al. 2014).  
1.1.7.2 Number and distributions of the diffusion gradients  
Determining the number and distributions of the diffusion gradients is not straightforward; 
however, they have to be uniformly distributed in the space. Several simulation studies 
have shown improvements in the estimation of the acquired fractional anisotropy map from 
the diffusion tensor, because the orientation of the diffusion gradients are increased up to 
30 orientations or more; this increases the accuracy of determining the diffusion direction. 
This means that the maximum number of diffusion encoding orientations should be 
acquired within the allowable experimental time (Seunarine & Alexander 2009).  
There is another related question, which is more advantageous to improve data quality, 
either repeating the multiple diffusion gradients of the same orientations or applying 
multiple directions. Repeating multiple directions is better for the motion correction in the 
acquired images, but it will not help in resolving crossing fibres (Tournier, Mori & Leemans 
2011).  
According to Moldrich et al., when the DWI data was acquired three-dimensionally at a 
high isotropic resolution (100 micron) and a high b-value (5000 s/mm2), there was no 
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distinct difference in the HARDI with 30 or 64 gradients directions in the tractography 
information of an ex vivo mouse brain. But the experiment time had increased by factor of 
two (Moldrich et al. 2010).  
In this section, several aspects of diffusion-weighted imaging experiments have been 
discussed. The next section is designed to explain how the directionality of the diffusion 
molecules can be exploited to assess the integrity of the anatomical structures. These 
include parametric indices of the diffusion tensor and fibre tractography.  
 
1.1.8 Diffusion tensor imaging (DTI) parameters  
DTI acquisition requires a minimum of six orthogonally encoded DW images and one 
unweighted image. From these measurements, three eigenvectors (v1, v2, v3) and their 
rotational invariant eigenvalues (λ1, λ2, λ3) can be derived to describe the diffusion tensor 
(Mori & Tournier 2014). From the diffusion tensor, several parameters can be derived 
(Winston 2012). These parameters are used to describe the dimensions and shapes of the 
diffusion ellipsoid depicted to define the anisotropic diffusion, as it has been depicted in 
Figure 1.1, section 1.1.3. The largest eigenvector (v1) and its association eigenvalues (λ1) 
represent the magnitude and direction of the major diffusion vector and reflect the 
orientation of the axonal fibre bundle (Mori & Van Zijl 2002; Mori & Zhang 2006). This can 
be exploited in the fibre tractography reconstruction in extracting the major fibre 
orientation. The λ1 refers to the longitudinal diffusivity and is known as the axial diffusivity, 
because it specifies the rate of diffusion along the main direction. On the other hand, the 
second and third eigenvectors are orthogonal to the major diffusion direction and their 
eigenvalues provide the diffusion measurement transverse direction. The mean of λ2 and 
λ3 is known as the radial diffusivity (Stieltjes et al. 2013).  
In addition to the axial and radial diffusivity, other rotational invariant diffusion metrics can 
be derived from the three eigenvalues, which include the mean diffusivity and the fractional 
anisotropy (Zhang, J 2010). Mean diffusivity (MD) describes the average of diffusivity 
components within each voxel (Zhang, J, Aggarwal & Mori 2012). It can be calculated from 
the mean of the three eigenvalues to determine the average of the diffusivity within each 
voxel, according to the following equation:  
                                                                                    𝑀𝐷 = λ!!  λ!!  λ!!                                    (5) 
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Fractional anisotropy (FA) is a sensitive indicator for microscopic changes of diffusion, 
because it indicates the degree of the directionality of the intra-voxel diffusivity and can be 
defined by the following equation:  
                                 𝐹𝐴 = 𝝀𝟏!  𝝀𝟐 !! 𝛌𝟐!  𝛌𝟑 !! 𝛌𝟑!  𝛌𝟏 !! 𝝀𝟏!!𝝀𝟐!!𝝀𝟑!     (6) 
The FA determines the shape of the diffusion ellipsoid, for example when the major 
eigenvector (e1) is larger than the second and the third eigenvector, this can be 
represented as prolate or cigar shape; therefore, the main direction of the diffusion can be 
indicated by the long axis of the ellipsoid (Ito, Mori & Melhem 2002; Mori et al. 1999). FA 
values in WM are generally higher than in GM due to increased diffusion directionality of 
the myelin axon bundles (Mori & Tournier 2014). Relative anisotropy (RA) also indicates 
the degree of the directionality of the diffusivity. The FA and RA are mostly equivalent, but 
they are differing in the mathematical calculation. However, the FA is more widely used in 
the DTI literature (Aung, Mar & Benzinger 2013; Mukherjee, Berman, et al. 2008). 
Example of estimating diffusion measurements from diffusion tensor can be seen in    
Figure 1.7.  
 
Figure 1.7 Schematic diagram of estimating diffusion measurements. 
(A) The diffusion measurements are estimated from multiple directions and fitted within the ellipsoid shape. 
(B and C) indicate the major orientation and the two perpendicular directions. (D) FA map represents the 
diffusion patterns where the hyper-intense signals represent the highly ordered structures (anisotropic 
diffusion) and the hypo-intense signals refer to randomly distributed diffusion (isotropic diffusion). The colour 
coded orientation map (E) is produced by combining the FA map (D) and the orientation converter (F). 
(reproduced from Mori & Zhang 2006). 
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1.1.8.1 DTI fibre tracking 
In each voxel, it is assumed that the directional of the axonal tract is parallel to the 
principle direction of the eigenvector derived from the diffusion tensor. In this case, the 
fibre can be tracked from voxel to voxel to determine the connected brain areas. These 
fibre tracks are usually overlaid on the anatomical images; due to lower the resolution of 
the diffusion weighted images (Mori & Van Zijl 2002; Mori & Zhang 2006).  
In general, fibre tracking is broadly divided into two categories, the deterministic and 
probabilistic methods. The common DTI deterministic tractography is the FACT (fibre 
assignment continuous tractography). In this technique, the fibre tracking is initiated from 
the defined voxel and continues propagating until it reaches the next voxel and continues 
as it matches the primary eigenvector (Behrens, Timothy E. J., Sotiropoulos & Jbabdi 
2014). Two constraints parameters are usually applied to prevent the induced error in the 
fibre tracking; they are the turning angle and the minimum FA (fractional anisotropy). This 
technique can generate one reconstructed trajectory (Mori & Zhang 2006; Tournier, Mori & 
Leemans 2011).  
On the other hand, probabilistic tractography, in which the propagation of large number of 
fibres is initiated from the determined seed points and multiple fibres passing through the 
destination, could be generated. Indeed, this can estimate the neuronal fibres based on 
the FA, Bayesian model or bootstrap statistics. Therefore, it generates more disperse 
trajectories compared with deterministic tracking (Behrens, Timothy E. J., Sotiropoulos & 
Jbabdi 2014). Figure 1.8 shows some differences between deterministic and probabilistic 
tractography.  
1.1.8.2 DTI limitations   
The DTI can completely define the Gaussian distribution of the water diffusion; however, it 
has several technical challenges. First, it cannot delineate the complex fibre architecture, 
because it defines only the major eigenvector; therefore, it fails in the case of presenting 
multiple fibres (Tournier 2008; Tournier, Calamante & Connelly 2012). In addition, in the 
case of using a high b-value, the attenuation of the signal raised from the intra-axonal 
components could have impacts on the acquired diffusion measurement, but it cannot be 
defined by the DTI approach (Tournier, Mori & Leemans 2011). 
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Figure 1.8  Example of deterministic (A) and probabilistic (B) tractography.  
The white lines in (A) show the fibre tract pathways, which were reconstructed, based on the principle 
diffusion direction. Blue box represents the crossing fibres in the adjacent anatomical structures. (B) 
Probabilistic tractography provides information about the precision and dispersion of multiple 1000 fibres 
lines (white box) associated with the tract reconstruction. Reproduced from (Tournier, Mori & Leemans 
2011).  
 
1.1.8.3 Non-tensor diffusion models 
The diffusion tensor imaging (DTI) does not provide an accurate estimation of the 
orientation fibre bundle in the voxel containing several fibre bundles (Behrens, T et al. 
2007; Behrens, T E. J. & Jbabdi 2009; Tuch, D.S. et al. 2002; Tuch, D. S. et al. 2003). 
Approximately one third of the white matter fibre bundles in the imaging voxel have more 
than one fibre population (Behrens, T et al. 2007; Behrens, T E. J. & Jbabdi 2009). This 
has negative impacts on the acquired DTI tractography, because most of the major tracts 
in the brain pass through the regions containing multiple fibres and this consequently will 
generate unreliable tracking results (Pierpaoli et al. 2001).  
Several reconstruction approaches have been developed to overcome the DTI problems. 
Examples of these techniques are Q-ball imaging (Corbo et al. 2014; Tuch, D. S. 2004) 
diffusion spectrum imaging (DSI) (Wedeen et al. 2005) and CHARMED (combine hindered 
and restricted models of water diffusion) model (Assaf et al. 2004). All these approaches 
have significant inherent limitations, which are a large b-value and their difficulty for in vivo 
applications studies owing to a lowering SNR. In addition, the DSI and CHARMED require 
a large number of diffusion encoding directions and this significantly increases the 
experiment time (Tournier, Mori & Leemans 2011).  
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Another developing approach is the PAS-MRI (Persistent Angular Structure), which 
requires an intensive computing procedure; therefore, it could not be practical for clinical 
studies (Jansons & Alexander 2003).  Diffusion orientation transform is another proposed 
approach, it is basically a relay on the mono-exponential signal decay and therefore it is 
not valid for high b-values that show a bi-exponential diffusion components profile (Cohen 
& Assaf 2002). On the other hand, the Constrained Spherical Deconvolution is based on 
estimating the fibre orientation distribution (FOD) function, because it allows resolving 
crossing fibres separated by small angles. This will assist in providing a reliable tracking 
result (Tournier 2007, 2008; Tournier, Calamante & Connelly 2012).  
 
1.2 Introduction to multiple sclerosis (MS)  
Multiple sclerosis (MS) can be defined as a chronic inflammatory demyelinating disease of 
the nervous system (Figure 1.9) (Khan & Smith 2013; Lassmann, H. 2013). Early 
indications of MS associated symptoms include loss of balance, fatigue, muscle spasms 
and dizziness, which can progressively develop to complete immobility (Trapp & Nave 
2008). Unlike dementia and Alzheimer’s disease that affect the older population, MS can 
cause clinical disability in the young adult population (Lassmann, H. 2013; Trapp & Nave 
2008).  
According to the MS Research Australia website (http://www.msra.org.au/living-ms), 
23,000 people in Australia have been diagnosed with MS and 2.5 million globally in recent 
years (Campbell et al. 2014). The incidence of the disease increases by 7% annually, with 
the total cost of health care in Australia for MS patients being approximately $2 billion 
dollars.  
The major cause of MS remains unresolved, as the exact pathobiological mechanisms are 
not fully understood (Lassmann, H. 2013). However, multiple factors including genetic, 
gender, ethnic and environmental factors have been suggested to increase higher disease 
susceptibility to MS (Hauser, Stephen L, Chan & Oksenberg 2013). For example, the gene 
Human Leukocyte Antigen (HLA) DR2 and/or DW2 is associated with an increased risk of 
developing MS in the European Caucasian population (Shivane & Chakrabarty 2007), with 
a higher incidence of HLA-DRB1*15-positive genotypes have been reported in females 
patients (Chao et al. 2011).  
MS is considered as an inflammatory demyelinating disease resulting in disruptions of 
nerve conduction and neurotransmission (Khan & Smith 2013). The disease initiates with 
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inflammation and damage to the myelin structure that normally provides protection and 
conductivity for the axons of the brain and spinal cord. Once myelin is destroyed, it is 
replaced by hardened sclerotic patches of tissue, known as sclerotic plaques. 
Inflammation might be a central driving force of neurodegeneration in all stages of MS and 
could play a major role in the disruption of the blood brain barrier (Figure 1.9) (Lassmann, 
H. 2013; Trapp & Nave 2008). 
 
Figure 1.9 Schematic diagram of pathology changes to nerve fibre during MS development.  
This diagram shows normal nerve fibre (1), demyelinated axonal fibre (2) (blue arrows); demyelination of 
axon could lead to axonal transaction. In this nerve fibre (3) the distal part is transacted while the proximal 
part is preserved (red arrows). Reproduced from Trapp & Nave 2008. 
 
Using MRI, MS plaques are commonly observed in several areas of the brain typically in 
the white matter (Filippi et al. 2012; Ontaneda, Hyland & Cohen 2012). Highly susceptible 
areas are the optic nerves, periventricular area, corpus callosum, cerebral peduncle and 
spinal cord (Bammer & Fazekas 2002; Filippi & Rocca 2011). According to several post-
mortem studies (Bo, L. et al. 2007; Kutzelnigg, A. et al. 2005; Pitt et al. 2010; Schmierer et 
al. 2010) and recent MR imaging studies (Calabrese, M. et al. 2011; Chen, WC, Foxley & 
Miller 2012; Wharton & Bowtell 2012; Yablonskiy et al. 2012) MS lesions are also present 
in grey matter. In addition, cortical lesions (Geurts, JJG, Bo, et al. 2005; Geurts, JJG, 
Pouwels, et al. 2005) have been detected by MRI with novel neuroimaging techniques, 
either imaging at ultra-high field (Figure 1.10) or utilising phase sensitive inversion 
recovery MRI (Calabrese, M. et al. 2011; Filippi, Absinta & Rocca 2013; Geurts, JJG, 
Pouwels, et al. 2005; Pitt et al. 2010; Sethi et al. 2012).  
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Conventional MRI contrast weighting methods such as inversion recovery, T1, T2 and T2* 
have been used widely to detect MS pathology, however, they are non-specific in 
describing the progression of neural degeneration (Filippi et al. 2012). More advanced MR 
imaging methods have been developed to address these issues: (1) A combination of high 
field scanners (≥7 T) for human (Sinnecker et al. 2013) and for rodents (≥9.4T)  (Aharoni 
et al. 2013) and novel contrast agents such as ultra-small iron oxide particles (USPIOs) 
have enabled better detection of early MS changes in the CNS as well as observation of 
small lesions within the subcortical layers (Dousset et al. 2006). (2) Magnetization transfer 
imaging (MTI) has been developed to probe myelin sheath integrity, especially in 
conjunction with voxel-based analysis to monitor lesion evolution in patients (Chen, JT et 
al. 2008). (3) Susceptibility-weighted imaging (SWI) is highly sensitive to tissue iron 
content. This sensitivity has been successfully exploited in detecting the presence of iron-
rich macrophages and vascular abnormalities during disease progression (Hammond et al. 
2008). (4) Diffusion-weighted imaging (DWI) techniques have been used for early 
detection of subtle changes in white and grey matters that appear normal in T1 and T2-
weighted scans, while DTI fibre-tractography can reveal deficits in brain connectivity 
(Pantano 2013). DWI methodology is becoming increasingly important as diffusion 
parameters, fractional anisotropy (FA) and axial/radial diffusivity measures are central to 
the assessment of MS pathology due to their specificity in detecting demyelination, axonal 
damage and injury (Ge, Law & Grossman 2006). 
1.2.1 Clinical presentation of MS stages 
The clinical presentations of MS are heterogeneous and vary according to the disease 
stage (McDonald et al. 2001; Polman et al. 2011; Polman et al. 2005). MS plaques or 
lesions could affect specific anatomical structures such as the optic nerve, brainstem or 
spinal cord, for approximately 85% of the MS patients. Such conditions are known as the 
clinical isolated syndrome (CIS) that may develop or evolve during the MS attack and 
change its pattern. In such case, the patient condition may be exacerbated within a period 
of several days, but subsequently stabilized and improved. This reversal process is 
described as a course of relapsing remitting (RR) MS (Filippi & Rocca 2011). RR MS is 
characterized clinically by existence of partial or complete inflammatory demyelination as 
well as formation of new white matter lesions (Lassmann, H. 2008, 2013). This is 
accompanied by a variable degree of acute axonal injury and loss, which could be followed 
by remyelination in most cases (Trapp & Nave 2008). 
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 RR MS, however, may further develop where the disease patterns are changing with the 
increasing relapsing status in addition to the progress of nervous system dysfunctions, this 
condition that could lead to a secondary progressive MS course (Lublin & Reingold 1996; 
Pandey et al. 2014). Once the disease is developed by the steady progression pattern 
from the onset without a clearly defined relapse, this course can be described as primary 
progressive MS, which may affect approximately 15% of the patients (Miller, DH & Leary 
2007). 
During the progressive phase; formation of new demyelinated lesions are rare but there 
are other developing pathological changes, which include diffuse atrophy of both white and 
gray matter, in addition to detecting obvious changes in the normal appearing white matter 
(Lassmann, H., Bruck & Lucchinetti 2007). However, 10% to 20% of MS patients are 
experiencing benign MS, which is described by modest neural dysfunction, or no 
disabilities long time such as absence of activity restrictions for normal employment 
(Gafson, Giovannoni & Hawkes 2012; Hawkins & McDonnell 1999). All the medical 
interventional treatment should be given earlier to avoid developing irreversible 
neurological dysfunction and definitely chronic stage (Miller, DH & Leary 2007). 
 
 
Figure 1.10 Double inversion recovery (DIR) imaging for detecting MS lesions at 1.5 Tesla.  
Two relapsing remitting MS patients (A) and (B). DIR sequence reveals intracortical lesions (Red arrows) in 
addition to white matter lesion or mixed cortical juxtacortical lesions (white arrowheads).  Data were acquired 
using fast spin echo (FSE) sequence; repetition time (TR) and echo time (TE) 15631/25 msec; inversion 
time: 3400 msec; second inversion time: 325 msec; echo train length: 17. Reproduced from Calabrese et al. 
2011. 
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1.2.2 Microstructural changes in MS  
There are several histopathological hallmarks in the MS plaques, but the major changes 
include the perivascular inflammation, oedema, demyelination, gliosis and axonal loss 
(Bammer & Fazekas 2002; Kermode et al. 1990). The disruption of the blood brain barrier 
(BBB) is an early indicator of inflammation, which could probably precede the 
demyelination (Lassmann, H. 2008, 2013). Earlier, before the BBB breakdown, 
autoimmune T-cells enter the CNS and initiate the cytokine cascade (Cramer et al. 2014). 
This process affects the integrity of the endothelial cells, resulting in the opening of the 
BBB. The interaction of the immune competent cells with the endothelial cells will cause 
the disruption of the BBB, making it permeable to foreign bodies. Consequently, more 
lymphocytes can penetrate the CNS and cause vasogenic oedema (shifting of water from 
the intravascular to the extra-vascular compartments) (Larochelle, Alvarez & Prat 2011). 
The major hallmark of MS is a demyelination, which can be defined as the destruction of 
the normal myelin sheaths compartment. Demyelination can be either primary or 
secondary. In primary demyelination, the myelin sheaths are injured fragmented and 
become loosely wrapped to the axons. During the secondary stage, the loosening of the 
myelin continues, leading to axonal injury and accelerated axonal loss. This condition is 
mostly appreciated in the case of trauma, viral infection and toxic encephalitis (Shivane & 
Chakrabarty 2007). The demyelinated plaques can interact with infiltrating lymphocytes; 
either T or B cells, in addition to activated macrophage or microglia to cause a further 
cascade of the inflammation process. In some cases, the oligodendrocytes assist in 
remyelination within chronic MS lesions (Inglese, M. 2006).  
Several pathological studies (Kidd et al. 1999; Peterson et al. 2001) have reported that MS 
is not only a demyelinating disease. Hence, the detection of the demyelination mechanism 
alone is not sufficient for describing or relating the development of the neurological 
abnormalities. Other pathological processes such as axonal damage and transection 
within MS lesions have been detected in several pathological studies (Ferguson et al. 
1997; Trapp & Nave 2008; Trapp et al. 1998). Also, it has been observed (Lassmann, H., 
Bruck & Lucchinetti 2007) that demyelination is the driving force during the early stage 
where as neurodegeneration processes control the progressive stages independent from 
inflammation (Zamvil & Steinman 2003). 
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1.2.3 Animal models of MS 
Experimental animal models are used to investigate and gain insights into the 
pathobiology of complex human diseases (Anderson, SA & Frank 2007). These models 
usually target a specific aspect of the disease rather than attempting to replicate the full 
spectrum of the corresponding human disease (Altmann & Boyton 2004). Although an 
enhanced understanding of particular aspects of disease can be gained from in vitro and 
ex vivo experimentation, in vivo experiments in animals are required to gain insight into the 
inter-relationships of multiple factors that contribute to complex pathobiological changes, 
such as the relationship between neurodegeneration and MS progression (Mix et al. 
2010). Research on MS pathobiology has relied upon conventional diagnostic imaging, 
involving experimental animal sacrifice for histological analysis at varying times throughout 
the disease course. However, as most pathological processes during the course of MS are 
dynamic, monitoring of disease progression requires longitudinal studies (Mackenzie-
Graham, A. 2012). MRI has played an increasingly pivotal role as a non-invasive imaging 
modality allowing longitudinal imaging of MS disease progression (Anderson, SA & Frank 
2007; Pirko et al. 2005). 
Rodent models have been developed to study the process of inflammation and 
demyelination associated with MS in the central nervous system. The most commonly 
used models are experimental autoimmune encephalomyelitis (EAE), Theiler’s murine 
encephalitis virus infection (TMEV) and toxic demyelination models (Mix et al. 2010). 
There is no single animal model that can faithfully reproduce all the pathological aspects of 
MS in humans. The available models complement each other to enable investigation of 
various features commonly observed in the human condition (Denic, Macura, et al. 2011). 
1.2.3.1 Experimental Autoimmune Encephalomyelitis (EAE) 
Since its introduction by Rivers et al. in 1930 (Rivers, Sprunt & Berry 1933) EAE has 
become a widely used animal model for multiple sclerosis. It can be induced in several 
mammalian species, including the mouse, rat and primate (Steinman & Zamvil 2006). 
Induction of EAE is achieved by an injection of an emulsion comprising an adjuvant and 
synthetic peptides derived from myelin proteins, such as myelin oligodendrocyte (MOG), 
myelin basic protein (MBP) or the proteolipid protein (PLP). Alternatively, adaptive or 
transfer EAE can be induced in mice by T cell transfer from EAE donors to native 
recipients and EAE will be produced without further immunization (Pettinelli & McFarlin 
1981). In most cases, EAE immunization will result in the activation and expansion of the 
peripheral antigen specific T-cells, which can penetrate the blood-brain barrier (BBB) and 
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interact with specific myelin antigen inducing MS (Denic, Johnson, et al. 2011). In addition 
to inflammation and demyelination, EAE is used to study acute and chronic axonal injury. 
In the EAE model, macrophages have been suggested to play a vital role in inducing 
axonal injury, although this has not been definitively confirmed (Howe & Rodriguez 2005).  
 
The course of the EAE model of MS disease varies depending on the immunisation 
protocols, as well as the choice of animal species and strain (Kipp et al. 2012). There are 
three types of adjuvants included in immunization protocols used to induce EAE: Quil 
Adjuvant (A), complete Freud’s adjuvant (CFA) and pertussis toxin (PT), (Pachner, AR 
2012; Simmons et al. 2013). A mild EAE model with a relapsing remitting (RR) cycle 
followed by a complete recovery period can be induced using MOG35-55 (myelin 
oligodendrocyte glycoprotein peptide sequence 35-55) and Quil A, which acts locally at the 
site of immunisation (Peiris et al. 2007). CFA is an adjuvant prepared from killed 
mycobacteria in water and oil emulsion (Pachner, AR 2012). Chronic EAE model is 
induced by injection of MOG35-55 with CFA, which slowly releases the antigen from the 
injection site (Hart & Amor 2003). The role of PT is unclear, but it is thought to help the 
initiation of EAE by opening the blood-brain barrier (BBB) allowing the migration of 
immune cells into the CNS. PT is required to initiate T cell and B cell immune reactivity to 
the antigen but it does not, by itself, produce EAE (Richard et al. 2011). Severe EAE 
models, however, should be avoided as confounding factors can influence the assessment 
accuracy of potentially effective treatments (Denic, Johnson, et al. 2011). The acute phase 
of EAE induction is associated with mononuclear cell infiltration into the CNS, followed by 
a recovery (remission) period or progressively relapsing in the chronic stage. If the animal 
has not recovered, the chronic stage is reached (Figure 1.11). Clinical scores for rodent 
models of MS commonly use a scale from 0 to 4, which correspond with no clinical 
symptoms to severe or flaccid limb paralysis (Kipp et al. 2012). 
The limitation of EAE-rodent models is that they do not adequately mimic the 
immunopathology of MS in human patients (Denic, Johnson, et al. 2011). CD4+ T-cells 
predominate in EAE CNS lesions (Hauser, S.L. et al. 1986) but without the predominance 
of CD8+ T-cells and macrophages, which are found in human MS lesions (Neumann et al. 
2002). Nevertheless, various EAE rodent models of MS have increased collectively 
understanding of the immunopathology aspects of MS. This approach led to FDA (The US 
Food and Drug Administration) approval of MS therapeutic drugs including glatiramer 
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acetate, mitoxantrone and natalizumab (Denic, Johnson, et al. 2011; Simmons et al. 2013; 
Steinman & Zamvil 2006). 
 
 
Figure 1.11 A clinical course spectrum of EAE mouse models. Immunisation of mice with myelin 
antigens produced an EAE cycle with a characteristic time-dependent pattern of disease severity.  
(A) Acute EAE followed by remission, (B) chronic EAE without recovery, (C) Relapsing-remitting EAE where 
animals developed relapses and remissions with accumulated neurological deficits. Note that the authors 
measured the clinical scores based on the paralysis of the hind limbs. (D) Adding anti-myelin antibodies at 
10 days post EAE-immunization results in exacerbated clinical scores (dotted line). Luxol fast blue histology 
revealed increased axonal damage as well as myelin loss (F) compared with control animals (E). The arrow 
in (F) points to remnants of myelin (Kipp et al. 2012). 
 
Glatiramer acetate can be used to reduce the frequency of relapses; in addition, it may 
slow the progression of neurological disabilities (Arnon & Aharoni 2004; Cross & Naismith 
2014). Mitoxantrone is an antineoplastic agent that can slow the progression of the 
secondary progressive MS and extend the time between each relapse (Martinelli 
Boneschi, F. et al. 2005; Martinelli Boneschi, Filippo et al. 2013). In addition, Natalizumab 
shows promise in minimizing the neurological disabilities associated with MS, such as the 
visual loss (Kappos et al. 2013; Ransohoff 2007). However, in some cases the EAE model 
may not be the most accurate predicator of response to the MS treatment due to 
difference in the fundamental pathological aspects of EAE and MS (Denic, Johnson, et al. 
2011; Nathoo, N, Yong, V  & Dunn, J 2014).  
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1.2.3.2 Virus-induced demyelination model 
In the 1980s, it was suggested that a combination of a certain genetic background and a 
viral infection could increase the risk of developing MS (Kurtzke 1980; Poser 1986), 
although at that time, there was no virus identified to potentially induce MS. More recently 
(Ascherio & Munger 2007; Ascherio et al. 2001; De Jager 2012), correlation of EBV 
(Epstein-Barr Virus) infection with MS suggests EBV as a potential environmental factor. 
These findings have led to the development of MS animal models using viral induction. 
The common model is the TMEV (Theiler’s murine encephalomyelitis virus), which is 
induced by an intra-cerebral injection of TMEV into susceptible mouse strains. TMEV 
pathology is limited to the CNS with an extensive spinal cord lesion (Rodriguez, Oleszak & 
Leibowitz 1987).  
TMEV infection can be highly or less virulent, for example, the immunisation of TMEV GD-
VII strain produced fatal encephalitis, whereas the BeAn’s and Daniel’s TMEV strains are 
less virulent (Zoecklein et al. 2003). The TMEV model is suggested to be superior to the 
EAE model for assessment of treatment efficacy due to better correlation with clinical MS 
(Nelson, A, Bieber & Rodriguez 2004). An example of successful application of the TMEV 
model is in the development of anti-glatiramer acetate antibodies as a remyelination agent 
(Ure & Rodriguez 2002).    
TMEV can be used to produce a mono- or a bi-phasic MS disease course in susceptible 
mice. During mono-phasic disease, mice experience transient meningo-encephalomyelitis 
that peaks by approximately seven days with recovery during a three-week period (Dal 
Canto et al. 1996). The mono-phasic disease course is characterized by animal recovery 
in the absence of persistent neurological impairments. In the case of the bi-phasic disease 
course, it begins with a mono-phasic stage that subsequently develops into a chronic 
demyelination stage (Katz-Levy et al. 1999). MS lesions are commonly observed in the 
spinal cord, akin to the EAE model (Altmann & Boyton 2004; Dal Canto et al. 1996; Miller, 
RH, Fyffe-Maricich & Caprariello 2013). 
In most cases, TMEV can produce chronic progressive MS, which mirrors progressive MS 
in humans. The TMEV mouse model offers several advantages; it is potentially able to 
mimic human MS, in addition to modelling the autoimmune response (Pachner, AR 2012). 
It also allows investigation of the role of viral infection in the aetiology of MS and the 
worsening of MS clinical symptoms (Compston & Coles 2008; De Jager 2012; Miller, RH, 
Fyffe-Maricich & Caprariello 2013; Nelson, A, Bieber & Rodriguez 2004). 
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1.2.3.3 Toxin-induced demyelination model 
Mouse models using toxin-induced demyelination have been developed, not to mimic MS, 
but to establish and investigate the process of demyelination and remyelination (Kipp et al. 
2009). Two toxins are generally used to induce demyelination, viz lysolecithin and 
cuprizone. Lysolecithin is an activator of phospholipase and cuprizone is a copper chelator 
(Blakemore & Franklin 2008). Lysolecithin acts as a detergent on the myelin sheath, rather 
than having a secondary effect on oligodendrocyte (Denic, Johnson, et al. 2011). On the 
other hand, a cuprizone-induced copper deficit is thought to be detrimental to 
mitochondrial function in the brain. This will disturb the energy metabolism in the 
oligodendrocyte and cell function and consequently lead to demyelination (Kipp et al. 
2009).  
The injection of 2 µl of 1% lysolecithin into the rodent spinal cord will produce focal areas 
of demyelination (Bieber, Kerr & Rodriguez 2003). This model has been successfully 
applied in both rats and mice. During the acute stage, spinal cord lesions are 
characterized by infiltrating T cells, B cells and macrophages and according to Bieber et al, 
T cells are essential for the remyelination process (Bieber, Kerr & Rodriguez 2003). In 
general, the lysolecithin-induced toxin model can produce a minimum chronic lesion and 
full remyelination occurs within five to six weeks. If the experimental animals are young, 
the repair process may occur rapidly (Shields et al. 1999).    
Cuprizone is the most frequently used toxin to study demyelination in mice (Kipp et al. 
2009; Rodriguez 2008). Conventionally, the addition of 0.2% cuprizone in the diet of young 
adult mice for four to five weeks (acute) or 12 weeks (chronic) will produce focal 
demyelinated lesions within several white matter structures, including the corpus callosum, 
internal capsule, cerebral peduncles, anterior commissure and thalamic white matter (Kipp 
et al. 2009; Rodriguez 2008). Once the cuprizone is removed from the diet, the mice will 
progressively develop remyelination within three to four weeks (Miller, RH, Fyffe-Maricich 
& Caprariello 2013). The toxin model is potentially reproducible and hence useful for 
testing novel therapeutic approaches that can suppress demyelination and accelerate 
remyelination (Matsushima & Morell 2001; Miller, RH, Fyffe-Maricich & Caprariello 2013). 
Table 1-3 summarizes commonly used rodent models of MS and their clinical features 
(Matsushima & Morell 2001; Miller, RH, Fyffe-Maricich & Caprariello 2013).  
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Table 1-3 Summary of the type and clinical features of rodent models of MS 
Animal models 
of MS 
Method of 
induction 
Clinical significance and severity Reference 
EAE MOG35-55+ CFA Chronic relapsing course without 
recovery	  
(Denic, Johnson, et al. 
2011) 
EAE MOG35-
55+Pertussis 
Toxin+ Quil 
Adjuvant 
Relapsing remitting 
(demyelination/remyelination) with 
complete recovery 
(Peiris et al. 2007) 
Virus-induced 
demyelination 
TMEV Monophasic stage (relapsing for seven 
days and recover within three weeks) or 
bi-phasic (mono-phasic with chronic 
demyelination) 
(Nelson, A, Bieber & 
Rodriguez 2004) 
Toxin-induced 
demyelination 
Cuprizone Acute or chronic demyelination during the 
cuprizone diet followed by remyelination	  
(Kipp et al. 2009) 
Toxin-induced 
demyelination 
Lysolecithin Acute demyelination followed by 
remyelination 
(Bieber, Kerr & 
Rodriguez 2003) 
 
1.2.4 Clinical diagnosis and assessment of MS in clinical patients  
1.2.4.1 Evoked potential (EP)  
The EP is an electrical potential that can be recorded from the central nervous system by 
exposing the subject to a presented stimulus such as a flashing light. The EP response is 
distinct from the spontaneous potential detected by the electrophysiological methods, such 
as the electro-encephalography (EEG) or electromyography (EMG) (Schlaeger et al. 
2012). In the case of acute demyelination, there is increase in the current leakage at the 
inter-nodal membrane and a significant depolarization at the next node of the Ranvier. 
Consequently, the threshold of the action potential is increased, severely affecting the 
conductivity of the neuronal transmission (Ziemann et al. 2011). The EP can be used as 
an effective biomarker to measure axonal demyelination and degeneration within the 
central visual and motor pathways (Schlaeger et al. 2012; Schlaeger et al. 2014). The EP 
can also be used to assess axonal changes within the auditory and somatosensory areas, 
but the observed diagnostic sensitivity is low (Jung, Beyerle & Ziemann 2008; Schlaeger et 
al. 2012).  
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1.2.4.2 Cerebrospinal Fluid (CSF) analysis  
CSF is the only test that can prove the chronic inflammatory nature of the disease and 
exclude other infectious causes (Tumani et al. 2009). However, there are no single CSF 
biomarkers that can specifically determine the MS. CSF is the closest fluid to the central 
nervous system that is accessible and can be collected and analysed. Assessing of the 
CSF at the cellular and molecular level provides distinct surrogate markers for monitoring 
the interventional treatment (Freedman et al. 2005).  
The MS biomarkers from the CSF can be classified according to their role in the 
inflammation, demyelination, axonal destruction and activation of the astrocyte and gliosis 
(Ziemann et al. 2011). An example of the demyelination indicator is the presence of the 
myelin basic protein (MBP) within the CSF; this can be an indicator of the myelin damage, 
because the MBP is a distinctive protein that can be observed within the inner myelin layer 
(Sellebjerg et al. 1998). The level of the MBP could increase during relapse MS courses in 
most of the MS patient and decline during the recovery stage within five to six weeks 
(Lamers, de Reus & Jongen 1998).  
Axonal destruction can be detected by the elevated level of CSF neurofilaments originating 
from the decompositions of the major components of the axonal cytoskeleton protein. The 
increase in the CSF neurofilaments level has been observed in relapsing remitting and 
progressive MS stages (Brettschneider et al. 2006). Total serum IgC (immunoglobulin 
constant domain) can be used as indicator of the severity of MS (Ziemann et al. 2011).  
CSF analysis is a valuable technique, but requires more standardization of the sampling 
and methodological procedures; this will assist in providing comparative studies and a 
better understanding of the pathological mechanisms (Teunissen et al. 2009; Tumani et al. 
2009).  
1.2.5 Conventional Magnetic Resonance Imaging (MRI)  
Conventional MRI has assisted and enhanced the monitoring and visualisation of the 
diagnosis and in determining the criteria of the disease (Figure 1.12). The MRI protocol for 
assessing MS patients often includes pre- and post-contrast T1-weighted imaging (T1 WI), 
T2-weighted imaging (T2 WI), and fluid attenuated inversion recovery (FLAIR) (Bakshi et al. 
2008; Filippi, Absinta & Rocca 2013). The most common contrast agents used in MRI are 
complexes of Gd3+, which is paramagnetic and shortens both T1 and T2 relaxation times 
(Filippi & Rocca 2011; Filippi et al. 2012). These contrast agents stay within the 
vasculature, unless there is a defect, and do not cross the blood-brain-barrier. At higher 
magnetic field (≥3T), Double Inversion Recovery (DIR) has recently been developed to 
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increase the sensitivity for detecting cortical lesions (Figure 1.13) (Calabrese, M. et al. 
2011). These structural MR imaging techniques have played an important role in the study 
of spatial and temporal characteristics of the disease progression (Filippi et al. 2012; 
Fisniku et al. 2008).  
High field strength (3T or 4T) and very high field (7T or higher) have improved the 
detecting performance of conventional MR Imaging (Filippi, Evangelou, et al. 2014). In a 
comparison study between the 1.5T and 3T scanners, there is increase in the detection of 
a MS lesion, but with little improvement in meeting the criteria of how the disease is 
disseminated in the space (Wattjes, MP et al. 2008). 
 
Figure 1.12 Conventional MRI in monitor the evolution of MS lesions.  
(A) axial proton density (PD)-weighted imaging and (B) T2-weighted imaging show hyper-intense multifocal 
lesions in the white matter (yellow arrows). Post-contrast T1-weighted imaging enhanced active lesions 
indicate a disruption of the blood brain barrier (BBB), reproduced form (Filippi & Rocca 2011). 
 
However, double inversion recovery has been more robust in depicting infra-tentorial 
lesions. In addition, a very high magnetic field has accurately delineated the lesions within 
the white and gray matter when exploring the morphology changes in addition to depicting 
the vasculature structures (Wattjes, M et al. 2007). A recent MS imaging study at a 7 Tesla 
field (Filippi, Evangelou, et al. 2014; Mainero et al. 2009) has reported three major cortical 
lesions, which were described previously with histopathological studies. They include the 
leukocortical, intracortical and subpial lesions, as can be seen in Figure 1.14 (Mainero et 
al. 2009). 
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Figure 1.13 Patterns of MS intra-cortical lesions.  
Intra-cortical lesion has been detected using 3D DIR at 1.5 T (D) comparing with the axial dual echo (A) 
intermediate T2-weighted and (B) strong T2-weighted image in addition to the (C) FLAIR, as indicated by the 
arrowheads. Reproduced from Geurts, Pouwels, et al. 2005. 
 
Figure 1.14 Patterns of cortical MS lesions in MRI comparable to histological patterns.  
FLASH (Fast Low Angle Shot) T2*-weighted and T2-weighted imaging at a 7 T can characterize the different 
(subpial and leukocortical) cortical lesions. Reproduced from Mainero et al. 2009.  
 
A very high magnetic field has added another diagnostic value, such as predicting the 
changes in the iron contents within specific brain structures (Khalil, Teunissen & 
Langkammer 2011). Increasing the magnet’s strength has increased the sensitivity of the 
local field shift caused by the iron in the basal ganglia and MS lesions. The iron changes 
can be observed by acquiring the gradient echo phase high-resolution images at a 7 T 
field. The findings of the imaging study have revealed increased iron contents within the 
caudate, putamen and globus pallidus of an MS patient, compared with healthy subject 
(Hammond et al. 2008). In the next section, MRI studies of MS in patients and animal 
models will be discussed in more details.  
1.2.6 MRI studies of MS in patients and animal models 
MS clinical studies require recruitment of large numbers of patients with long follow-up 
procedures and grouping of patients into relevant MS stages. Animal models of MS (Kipp 
et al. 2012; Mix et al. 2010) provide better accessibility, allowing monitoring of the 
environment as well as validation of in vivo MRI results using ex vivo histology, which is 
more difficult to achieve in human studies.  
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In vivo MRI is preferred in MS research as it is non-invasive, facilitates longitudinal studies 
(Mackenzie-Graham, A. 2012) and enables correlative analysis of various MRI parameters 
with the status of neurological impairment (Pirko et al. 2008). On the other hand, ex vivo 
imaging is useful to provide higher resolution without experiment time restrictions 
increasing the sensitivity of detection of more subtle changes (von Elverfeldt, Reichardt & 
Harsan 2012).  
1.2.6.1 T1-weighted MRI 
1.2.6.1.1 T1-weighted imaging in MS patients 
In pre-contrast T1 WI, MS plaques appear hypointense, which is a characteristic of 
neuronal tissue damage (Filippi & Rocca 2011; Filippi et al. 2012). However, pre-contrast 
T1 WI cannot distinguish the heterogeneous nature of the lesions. Lesions that appear 
hypointense in pre- and post-contrast T1 WI are thought to be associated with more severe 
MS tissue damage exhibiting both demyelination and axonal loss. Post-contrast T1 WI 
provides the benefit of measuring blood brain barrier (BBB) permeability, where leakage 
has been linked to MS lesions and the progression of relapsing symptoms (Ceccarelli, 
Bakshi & Neema 2012).  
1.2.6.1.2 T1-weighted imaging in MS animal models 
Similar approaches have been used to study MS animal models, including 2D/3D pre- and 
post-contrast T1 WI. T1 WI has been shown to be sensitive to monitor chronic progression 
in the TMEV mouse model using normal C57BL6 mice and immune differentiation marker-
deficient mice (Pirko et al. 2008). In this experiment, TMEV was administered to four 
groups of mice, viz: (1) normal C57BL6 mice, as a reference of T1 hypointensity lesion 
load; (2) immuno-deficient C57BL6 mice RAG (Recombination activation gene)-1 deficient; 
(3) RAG-1 deficient mice with CD4+; and (4) RAG-1 deficient mice with CD8+ T-cells. T1 
WI was performed at 7T to study TMEV lesions. In control C57BL6 mice, T1 hypointense 
regions were mostly located in the periventricular area and hippocampus (Figure 1.15). In 
RAG-1 deficient mice, there was a significant reduction in the T1 hypointensity lesion load 
compared with C57BL6 TMEV mice, indicating the importance of the innate immune 
system for disease progression. T1 hypointense lesions increased in RAG-1 mice 
administered CD8+ T-cells, but were unaffected in RAG-1 mice administered CD4+ T-
cells.  
Lesions with strong T1 hypointensity (also referred to as T1 black holes) were suggested to 
represent areas of severe tissue damage with axonal and neuronal loss, and helped to 
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distinguish the significance of different types of T cells in mediating brain damage. This 
study further highlights the distinctive role of CD4 + T cells (or T helper cells), which play a 
major role in the EAE model (Nelson, A, Bieber & Rodriguez 2004; Sriram & Steiner 2005); 
compared with the role of CD8+ cells in the TMEV mouse model of MS. It has been 
suggested that these differences may have contributed to the lack of success of 
treatments targeting CD4+ T cells in the treatment of human MS (Pirko et al. 2008). 
 
 
Figure 1.15 3D T1 weighted imaging at 7T of C57BL6 infected with TMEV.  
(A), (B) coronal and (C) axial sections were extracted from 3D T1 WI. 7 days post infection. T1 hypointense 
lesions were more pronounced in the periventricular area and adjacent to the hippocampus as indicated by 
the white frames. (TR/TE= 200/10 ms, voxel dimensions= 135×200×200 µm3) (Pirko et al. 2008).   
 
1.2.6.2 T2-weighted MRI 
1.2.6.2.1 T2-weighted imaging in MS patients 
T2 WI plays a major role in the detection of MS lesions. The detection of new T2 
hyperintense lesions after the onset of the first MS attack signifies further progression of 
the disease, and indicates the beginning of the relapsing remitting disease course (Fisniku 
et al. 2008). High resolution T2 WI has also been used to detect brain atrophy in patients 
with MS (Ge et al. 2000).  
On one hand, T2 hypointensity may be caused by several factors including iron, free 
radicals, the presence of macrophages and deoxyhemoglobin (Neema et al. 2007). T2 
hypointensity has been reported in human studies, but as the lesions were located within 
the deep grey matter, biopsies were difficult to perform to investigate the tissue properties 
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(Neema et al. 2007). In a human MS study at 3T (Zhang, Y. et al. 2007), there was a 
correlation between the physical changes assessed using the Expanded Disability Status 
Scale (EDSS) and alterations of signal intensities in the globus pallidus and caudate 
nucleus (r = -0.5, P<0.05). In a separate study, iron deposition in deep GM structures have 
been assessed by T2 hypointensity and was shown to have some correlation with 
neuropsychological score (NCS) of cognitive dysfunction (Pearsons correlation between T2 
hypointensity and NCS has the range between r = 0.265 to 0.395) (Brass et al. 2006).  
On the other hand, T2 hyperintensity may serve as a potential biomarker for detecting 
active MS lesions (Filippi et al. 2012) but with low specificity to acute and chronic MS 
disease pathology (De Groot et al. 2001). This is due to the presence of inflammation, 
edema and demyelination in acute lesions, and profound demyelination, axonal loss and 
gliosis in chronic lesions (Filippi et al. 2012), which could result in the elevation of tissue 
water content and consequently lead to indistinguishable causes of T2 hyperintensity 
(Traboulsee et al. 2005). A 20 year follow up study with more than 100 patients (Fisniku et 
al. 2008), showed that T2 lesion volume at multiple time-points (0, 1, 5, 10, 14 and 20 
years) correlated moderately to EDSS (rs = 0.48 to  0.67; P < 0.001) and to multiple 
sclerosis functional composite (MSFC) z-score (rs = -0.50 to -0.61 P<0.001). The rate of 
volume increase in T2 lesions is three times higher in the patients who develop secondary 
progressive compared with the patients who remain in relapsing remitting. 
1.2.6.2.2 T2-weighted imaging in MS animal models 
High resolution T2 WI has been shown to be useful for measurement of volumetric 
changes in EAE mouse brains and can be correlated with histopathological analysis 
(MacKenzie-Graham, A. et al. 2009). This ex vivo MRI study in EAE-mice found significant 
reductions in the volume of the cerebellum, cerebellar cortex and molecular layer of the 
cerebellar cortex. Atrophy in the molecular layer of the cerebellar cortex is related to loss 
of Purkinje cells (Kutzelnigg, A et al. 2007). Such detection of grey matter (GM) atrophy 
was important as it was correlated with progressive development of clinical disability          
(r=-0.6207,n=21, p=0.0027) (MacKenzie-Graham, A. et al. 2006; MacKenzie-Graham, A. 
et al. 2009). 
Brain atrophy is a common feature of MS in humans (Lassmann, H. 2013) and this has 
been observed in TMEV model. Using serial 3D T1 WI and T2 WI of in TMEV SJL/J mice 
from 0 to 12 months post immunisation, significant atrophy was observed in affected mice 
at 3 months and reaches its peak by 6 months with 118% increase in the ventricular size. 
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However, it is still not understood how deep TMEV GM lesions contribute to the observed 
atrophy (Pirko et al. 2011). A more recent T2 WI in vivo study in EAE-mice from the same 
group (MacKenzie-Graham, Allan et al. 2012) re-affirmed the presence of GM atrophy in 
the cerebral cortex, characterized by a major decrease in the volume of the cerebellum by 
80 days post-EAE induction (Mackenzie-Graham, A. 2012). However, there was no 
discernable correlation between disease severity and whole brain volume, or volume 
changes in the cerebral cortices during the course of the disease. Detailed volumetric 
analyses of various brain regions in C57BL6 mice may benefit from recent high-resolution 
C57BL6 brain atlas acquired at 16.4T (Ullmann et al. 2013). 
T2WI hypointense regions have been detected in the deep GM structures of TMEV SJL/J 
mice, in the thalamus, caudate, putamen and dentate nuclei (Figure 1.16). The gradual 
development of T2 hypointensity intensity thalamic lesions appeared to be correlated with 
progressive rotarod detectable disability (P<0.001) (Pirko et al. 2009). It was suggested 
that the hypointensity is due to the presence of extravasated blood in this area. 
 
 
Figure 1.16 The correlation between increasing hypointensity of the medio-dorsal thalamic nucleus 
on T2 weighted images and disease progression.  
(A) One month, (B) 4 months, (C) 6 months and (D) 12 months post disease induction as indicated by red 
arrows. 3D volume RARE sequence at 7T with TR=1500 ms, TE=70 ms, ETL=16, FOV=3.20×1.92×1.92 cm, 
voxel dimensions=125×150×150 µm3, reproduced from (Pirko et al. 2009). 
 
Correlation of T1 and T2 weighted signal intensity with histopathology requires animal 
models that can produce a large number of inflammatory lesions. This has been 
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established in a T-cell clonal adaptive transfer EAE model using SJL/J mice, in which the 
lesion formation was traced using 3D high resolution T1 WI and T2 WI at 2.35T (Nessler et 
al. 2007). During the acute stage (9 days post adaptive transfer), two independent patterns 
of lesions were detected: (1) hypointense lesions on both T1 and T2 WI (Type A lesions), 
(2) other lesions, characterized by slightly hypointese or isointense T1 WI and 
hyperintensity on T2 WI (Type B lesions). Histology studies showed that type A lesions 
contained a higher density of inflammatory cells and myelin loss and they were more 
destructive than type B lesions. Serial MRI was performed during the disease cycle, and 
the patterns of two lesions were heterogeneous. At the end of the disease cycle (30 days 
post adaptive transfer), for type A lesions, T1 hypointensity persisted and T2 hypointensity 
diminished (return to isointensity). For type B lesions, T1 hypointensity diminished and T2 
hyperintensity persisted. 
This experiment also revealed high correlations between T1 and T2 signal intensity with 
cellular parameters of inflamatory tissue damage (Nessler et al. 2007). The density of 
activated microglia cells, reactive astrocytes and immunoglobin deposition were positively 
correlated with the signal intensities of the T2 WI (with the corrlation r = 0.62 to 0.73, 
P<0.04). However, the signal intensities of T1 WI have negative correlations with microgila 
cell densities and astrocytes (r = -0.67, P<0.02).  
 
1.2.6.3 Inversion recovery MRI 
1.2.6.3.1 Inversion recovery applications in MS patients 
DIR and FLAIR imaging can increase the sensitivity of detecting focal areas of 
hyperintensity especially in grey matter and cortical lesions by suppressing either the WM, 
GM or CSF signals (Kilsdonk et al. 2013; Sati et al. 2012). However, these techniques 
have low sensitivity for the heterogeneous pathologic substrate of individual lesions. 
FLAIR can detect lesions that are involved in WM structures such as leukocortical or 
juxtacortical lesions but the vast majority of the intracortical lesions are not detected such 
as subpial cortical lesions (Kilsdonk et al. 2013). On the other hand, the DIR sequence 
consists of double inversion pulses: one to suppress CSF signals and another one to 
supress the WM signals. This sequence provides low SNR; however, it offers excellent 
contrast to noise ratio, which facilitates detection of more MS lesions in gray matter 
(Seewann et al. 2012). A recent post mortem MS study carried out on 14 patients 
assessed the sensitivity and specificity of 3D DIR and 3D FLAIR. 3D DIR was more 
 70 
sensitive and specific by 18% and 90% in detection cortical lesions. These findings have 
been confirmed using Proteolipid protein (PLP) myelin stain (Seewann et al. 2012).     
A recent study (de Graaf et al. 2013) compared T1 WI, T2 WI and FLAIR at both 3T and 
7T, but imaging using these techniques at higher magnetic field did not appear to increase 
sensitivity for detection of WM lesions. 3D-FLAIR at 7T has been tailored to improve 
sensitivity in depicting grey matter lesions (de Graaf et al. 2013). This technique combined 
axial FLAIR (1mm3 isotropic resolution) and T2* WI (0.55mm3 isotropic resolution), to 
produce FLAIR* with 0.55 mm3 isotropic resolution(Sati et al. 2012). The resulting image 
showed suppression of cerebrospinal fluid (CSF) and high-resolution visualization of 
microvascular structures, which enabled investigation of the presence of interlesional veins 
in WM lesions (Sati et al. 2012). Such lesions were detected in the pons and cerebellum 
and were related to the presence of iron-containing macrophages (Sati et al. 2012). 
1.2.6.3.2 Inversion recovery applications in MS animal model 
In rodent brain MRI, inversion recovery is used to produce a stronger T1-weighting and 
CSF suppression. For example, a T1 weighted 3D Modified Driven Equilibrium Fourier 
Transformation (MDEFT) sequence at 9.4T (Waiczies et al. 2012) was used to enhance 
visualisation of cortical areas, the striatum and the ventricular system. However, T1 WI 
MDEFT could not detect EAE inflammatory lesions, in contrast to T2 and T2* WI (Waiczies 
et al. 2012). FLAIR with inversion recovery does not appear to have been applied to the 
study of rodent models of MS. Fluid attenuation using FLAIR is not commonly used as the 
T1 relaxation time is considerably longer at the high magnetic fields commonly used in 
animal MRI studies (Waiczies et al. 2012).  
 
1.2.6.4 Limitation of conventional MRI in rodent models of MS 
The low specificity of conventional MRI techniques to monitor and characterise MS lesions 
is due to the heterogeneity of MS lesions, comprising cellular debris from 
demyelination/remyelination processes, permanent axonal loss, increased immunocellular 
activity and tissue edema, all of which can affect the T1 and T2 contrast (Filippi et al. 2012). 
However, T1- and T2 WI could not detect MS lesions within normal-appearing white matter 
(NAWM), which was shown to be present in post-mortem studies (Bjartmar et al. 2001).  
Imaging of the rodent brain is challenging due to several technical issues such as subject 
breathing motion and susceptibility image artefacts from sinus and ear cavities. 
Respiratory gating, however, is rarely used for brain imaging, except for DWI, as it 
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significantly prolongs the acquisition time. High in-plane resolution (sub 100 µm2) with 
relatively thicker slices (1mm) are often used to provide sufficient resolution to distinguish 
small structures in the rodent brain at the expense of partial volume effects (Aggarwal, 
Zhang & Mori 2012). The acquisition of 3D isotropic dataset at medium resolution 
(>125µm3) can be accomplished but this will increases the acquisition time and is more 
sensitive to motion (Mackenzie-Graham, A. 2012). For high-resolution rodent brain 
imaging, high magnetic fields (>7T) are typically used to boost signal to noise ratio (SNR), 
but suffer from higher local magnetic field susceptibility and longer T1 and shorter T2 
relaxation times. In live imaging, acquisition parameters should be optimised to acquire 
high SNR and resolution within the shortest experiment time (Aggarwal, Zhang & Mori 
2012).    
 
1.2.6.5 Cryogenic radiofrequency coil mouse brain MRI 
The recent introduction of cryogenically cooled radio frequency (RF) coils (cryocoil) may 
improve the role of conventional micro MRI in assessing pathological changes in rodent 
models. At 9.4T, cryogenic coils boost Signal to Noise Ratio (SNR) by a factor of up to 2.9, 
which can be exploited to significantly shorten experiment time for in vivo imaging (Baltes 
et al. 2009; Nouls et al. 2008). For example, a volumetric T2 WI at (60 µm3) isotropic 
resolution could be acquired within 45 min. The cryocoil has a maximum signal penetration 
of approximately 3 mm from the brain surface and can reveal intricate cortical and 
subcortical details of the mouse brain (Baltes et al. 2009). Despite its high sensitivity, the 
cryocoil has some disadvantages in terms of its inhomogeneous RF excitation profile. 
Gradual loss of signal-to-noise ratio for deeper (ventral) brain structures were also 
observed due to the positioning of the surface array coil on the cortex. However, such 
artefacts can be minimized with careful adjustment of the RF power and image post-
processing (Baltes et al. 2009; Nouls et al. 2008).  
In vivo conventional micro MRI using the cryocoil (T1, T2 and T2* weighted imaging) has 
been used to detect MS lesions prior to the appearance of the symptoms in EAE-mice 
immunized with PLP139-151 (Waiczies et al. 2012). High-resolution images T1WI, T2WI 
(47×47×400 µm3) and T2* WI (35×35×400 µm3) were used to detect MS lesions in the 
cerebellum, cerebral cortex and subcortical region before the disease manifestations 
(Figure 1.17) (Waiczies et al. 2012).  
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Figure 1.17 Application of micro MRI T2 WI in assessing evolution of the lesion prior and during 
disease onset.  
(A) Detection of MS lesions in subcortical region, cerebellum and cerebral cortex in seven EAE-mice prior to 
the disease onset until the disease starting time. (B) T2 weighted images from day 14 (d-14) prior to disease 
manifestation until the first day when symptoms were initiated (d0), reproduced from (Waiczies et al. 2012). 
 
1.2.6.6 Contrast agent enhancement and cellular tracking 
Paramagnetic gadolinium (Gd) contrast agents and ultra-small and small 
superparamagnetic iron oxide (USPIO and SPIO) particles are commonly used to 
investigate MS. These compounds produced distinctive contrast by shortening the T1 and 
T2 relaxations of the surrounding tissue. Due to their specific relaxivity, Gd-DTPA is often 
used for T1 WI as hyperintensity, whereas USPIO/SPIO with T2 or T2* WI as hypointensity 
(Ceccarelli, Bakshi & Neema 2012).  
1.2.6.6.1 USPIO and SPIO particles  
USPIO and SPIO particles (Ceccarelli, Bakshi & Neema 2012) have been used to monitor 
the cellular mechanisms of MS inflammation. The cells of the monocyte-macrophage 
system take up the iron oxide particles and their infiltration into the lesion sites could be 
detected using MRI using T2* WI (Corot et al. 2006). Several studies (Dousset et al. 2006; 
Vellinga et al. 2008) have shown that the USPIO pattern of enhancements is correlated 
with MS disability, axonal loss and patient’s response to treatment.  
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The biological specificity of the USPIO depends upon the molecular characteristics of the 
applied particles (Dousset et al. 2006). For example, USPIO particles SHU555C and 
Ferumoxtran-10 differ in size (25 nm vs. 30nm), and body circulation half-life (6-8 h vs. 24-
30 h). In-vitro, the negative charge on SHU555C particles produced preferential uptake by 
activated monocytes (Metz, S et al. 2004).  
USPIOs have been used as indicator of disease progression in rats with RR EAE (Brochet 
et al. 2006). Rats with positive detection of USPIO particles (+USPIO rats) show significant 
tissue alteration at the first attack and more severe clinical signs compared to -USPIO rats 
during the second attack (Figure 1.18). This study demonstrates how USPIOs can be used 
to determine the role of macrophage infiltration as an indicator of progressing inflammatory 
demyelination.  
 
 
Figure 1.18 Detection of macrophages using USPIO contrast agent at 1.5T for assessment of their 
role in the development of secondary progressive EAE in rats. 
(A) Sagittal T1 WI and (B) axial T1 WI show hyperintensity and reflect the uptake of USPIO in the CNS. (C) 
Axial T2 WI shows hypointensity as in indicated by arrows. These signal alterations were not observed (D), 
(E) and (F) with other EAE rats in this experiment (Brochet et al. 2006). 
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1.2.6.6.2 Gd-contrast agent 
Gd T1 WI post-contrast studies have been used to monitor BBB permeability which can be 
disrupted during deposition of new MS lesions (Johnson, HL et al. 2012; Johnson, HL et 
al. 2013). In one study, Gd T1 WI post-contrast was used to determine the role of CD8 T 
cells and neutrophils in causing BBB permeability, using a modified model of C57/BL6 
TMEV mice exhibiting peptide-induced fatal syndrome (PIFS) (Figure 1.19) (Johnson, HL 
et al. 2012).  
 
Figure 1.19 Analysis of the role of CD8 T cells and neutrophils for the initiation of BBB disruption in 
PIFS modified TMEV model using Gd-enchanced T1 WI.  
(A) a 7 day TMEV mouse without PFIS (control). (B-D) C57BL/6 mice undergoing PIFS receiving treatments 
to deplete neutrophils in vivo: (B) normal rat serum (as a negative control treatment), (C) with non-specific 
antibody RB6-8C5, or (D) with neutrophil specific 1A8 antibody. (E)–(H) red sub-volumes are rendering of 
gadolinium-enhancing areas. (I) Quantification of BBB permeability areas from each group, reproduced from 
(Johnson, HL et al. 2012). 
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Gd T1 WI post-contrast showed that the ablation of immune cells using non-specific anti–
GR-1 monoclonal antibody RB6-8C5 (which also ablated CD8 T cells) successfully 
prevented BBB leakage. However, this was not the case for animals receiving treatments 
with NRS (normal rabbit serum) as a negative treatment control, nor animals treated with 
anti–Ly-6G mAb 1A8 (specific to ablate neutrophils) (Figure 1.19). The Gd T1 WI post-
contrast data show strong correlation between the prevention of BBB damage and the 
preservation of motor function, and it helped to determine that the activity of CD8 T cells in 
damaging BBB was independent of neutrophils activity (Johnson, HL et al. 2012).  
To assess the development dynamics of MS lesions, the TMEV mouse model of MS has 
been induced in interferon-gamma receptor knockout mice (Pirko et al. 2004). In TMEV 
mice, there was acute progressive demyelination without remission resulting in extensive 
brain and brainstem lesions. This model has allowed a comprehensive understanding of 
the T2 lesion load and enhanced lesions. One study (Pirko et al. 2004) has explored four 
unique patterns of T2 lesions, including expanding, expanding retracting, fluctuating and 
stable (Figure 1.20). As this model produces extensive MS lesions, the T2 WI detects more 
MS lesions compared with post-contrast enhanced imaging, and with earlier temporal 
sensitivity compared with Gd enhancement. 
 
 
Figure 1.20 Characterisation of lesion developments in interferon-gamma receptor knockout mice 3D 
volume rendering resampled from T2 WI 3D datasets of the examined mice.  
3D RARE acquired at 7T (TR=1500 ms, TE=70 ms, ETL=16, FOV=3.5×3.5×3.5 cm voxel dimensions 218 × 
218 × 218 µm). Reproduced from (Pirko et al. 2004). 
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There remains controversy as to whether Gd or USPIO provides a better early indication of 
MS pathology (Dousset et al. 2006). In some cases, USPIO is superior to Gd, because it 
can detect lesions a few weeks earlier than Gd enhancement (Dousset et al. 2006). 
USPIO lesion enhancement may persist longer after Gd enhancement has ceased and 
show spatial distribution of the immune-reactive cells post BBB repair (Ceccarelli, Bakshi & 
Neema 2012).  
A recent comparison between USPIO and Gd enhancements in 10 patients with RR-MS 
(Vellinga et al. 2008) showed that the same lesions were seen with both contrast agents, 
but that some of the lesions were specifically observed by USPIO only or Gd only (Figure 
1.21) (Vellinga et al. 2008). Nevertheless, current data indicates that USPIOs and Gd have 
specific biological pattern of enhancements which are important in characterizing MS. 
Gadolinium enhancement reflects leakage of the blood brain barrier (BBB) whereas the 
USPIOs’ enhancements represent cellular infiltration (Vellinga et al. 2008). Careful 
considerations must be given when choosing these contrast agents to take advantage of 
their specificity.  
 
 
Figure 1.21 Pattern of MS lesion enhancement.  
(A) T2-weighted images show typical peri-ventricular MS lesion, (B) Hypointensity pattern observed in some 
of the lesions on the T1-pre-contrast, (C) post-Gad T1 WI reveals two enhancement pattern, focal and ring, 
(D) post-USPIO T1 WI shows a focal enhancement (upper row arrowheads), ring enhancement (upper row 
arrows) and the isointensity pattern (bottom row arrow), which was hypo-intense on the T1-pre-contrast, 
reproduced from (Vellinga et al. 2008). 
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1.2.6.7 Diffusion tensor imaging (DTI) 
The measurement of tissue molecular diffusion using diffusion weighted imaging (DWI) is 
widely used in MS research (Rovaris, M. et al. 2005). MRI is sensitized to microscopic 
diffusion of water in tissue by the application of diffusion gradients. Gaussian modelling of 
tissue water diffusion can broadly be classified as non-restricted (isotropic) and 
directionally restricted (anisotropic) diffusion. In neuronal tissues, isotropic diffusion can be 
identified within cerebrospinal fluid (CSF) and to a lesser extent in GM, whereas 
anisotropic diffusion has often been correlated with the degree of myelination and axonal 
fibre directionality of the WM (Winston 2012). 
1.2.6.7.1 DTI parameter changes in MS patients 
DTI derived parameters are powerful and sensitive measures for assessing MS 
pathological changes. MS pathology is associated with damage to the white matter myelin 
structure, resulting in disruption of molecular water diffusion and a consequential reduction 
in diffusion anisotropy (Filippi et al. 2012). A summary of DTI parametric changes in WM 
affected by MS is illustrated in Figure 1.22. 
 
Figure 1.22 The relationships between the white matter axonal fibres, myelin structure and DTI 
derived parameters in MS pathology.  
The demyelination, axonal injury and inflammation processes in MS typically result in a decrease of FA, and 
AD and an increase in RD. 
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DTI parametric maps provide distinguishing characteristics for careful interpretation of MS 
lesions, even for those that are readily detectable by the conventional imaging techniques 
(Hygino Jr et al. 2011). Compared with the normally-appearing white matter (NAWM), MS 
focal lesions showed increased MD which indicated some loss of the structural barrier to 
water molecular diffusion and a decrease in FA due to disorganisation of WM structures 
(Rovaris, M. et al. 2005). Co-localisation of T1 hypointense and DTI lesions may signify 
areas suffering from irreversible tissue damage (Bammer et al. 2000). Additionally, a 
longitudinal progressive MS study (Castriota-Scanderbeg et al. 2002) showed that 
worsening lesions could be detected more sensitively as areas with increasing MD, which 
were otherwise indistinguishable using post-contrast T1 WI. On the other hand, lesion 
areas with increased T2 relaxation time and increased MD appear to reflect a decrease in 
the axonal myelin (intracellular) water content and an increase in the extracellular water 
due to tissue damage (Kolind et al. 2008). 
A recent study (Roosendaal et al. 2009) has assessed the axial and radial diffusivities 
within the abnormally low FA areas in the brains of patients with MS. The brain regions 
examined include fornices, inferior longitudinal fasciculus, optic radiations, and parts of the 
corpus callosum. There was an increase in RD caused by demyelination but surprisingly, 
there was only a small increase in AD (Roosendaal et al. 2009) 
A complicated pattern of change in diffusivities may occur due to axonal loss (Trapp et al. 
1998) or an increase in axonal diameter. This was supported by previous findings in post-
mortem MS spinal cord studies which showed areas of T2 WI hyperintensities (Bergers et 
al. 2002). For areas containing crossing fibres, abnormal changes to the FA, AD and RD 
must be carefully assessed as MS pathology in these areas can produce unexpected 
results such as an apparent increase in diffusion anisotropy (Tournier, Mori & Leemans 
2011). 
Many DTI studies of human MS (Hu et al. 2011; Koenig et al. 2013) and rodent models 
(Sun, S et al. 2007; Wu, QZ et al. 2007) are focused on the WM structures as they are the 
anticipated sites of MS pathological changes. High WM anisotropy provides characteristics 
for sensitive detection of MS pathological changes using DTI measures (Koenig et al. 
2013; Roosendaal et al. 2009). MS, however, is a whole brain disease and can also affect 
GM and cortical areas (Ceccarelli, Bakshi & Neema 2012). A three year longitudinal study 
of relapsing remitting MS patients at 1.5T has reported an increase of FA in normal 
appearing grey matter (NAGM) and cortical lesion volume, which are correlated with 
clinical disability (r > 0.75, P<0.01) (Calabrese, M. et al. 2011). The increase of FA was 
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unexpected, but it was suggested to be associated with a low degree of inflamation, 
demyelination, axonal damage and neuronal loss in NAGM cortical lesions. The presence 
of activated microglia could play a strong contribution to this increase of FA, as activated 
microglia are known to change their shape into a more anisotropic flat bipolar structure, 
resulting in apparent increase of anisotropy in these lesions (Calabrese, M. et al. 2011).  
1.2.6.7.2 DTI studies of MS animal models  
AD and RD measurements are potentially more sensitive than MD in diagnosis of MS 
lessions due to characteristic high diffusion anisotropy in the WM (Aung, Mar & Benzinger 
2013; Inglese, M & Bester 2010). In MS studies using the cuprizone rodent model (Song et 
al. 2002; Song et al. 2005), decreasing AD and increasing RD were robust surrogate 
markers for axonal damage and demyelination, respectively. These conditions were 
observed in various DTI MRI animal studies, for example: (i) In a retinal ischemia mouse 
model, where a decrease of AD correlated with axonal injury (Song et al. 2003). (ii) In a 
spinal DTI study of a mouse model of chronic EAE (Kim, JH et al. 2006), histology data 
confirmed a correlation of intense anti-β-amyloid precursor protein staining with  a 
decrease in AD associated with axonal damage; and an increase in radial diffusivity with 
diminished luxol fast blue (LFB) staining as a biomarker of demyelination. (iii) In a 
cuprizone-induced demyelination/remyelination mouse model (Wu, QZ et al. 2007), T2 
hyperintensity, a reduction in AD and an increase in RD were specifically observed in the 
caudal segment of the corpus callosum, and these were correlated with histological 
observations of demyelination (LFB staining), axonal injury (neurofilament staining), 
microglial accumulation and cellular infiltration. (iv) In inflammatory optic neuritis (ON) in 
an EAE mouse model (Sun, SW et al. 2008; Xu et al. 2008), uniform ON resulted in axonal 
injury (decreased AD) and demyelination (increased RD), as shown in Figure 1.23. 
Investigation of DTI parametric changes in MS rodent models (Sun, S et al. 2007; Wu, QZ 
et al. 2007) may not necessarily translate to detection of pathological changes in patients 
with MS. For example in the mouse model of MS, changes in RD were not observed, 
although severe demyelination, inflamation and axonal damage were detected by histology 
(Zhang, J, Aggarwal & Mori 2012). Such negative observations may be due to confounding 
factors affecting RD senstivity for detection of demyelination; for example, inflammation 
due to the presence of activated microglia and macrophages, T cell infiltration, as well as 
vasogenic oedema affect the apparent diffusion anisotropy in MS lesions (Wang, Y et al. 
2011; Zhang, J, Aggarwal & Mori 2012).  
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Figure 1.23 Assessment of optic nerve degeneration in EAE-mice using DTI indices.  
A reduction in relative anisotropy (RA) value can be observed in the EAE mouse (b) compared with the 
control subject (a). Axial diffusivity decreases and radial diffusivity increases in the EAE mouse (d, f, 
respectively), in comparison with the control (c, e, respectively). DTI was acquired using Stejskal-Tanner 
sequence at 4.7T, TR=1.7 second, TE=50 ms, 6 diffusion directions acquired with b-value=838 s/mm2, 
NEX=4, slice thickness=0.5 mm, FOV=3×3 cm, and resolution=59 ×59 ×500 µm3, reproduced from (Sun, S 
et al. 2007).  
 
1.2.6.7.3 DTI Tractography studies in MS patients 
DTI tractography reconstruction provides a unique depiction of three-dimensional 
projections of neural structures, which is useful for studying brain connectivity. DTI 
tractography can potentially be used to stage MS progression as MS lesions produce local 
or global disruptions in the WM fibre architecture that affect fibre tractography profiles and 
streamline numbers (Harsan et al. 2010). DTI tractography is useful for extracting WM 
pathways in patients with MS, for example, in the corpus callosum, for investigation of 
undetected NAWM lesions and consequential correlation between the clinical symptoms 
and the imaging findings (Figure 1.24) (Hu et al. 2011; Hygino Jr et al. 2011).  
There are various methods available to process diffusion-weighted imaging data in 
performing tractography (Johansen-Berg & Rushworth 2009). In general, tractography 
image processing firstly involves the determination of fibre orientation distribution, followed 
by the propagation of tracts (streamlines) using deterministic or probabilistic fibre tracking 
methods (Tournier, Calamante & Connelly 2012; Tournier, Mori & Leemans 2011). 
Tractography can be performed for the whole brain, or selectively using specific seeding 
and targeted regions of interest (Tournier, Calamante & Connelly 2012).  
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DTI tractography has been used to visualize the effect of MS lesions on the projection, 
association and commissural fibres (Hu et al. 2011). MS patients exhibited an increase in 
ADC and reduction in FA, fibre density and streamline profiles within MS lesions and 
NAWM compared with healthy subjects, in which measures were correlated with the 
pattern of EDSS or clinical score of disability. Region-specific DTI tractography has also 
demonstrated sensitivity to functional changes: (i) disruption of pyramidal and corticospinal 
tracts resulting in motor dysfunction (Lin, F et al. 2007); (ii) disruption of left/right thalamic 
connectivity affecting working memory in early MS (Audoin et al. 2007). Tractography, 
however, has not been used to study animal models of MS. 
 
 
Figure 1.24 Deterministic DTI fibre tracking has been used to assess an RR-MS patient.  
(A) There is a disruption in the fibres connecting in the body of the corpus callosum, as indicated by an 
arrow; arrowheads (black holes) indicate lost fibre tracking. (B) Front view, lost fibres are indicated by an 
arrow, and the corticospinal tract fibres are thinner compared with healthy subjects (Hu et al. 2011). 
 
1.2.6.8 Limitations of DWI studies in animal models 
DWI studies of the mouse brain, either ex vivo (Moldrich et al. 2010; Song et al. 2005) or in 
vivo (Boretius, S. et al. 2012; Sun, S et al. 2007; Wu, QZ et al. 2007) are based upon FA 
or orientation colour-coded FA maps, rather than fibre tracking (Zhang, J 2010). In 
addition, most of the fibre-tracking algorithms require high diffusion gradient weighting (b-
values) and a large number of the applied diffusion-encoding gradients directions (High 
Angular Resolution Diffusion Imaging, HARDI). This contributes significantly to the 
experiment time, and can be problematic for in vivo DWI involving unhealthy participants.  
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Ex vivo HARDI may be a reasonable option when high-resolution, high number of 
directions and high b-values are required, but changes to tissue diffusion characteristics 
must be taken into consideration. In basic studies to compare ex vivo and in vivo rodent 
brain DWI, post-fixation procedures have been shown to reduce the diffusivity measures in 
comparison to data obtained from in vivo imaging (Sun, S et al. 2005; Sun, S, Neil & Song 
2003). This difference may be due to variable tissue temperatures, microstructure 
properties, cell death and chemical fixation solution (Shepherd et al. 2009).  
One recent study examined the difference between in vivo and ex vivo DTI in assessing 
the corpus callosum in both wild type C57BL6 and cuprizone-induced mice. In control 
subjects, FA measurements were not significantly different between the in vivo and ex vivo 
samples; however, the diffusivity measurements (AD and RD) were drastically reduced in 
the ex vivo experiments (Zhang, J et al. 2012). Demyelination has been detected in the 
corpus callosum of cuprizone mice but there is little agreement between in vivo and ex 
vivo FA measurements. This study suggested that ex vivo RD serves as a potential 
indicator of demyelination better than in vivo RD, but in vivo AD is more reliable than ex 
vivo AD in detecting axonal injury (Zhang, J et al. 2012).  
The primary technical challenge of performing mouse brain DWI studies is achieving the 
required spatial resolution while preserving satisfactory signal-to-noise ratio (SNR). This is 
especially important during the application of strong diffusion-encoding gradients, which 
results in significant signal attenuation and lower SNR. In addition, with high numbers of 
sampling diffusion-encoding directions, DWI requires a longer experiment time compared 
with other conventional MR imaging modalities (Zhang, J, Aggarwal & Mori 2012). In most 
cases, rodent DWI images are acquired at high magnetic field (>7T) with small custom 
coils built to boost SNR. The use of higher magnetic fields brings undesired effects such 
as increased magnetic susceptibility and chemical shift artefacts, longer T1 and shorter T2 
relaxation times (Pirko et al. 2005). DWI is inherently sensitive to motion to measure 
microscopic water displacement; and therefore, voluntary and involuntary movement can 
severely affect image quality. The use of respiratory gating and the navigator sequence 
has been developed to reduce these artefacts (Aggarwal et al. 2010). 
Assessing axonal pathology has become an integral and critical part in the diagnosis of 
MS. DW-MRI provides unique measurements of the distribution of water molecules in 
neural tissue, especially along the axons (Barazany, Basser & Assaf 2009; Caminiti et al. 
2013). Recent advances of DWI-MRI involves development of axon density and diameter 
measurements in the white matter of the living human brain, which potentially bring 
 83 
significant improvement to the detailed characterisation of MS pathology (Alexander, DC et 
al. 2010; Caminiti et al. 2013). However, challenges remain before DWI methods can be 
applied in clinical studies. These include the requirement for high gradient amplitude 
(b>3000 s/mm2), relatively long imaging times to account for multiple diffusion directions 
and diffusion weightings, and prior knowledge of the fibre orientation (Alexander, DC et al. 
2010).  
Compared to high resolutions T1 or T2 WI anatomical scans, DWI contains substantially 
higher partial volume effects. This makes comparison with histological sections, which has 
high in-plane resolutions (<5µm) and thin slices thickness (5-40µm), more difficult. Recent 
developments using 16.4T ultra-high field imaging (Moldrich et al. 2010) and new gradient 
spin echo (GRASE) DWI sequences at 11.7T can increase the resolutions of ex vivo DWI 
to 0.055 mm isotropic resolution (Aggarwal et al. 2010). A combination of GRASE and 
cryocoil at 11.7T how pushed in vivo DWI to unprecedented 0.125mm isotropic resolutions 
(Wu, D et al. 2013).   
 
1.2.6.9 Magnetization transfer imaging (MTI) 
1.2.6.9.1 MTI in MS patients 
MTI is a quantitative MRI technique utilising the interaction and exchange between mobile 
protons in a free water pool and protons in water bound to macromolecules, for example 
myelin structure. The magnetization transfer ratio (MTR) is measured by the incorporation 
of saturation pulses into the preparative part of a gradient echo or a spin echo sequence 
(Bakshi et al. 2005). MTR analysis can be done through a whole brain voxel based 
analysis (VBA) or using regions of interest, in which the MTR values are calculated from 
two sets of images acquired with and without the magnetisation transfer saturation pulses 
(Bakshi et al. 2005). MTI allows the depiction of several diffuse occult MS pathologies, for 
example, demyelination, gliosis and inflammation (Abdel-Fahim et al. 2014; Bakshi et al. 
2008). 
In MS patients (Button et al. 2013) and animal models (Aharoni et al. 2013), pathology was 
detected as an abnormal reduction in MTR, which was suggested to reflect demyelination 
and axonal loss. However, MTR determination of MS-related pathology is somewhat non-
specific, because MTR reduction can also be caused by other pathological processes, 
such as oedema, gliosis and inflammation (Aharoni et al. 2013; Button et al. 2013).  
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Several groups (Fazekas et al. 2002; Filippi & Agosta 2007) have investigated change in 
MTR and correlated it with lesion genesis and evolution (Figure 1.25). MTR reduction was 
observed a few months preceding observable Gd enhancement, and a further reduction in 
MTR for Gd-enhanced lesions has potential to highlight deteriorating MS lesions. MTR can 
be combined with conventional MRI methods, providing additional diagnostic value in 
predicting the evolution of T1 WI hypointense lesions (Fazekas et al. 2002; Filippi & Agosta 
2007).  
 
 
Figure 1.25 Correlation of Gd enhancement and MTR changes.  
All image volumes were registered first to baseline assessment images; (A) post Gd T1 WI at second 
baseline assessment and (B) the corresponding MTR within the same time frame; (C) and (D) 39 post-
enhancement T1 WI and MTR respectively. The lesion regions are colour-coded according to the changes in 
the MTR, where remyelinated and demyelinated lesions are shown in green and red, respectively. The 
yellow colour refers to the evolution of the MTR in normal-appearing white matter and the blue colour 
represents a stable MS lesion (Reproduced from Chen et al. 2008).  
 
A modest reduction in MTR followed by a partial or complete recovery of MTR could 
indicate remyelination or other repair mechanisms during resolution of inflammation or 
gliosis (Miller, D, Thompson & Filippi 2003). Abnormal changes in MTR were also sensitive 
for detection of MS lesions within the normal appearing white and grey matter (Miller, D, 
Thompson & Filippi 2003). In another report (Chen, JT et al. 2008), significant fluctuations 
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in the MTR within active gadolinium-enhanced lesions were observed, consistent with the 
demyelination and remyelination process over a period of three years. 
1.2.6.9.2 MTI in MS animal model 
In a comparitive study of relapsing remitting EAE using PLP (proteolipid protein) and a 
chronic MOG-induced EAE, MTR histogram analysis of the whole brain showed a 
significant reduction in MTR values in early stage disease (13 days post immunization) 
(Aharoni et al. 2013). Using VBA, MTR reduction was found in multiple brain regions such 
as the corpus callosum, caudate putamen and hippocampus. These early remarkable 
changes may reflect widespread changes to the myelin structure and/or existence of 
oedema (Aharoni et al. 2011). However, as the disease progressed and during the chronic 
stages of the disease cycle (28 days post immunization), further reduction in MTR values 
was not significant, which could indicate no further structural damage, initiation of the 
myelin repairing mechanism, or combination of further demyelination and oedema 
resolution (Figure 1.26) (Aharoni et al. 2013).  
 
Figure 1.26 MTR is sensitive to detect the effect of GA treatment in chronic MOG-induced EAE.               
(A) Histogram of whole brain MTR showing changes of the MTR profile of EAE animals closer to naïve 
animals after treatments with GA. (B) A corresponding graph showing changes of the MTR peak position 
from 0.19 to 0.24 (naïve) after GA treatments. (C) Voxel based analysis shows areas with significant MTR 
changes between GA treated and non-treated EAE animals. Numbers 1-9 indicate caudate putamen, corpus 
callosum, sensory cortex, amygdala, piriform cortex, hippocampus, thalamus, deep mesencephalic nucleus 
and cerebral peduncle, reproduced from (Aharoni et al. 2013). 
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On the other hand, in MOG chronic EAE, there was a reduction in MTR during three 
stages (11, 17 and 28 days post immunisation) (Aharoni et al. 2013), emphasising 
significant structural and axonal damage as a primary pathological process in the MOG-
induced model and confirming similar changes observed in the spinal cord using the same 
EAE model (Aharoni et al. 2005; Aharoni et al. 2011). The administration of glatiramer 
acetate (GA) to both the relapsing remitting PLP and chronic MOG EAE groups showed 
that the MTR values recovered toward normal as in naïve animals (Figure 1.26). These 
results support the role of MTR imaging as a marker of remyelination (Aharoni et al. 2013). 
 
1.2.6.10 Susceptibility Weighted Imaging (SWI) 
1.2.6.10.1 SWI in MS patients 
Susceptibility differences between tissues offers a unique contrast (Haacke, EM et al. 
2004). SWI is based on T2* weighted imaging, but consists of magnitude and phase 
information (Chavhan et al. 2009). At sufficiently long echo time (TE), the signals from 
white and grey matter, due to their different magnetic susceptibility, become out of phase. 
Therefore, phase imaging can be used to enrich the contrast between tissue types as well 
as accentuating iron laden tissues and venous blood vessels (Chavhan et al. 2009; 
Haacke, E et al. 2009). 
A recent MS imaging study using T2* weighted imaging at 7T (Tallantyre, E et al. 2011) 
has explored the relationship between MS lesions and deep veins (Figure 1.27). The 
occurrence of plaque in association with deep veins has been established in previous 
histopathological studies, where the presence of the central vein or venule in the white 
matter lesion were suggested to be a distinctive marker for differentiating between 
demyelinated MS lesions and non-MS lesions (Tallantyre, E et al. 2011). However, this 
technique requires investigation at lower field strength to assess its sensitivity in a clinically 
relevant environment. Susceptibility weighted angiography at 3T (Lummel et al. 2011) 
showed that central veins could be correlated with white matter lesions (WML) with or 
without demyelination. Therefore, distinguishing the origin of central vein WML from MS or 
other neuropathological changes is still problematic (Lummel et al. 2011).   
The role of perivenous space in developing MS lesions is still controversial (Ceccarelli, 
Bakshi & Neema 2012; Gaitán et al. 2013; Qian et al. 2011). Dynamic contrast enhanced 
studies may provide a better understanding of the relationship between the central vein 
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and MS lesions. Disruption of the blood brain barrier (BBB) is an early-established MS 
lesion formation indicator (Gaitán et al. 2011).  
 
 
Figure 1.27 Distinguishing MS lesions from asymptomatic white matter lesions using T2* WI at 7T 
(A) A white matter lesion from MS patient and it shows perivenous appearance in the three orthogonal 
planes, as they are highlighted by red crosshairs. (B) A white matter lesion in non-MS patient, as we can 
observe in the zoom images, no central vessel within the lesion, reproduced from (Tallantyre, E et al. 2011).  
 
However, it is not well defined whether the BBB disruption is the primary event that leads 
to lesion formation, or a secondary event that occurs after diffuse parenchymal tissue 
damage (Ceccarelli, Bakshi & Neema 2012). A recent study (Gaitán et al. 2011) has 
explored two patterns of enhanced lesions: new lesions tend to enhance centrifugally and 
established, whereas old lesions tend to enhance centripetally. This observation may be 
significant in resolving questions between opening and closing of the BBB; and also 
establishing whether vascular permeability could be used as a distinctive surrogate 
distinctive marker of acute and chronic lesions (Qian et al. 2011). 
 
1.2.6.10.2 SWI in MS animal models 
SWI hypointense lesions have been demonstrated in EAE mice immunized with MOG35-55, 
CFA and PT (Nathoo et al. 2012). These lesions were more prevalent in the lumbar spinal 
cord and cerebellum during the peak of disease severity at around days 16-19, as well as 
during long-term imaging at day 30 up to 6 months (Figure 1.28). Some of the lesions were 
no longer visible following perfusion. The percentages of the remaining lesions after 
 88 
perfusion were 60.1 % and 46.6% in the spinal cord and cerebellum, respectively. This 
could be an indicator of the role of deoxyhemoglobin in the lumen vessels, in which they 
would have disappeared in ex vivo imaging (Nathoo et al. 2012). Histopathology analyses 
of SWI hypointense lesions revealed iron deposition, inflammation and demyelination 
within the white matter of the lumbar spinal cord, and inflammatory perivascular cuffs 
within the white matter of the cerebellum (Nathoo et al. 2012).  
Table 1-4 summarizes MRI observations that are similarly observed in both patients with 
MS as well as rodent models of MS. In Table 1-5, the underlying pathologies, which cause 
changes in MRI signals in MS, have been summarized. The typical parameters used in 
MRI studies of using rodent models of MS are summarized in Table 1-6. 
 
 
Figure 1.28 Visualization of SWI hypointense lesions in the cerebellar white matter of EAE mice.  
MS lesions can be observed in SWI (zoomed column) during the peak EAE (18 days post immunisation) and 
long-term disease progression (6 months post immunisation). These lesions (black arrows) have not been 
detected in the naive and control mice immunized with complete Freud adjuvant and pertussis toxin. SWI 
was acquired using 3D gradient echo flow compensated at 9.4T, imaging parameters: TR/TE= 50/4 ms, 
FA=15°, NEX=17, FOV=0.92×1.28×1.28, voxel size=48×100×400 µm), reproduced from (Nathoo et al. 
2012).  
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Table 1-4 Correlation between MRI observations in patients with MS and rodent models 
MRI observations Human MS studies Rodent MS studies 
T1WI hypointensity 
lesions 
Detection of advanced MS 
lesions and tissue damage 
(Ceccarelli, Bakshi & 
Neema 2012). 
Detected in the TMEV mouse model to 
investigate the role of the adaptive 
immune system(Pirko et al. 2008). 
T2WI hypointensity 
lesions in the deep grey 
matter 
Correlation with clinical 
disabilities (Bakshi et al. 
2001). 
Requires detection using 
high magnetic field, such 
that it may be difficult to 
apply in the clinical setting.  
Observed in the TMEV mouse model and 
could be useful for efficacy assessment 
of novel MS treatments (Pirko et al. 
2009). 
Changes in brain 
volumes 
Distinct biomarker for 
advanced disease 
progression(Ge et al. 2000; 
Rudick et al. 1999; 
Stevenson et al. 2000). 
In EAE mouse model, the loss of cortical 
volume was due to loss of Purkinje cells 
in the molecular cortex (MacKenzie-
Graham, Allan et al. 2012; MacKenzie-
Graham, A. et al. 2009). 
USPIO enhancement  An indicator of immune cell 
infiltration and 
inflammation (Vellinga et 
al. 2008). 
Observed in the relapsing remitting EAE 
mouse model of MS; linked with 
presence of macrophages and 
demyelination(Brochet et al. 2006).  
Central veins observed 
on T2* WI and 
hypointensity on SWI 
Distinctive markers in 
distinguishing 
demyelinating from non-
demyelinating MS lesions 
(Tallantyre, E et al. 2011) 
Similar type of lesions were observed in 
the lumbar spinal cord and cerebellum of 
chronic EAE-mice (Nathoo et al. 2012) 
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Table 1-5 Summary of MRI observations and pathological correlations 
Technique MRI changes 
in patients 
with MS 
Pathobiological correlations Human study Ref Animal study 
Ref 
T1 WI Hypo-intensity Severity of tissue damage (Bakshi et al. 2005) (Pirko et al. 
2008) 
T2 WI Hyper-
intensity 
Active (developing) MS lesions (Ceccarelli, Bakshi 
& Neema 2012) 
(Nessler et al. 
2007) 
T1 pre/post 
contrast 
Hypo-intensity Combination of demyelination and 
axonal loss 
(Filippi et al. 2012) (Nessler et al. 
2007) 
T1 post 
contrast 
Hyper-
intensity 
Permeability of the blood brain 
barrier and activity of MS lesions 
(Vellinga et al. 
2008) 
(Nessler et al. 
2007) 
MD Increase Extracellular edema and 
inflammation 
(Rovaris, M. et al. 
2005) 
(Wu, QZ et al. 
2007) 
FA Decrease Lower axonal bundle coherence in 
WM lesions or lesions in NAWM 
(Hygino Jr et al. 
2011; Pagani et al. 
2007) 
(Sun, S et al. 
2007) 
Axial 
diffusivity 
Decrease Axonal damage (Roosendaal et al. 
2009) 
(Song et al. 
2005; Zhang, J 
et al. 2012) 
Radial 
diffusivity 
Increase 
 
Demyelination 
MTR Decrease Progressive demyelination over 
time 
(Chen, JT et al. 
2008; Horsfield et 
al. 2003; Miller, D, 
Thompson & Filippi 
2003) 
(Aharoni et al. 
2013) 
Recover Partial remyelination within active 
MS lesion 
SWI Hypointense 
lesions on 
SWI images 
Distinguishing biomarker of active 
and chronic MS lesions 
(Lummel et al. 
2011) 
(Nathoo et al. 
2012) 
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Table 1-6 Typical MRI parameters for imaging animal models of MS 
MRI acquisition parameters and analysis	   MS model Ref 
2D in vivo imaging at 9.4T 
Quantitative T2: multi spin multi echo (MSME) sequence, 16 
echoes (TE=10-160 ms), TR=300ms, NA = 2, in plane resolution 
86×86 µm2, 1 mm slice thickness 
MTR: two spin echo (SE) images with and without off-resonance 
pulses, TR/TE = 3000/10 ms, 2KHz off resonance pulse, NA =2, 
in plane resolution 86×86 µm2, 1 mm slice thickness 
DTI: DWI spin-echo EPI, TR/TE = 3000/25 ms, Δ/δ = 10/4.5 ms, 
four EPI segments, 1 b0, 15 diffusion encoding gradients, b= 
1000 s/mm2, 150×150 µm2, 1mm slice thickness 
Data analysis based on whole brain histogram and voxel based 
analysis (VBA) 
Chronic EAE in 
C57BL6 mice 
Relapsing remitting 
EAE  
in SJL mice 
(Aharoni et al. 
2013) 
3D in vivo imaging at 7T 
T1 WI: gradient echo fast low angle shot (FLASH) sequence, 
TR/TE = 15/4.5 ms, NA = 2, with 125x150x150 µm3 resolution 
T2 WI: fast spin echo (FSE) sequence, TR/TE=1500/70ms, RARE 
factor 16, with 125x150x150 µm3 resolution 
Brain structure (ventricular volume) was measured using semi 
automated tracing method. 
TMEV induced 
chronic progressive 
demyelination  
in SJL mice 
(Pirko et al. 
2011) 
3D in vivo imaging at 7T 
T2 WI: MSME sequence, TR/TE=5741/50ms, 8 echoes, NA = 16, 
150 µm3 isotropic resolution 
3D ex vivo imaging at 7T 
T2 WI: fast spin echo (FSE) sequence, TR/TE=5741/50ms, Echo 
train length (ETL) factor= 8, NA = 80, with 64 µm3 resolution 
Semi-automated skull stripping using BrainSuite2, image 
registration using Automated Image Registration, and processing 
using LONI Pipeline Processing Environment. 
Chronic EAE by 
CFA+PTX 
immunization in 
C57BL6 mice 
(MacKenzie-
Graham, Allan 
et al. 2012) 
 
2D in vivo imaging at 4.7T 
DTI: DWI spin echo sequence resolution, TR/TE = 1500/50 ms, 
D/d = 25/8 ms, 6 diffusion encoding directions, NA = 4, in-plane 
resolution 59×59 µm2, 1 mm slice thickness, 3h acquisition 
AD, RD and RA maps were analysed using ROI based analysis. 
Cuprizone induced 
demyelination in 
C57BL6 
(Xie et al. 2010) 
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3D in vivo imaging of cerebellum and lumber spinal cord at 9.4T 
SWI: Gradient echo flow compensated (GEFC) 
TR/TE=4/50 ms, NEX=17, Resolution 48×100×400µm3,coronal 
slices for cerebellum and axial slices for lumber spinal cord. The 
mice were imaged at 16-19 days, in addition to long term 30 days 
and 6 months post immunization 
Chronic EAE 
induced in C57BL6 
by MOG+CFA+PTX 
(Nathoo et al. 
2012) 
2D in vivo of the brain and upper spinal cord at 1.5T 
Detection of USPIO/macrophages: Coronal T2 WI fast spin echo 
(FSE), TR/TE= 1437/100 ms, coronal T1 spin echo (SE), TR/TE= 
500/10 ms, with in plane resolution =58.6×58.6 µm2, Slice 
thickness=3000µm 
The mice were imaged 9.2±2.8 days post immunisation after the 
first attack and another group imaged again during the second 
attack 17.9±4.4 post immunisation 
Relapsing-remitting 
EAE induced in DA 
rats using emulsion 
consists of spinal 
cord + incomplete 
Freud’s adjuvant 
(IFA) 
(Brochet et al. 
2006) 
3D in vivo imaging at 7T 
Detection of BBB leakage: Pre and post Gd contrast T1 WI SE 
TR/TE= 150/8 ms, NEX=1, Resolution= 200×200×200 µm3 
BBB leakage volumes were generated using semiautomatic 
method based on combination of threshold and seed growing tool. 
Assessing vascular 
permeability using 
combination of 
PIFS and TMEV 
models 
(Johnson, HL et 
al. 2012) 
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2 Research hypothesis and aims 
2.1 Justification  
The major hallmarks of MS include neurodegeneration, demyelination, axonal damage and 
nerve injury (Lassmann, H. 2013; Trapp & Nave 2008). Detection of demyelinated lesions 
in the cerebral cortex has been an integral part of multiple sclerosis pathology (Cifelli et al. 
2002; Kidd et al. 1999). It has been recognized in several MS pathology studies that 
demyelination may not only affect the white matter structures, but also in the cortical grey 
matter and deep grey matter nuclei (Lassmann, Hans 2012; Vercellino et al. 2009). In MS 
patients, the common observed cortical lesions are subcortical, perivascular intracortical in 
addition to subpial, which appear as band-like and extends to over the adjacent gyri and 
sulci. The subpial lesions are extensive and can be observed in cerebrum (Kutzelnigg, A. 
et al. 2005), the cerebellum (Kutzelnigg, A et al. 2007), and the hippocampus (Geurts, JJ 
et al. 2007).  
Cortical lesions are especially interesting because they were observed during both early 
(Lucchinetti et al. 2011) and late stages of MS (Magliozzi et al. 2007; Serafini et al. 2004). 
However, investigation and tracking these lesions in the early stage relapsing remitting MS 
patients were difficult due to limitation of the acquired spatial resolution (Tallantyre, EC et 
al. 2010) and accurate diagnosis of the MS onset (Robinson et al. 2014).  
Conventional MRI has only low sensitivity in detecting cortical GM lesions (Seewann et al. 
2012). The structural contents of the cortex and the gray matter are characterized by 
relatively low myelin component concentration and therefore any existence cortical lesion 
would only cause small increase in T2 relaxation times (Geurts, JJG, Bo, et al. 2005; 
Geurts, JJG, Pouwels, et al. 2005). Recent developments of double inversion recovery 
(DIR), magnetisation prepared rapid acquisition gradient-echo (MPRAGE) and simple 
gradient echo T2* imaging sequences at ultra high field such as 7T have increased the 
sensitivity in diagnosing more cortical and gray matter lesions which were previously only 
reported in the autopsy studies (Sethi et al. 2012; Tallantyre, EC et al. 2010). More 
promising results were observed in a recent follow up study (Calabrese, M. et al. 2011), 
where a combination of the DTI and DIR was shown to increased the sensitivity of 
detecting pathological changes in the cortex of MS.  
The establishment of basic knowledge in neurology and immunology is important to 
develop effective therapeutic strategies for MS. Various rodent models of MS have been 
developed to investigate these specific aspects of this disease and explore the underlying 
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mechanisms (Kipp et al. 2012). EAE in the mouse is a classical MS model, which is 
characterized by development of CNS neuroinflammation that leads to demyelination and 
neurodegeneration (Robinson et al. 2014). EAE disease severity in mice varies according 
to the mouse strain and the utilized immunization protocols (Lassmann, H. 2008). But most 
importantly, recent studies showed that mouse RR-EAE model could potentially elucidate 
the factors that modulate the relapsing/remitting episodes in a human MS (Aharoni et al. 
2011; Peiris et al. 2007; Robinson et al. 2014).  
Robust imaging approaches for assessing whether axonal damage or demyelination 
occurs first in RR-EAE mice is still required (Aharoni et al. 2013; Zhang, Yunyan et al. 
2014). Axonal damage has been identified as an early feature of MS (Friese, Schattling & 
Fugger 2014; Trapp & Nave 2008), however, literature review showed that this is still a 
controversy (Lassmann, H. 2013). Most of the conventional rodent EAE models regularly 
affect the WM structures. Establishing MS animal model with clear pathological changes in 
GM motor and sensory cortex is significant for understanding the progression of CNS 
dysfunctions and it can serve as a platform for establishing new MS imaging biomarkers.  
MRI diffusion weighted imaging may aid in interpreting some specific processes occurring 
in these complex mechanisms of MS (Aharoni et al. 2013; Sun, S et al. 2007; Sun, SW et 
al. 2006). Several studies (Sun, S et al. 2007; Wang, Y et al. 2011; Xie et al. 2010) have 
reported that there are strong correlations between the myelin and axonal integrity with the 
DTI parameters. Specifically, the increase in RD could be an indicator of the myelin loss 
and axonal damage, and the decrease in AD can be linked with the changing of the axonal 
morphology and demyelination (Budde et al. 2009; Klawiter et al. 2011). Additionally, FA 
appears to be sensitive imaging marker for detecting demyelination and determine the 
integrity of the connectivity of the brain structures in mild model of mouse RR-EAE. It was 
shown that changes in the anisotropy of the affected white matter in the chronic EAE 
model such as the optic tract could be detected as a reduction in FA and AD (Sun, S et al. 
2007; Zhang, J 2010).	   Also, ADC has been suggested to be indicator of existing 
inflammation after the onset of the disease in the RR-PLP model (Aharoni et al. 2013).  
  
 95 
2.2 Hypothesis and Aims  
The aim of this project is to use DWI to assess the sensory and motor deficits in EAE-
mice. This study will use novel optimized EAE immunization protocol to produce mild 
relapsing remitting MS-like clinical symptoms with partial recovery between relapses 
(Khan, Woodruff & Smith 2014; Peiris et al. 2007).  
We hypothesize that conventional MRI diffusivity parameters (MD, FA, AD and RD) can 
serve as surrogate biological markers in the mild RR-EAE model associated with the 
disease progression.  
Three groups of mice were studied: (1) normal healthy controls, (2) mice induced with RR-
EAE that develop relapsing and remitting multiple sclerosis signs and, (3) mice 
administered with adjuvant only which showed only low clinical score.  
 
The specific aims of this project are as follows:   
(A) To achieve an optimal high-resolution diffusion-weighted (DWI) imaging in vivo at 
16.4T, using a high b-value and high number directions.  
This first step is fundamental to resolve several technical imaging issues that may degrade 
the quality of the acquired data at such high field strength, for example, magnetic 
susceptibility and subject motion. Two diffusion-weighted imaging sequences: spin echo 
DWI and segmented echo planar imaging were tested. The imaging sequences were 
optimized first in control subjects and subsequently applied in a small cohort of RR-EAE 
mice to probe the pathological changes during the disease cycle.  
Two experimental design questions have to be resolved to achieve this aim. Firstly, at 
which time points the mice should be scanned to effectively monitor the MS relapsing and 
remitting symptoms. Secondly, how the MRI protocol can specifically be designed to 
accommodate the diseased mice.   
 
(B) To track the pathological changes using high angular resolution and spatial resolution 
ex vivo DWI with increased spatial resolution using acute relapsing and chronic relapsing 
EAE mice. 
This step involved establishing MRI diffusion markers, which are sensitive to detect 
disease onset, and to differentiate the advanced progression of the 
demyelination/remyelination processes and the axonal damage in the mild MS model. In 
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this RR-EAE mice model, the clinical presentation of the disease fluctuates with time. This 
opens opportunities for understanding the mechanisms of the MS in the relapsing remitting 
course, which has complexity aspects (Khan, Woodruff & Smith 2014; Peiris et al. 2007). 
For instance, this will assist in differentiating between the destruction of the myelin and the 
axonal damage that is critical for the interpretation of the MS mechanism in addition to 
developing treatment strategies (Zhang, J 2010; Zhang, J, Aggarwal & Mori 2012).  
Three statistical analysis approaches were applied including ROI (region of interest) based 
analysis (Cercignani 2010), VBM (voxel based morphometry) analysis (Smith, Kindlmann 
& Jbabdi 2014) and TBSS (tract based spatial statistics) (Bodini et al. 2009); to establish 
correlation between the control, adjuvant and EAE mice.   
  
(C) To establish the correlation of the diffusion parametric images with the disease 
progression in RR-EAE mice with validation using histology.  
After the ex vivo MRI experiment, the animal were sacrificed and the appropriate histology 
examination performed. Black and gold (BG) Myelin staining can be useful for correlating 
pathological changes in the brain with the pattern of changes in the DW images of control 
and RR-EAE mice. BG staining can be used to visualize and confirm the area of the 
demyelination and loss fibres in the motor and sensory cortical areas (Savaskan et al. 
2009; Schmued et al. 2008).  
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3 Materials and Methods  
All mice were housed and handled in accordance with Queensland Animal Care and 
Protection Act 2001 and the current NHMRC Australian Code of Practice for the Care and 
Use of Animals for Scientific Purposes, under two ethics approvals: 
CIPDD/170/11: Model design and imaging sequence development 
CAI/004/11: RR-EAE mouse brain imaging study 
 
3.1 Immunization Protocol  
EAE was induced in C57BL/6 female mice (4-6 weeks old) by subcutaneous injection of 
MOG35-55 (200µg) emulsified in saponin adjuvant (Quil-A) (45µg) and an intraperitoneal 
injection of pertussis toxin (PT) (200-250ng) as adjuvant to temporarily open the blood 
brain barrier. A second, identical injection of pertussis toxin was administered after 48 h. 
Sham mice received Quil-A and pertussis toxin only. Mice were monitored once daily over 
the 60-day experimental period for clinical scoring using a 0-5 point scale with half-point 
gradations (Khan, Woodruff & Smith 2014; Peiris et al. 2007).  
 
3.2 Animal behaviour measurements 
EAE is an MS model that can be adapted to mimic specific aspects of the complex MS 
disease. It can be tailored to obtain mono- or multiphasic clinical symptoms, with either 
acute, chronic or relapsing patterns (Khan & Smith 2013; Kipp et al. 2012). For this study, 
a novel relapsing remitting multiple sclerosis mouse model has been developed in the 
School of Pharmacy at The University of Queensland. The initial development of this 
model on C57BL/6 mouse strain (Khan, Woodruff & Smith 2014; Peiris et al. 2007) 
showed fluctuating MS symptoms and reduction of clinical symptoms during the remission 
period. Symptomatic progression of EAE in this MS model was tracked by assigning 
clinical scores on a scale of zero to 5 according to correlation with animal behaviour. Table 
3-1 shows the correlation between the score and the clinical symptoms (Khan, Woodruff & 
Smith 2014; Peiris et al. 2007). 
Figure 3.1 shows the clinical course of the relapsing remitting MS in EAE and sham mice, 
as assessed by the clinical behaviour of the first EAE (MOG) group: the first episode, the 
acute stage, occurred between days 12-14 post immunization and reached the maximum 
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score of 1.5, which is characterised by limp tail and hind limb weakness. The first EAE 
episode is followed by a recovery period and a decrease in the disease symptoms until it 
reaches the minimum achievable clinical score of approximately 1 between days 18 to 20. 
Then followed, five days after the recovery, a period of relapse. The first relapse was 
similar to the initial disease presentation, whereas two later relapses were milder. After the 
first EAE episode, the EAE mice continued showing a fluctuation of the clinical score 
between 1 to 1.5. This suggests our model is mild in term of MS symptoms potentially 
providing significant understanding of how neurological impairment occurs during the 
relapsing remitting cycle. In addition to naïve control mice, a second control group was 
generated by administering mice with adjuvant and pertussis toxin only without MOG. The 
maximum clinical score observed for this group was 0.5 which is characterised by distal 
tail limpness, hunched appearance and quiet demeanour. The mice behaviour scored 
fluctuated continuously until the end of the cycle (Kipp et al. 2012; Peiris et al. 2007). 
Naïve control mice experienced no clinical symptoms and had zero clinical score. The 
preparation and animal score monitoring procedures were carried out by Nematullah Khan 
(PhD student supervised by Prof Maree Smith at the School of Pharmacy; University of 
Queensland). 
 
Figure 3.1 Cinical score and animal behavior of sham and EAE mice during the RR disease cycle. 
Adapted from (Khan, Woodruff & Smith 2014). 
 
Two experimental design questions were to be tested during the development of the MRI 
study of this EAE model. (1) At which time points should the mice be scanned to effectively 
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monitor the MS relapsing and remitting symptoms? This can be determined using 
conventional MRI sequences to identify MS lesions, whilst also considering the scores of 
the clinical symptoms of the affected mice. (2) What is the tolerance of the diseased mice 
to the imaging experiment? This was examined by monitoring the EAE mice during 
scanning with DWI sequences, recognising that the acquisition time is approximately two 
hours, uses respiratory triggering and the affected mice are experiencing mild symptoms.  
 
Table 3-1 Correlation between clinical scoring and RR-EAE symptoms 
Clinical score	   Animal behaviour	   Clinical score	   Animal behaviour	  
0	   No observed signs; the mouse can 
move normally and very active; e.g. 
the tail is erect. 	  
0.5	   Distal tail limpness, hunched 
appearance and quiet 
demeanour. 	  
1.0	   Completely or partially limp tail. The 
mouse has poor gait because of the 
weakness in the hind limbs. Another 
observed sign is reduced ability of 
the hind limbs grip. 	  
1.5	   Limp tail and hind limb 
weakness. This characterized by 
unsteady gait and significant 
activity reduction. 	  
2	   Unilateral partial hind limb paralysis	   2.5	   Bilateral hind limb paralysis	  
3	   Complete bilateral hind limb paralysis	   3.5	   Complete hind limb paralysis 
and unilateral forelimb paralysis	  
4	   Total paralysis hind limb and forelimb	   4.5	   Moribund	  
5	   Death	     
Adapted from (Peiris et al. 2007). 
 
3.3 In vivo MRI studies at 16.4 T 
3.3.1 Animal preparation 
Anaesthesia was induced with 3% Isoflurane/oxygen and maintained at 1–1.5%, at a flow 
rate of 1 L/min (Aggarwal et al. 2010) during DWI experiments. Small adjustments to the 
isoflurane concentration was used to maintain the respiratory rate between 60 and 75 
beats per minute and the animal body temperature was maintained at 30oC using warm 
water circulation of the MRI gradient (Aggarwal, Zhang & Mori 2012; Harsan et al. 2010).  
3.3.2 Imaging equipment 
MRI data were acquired on a 16.4T vertical wide-bore microimaging system, running 
Paravision 5.1 (Bruker Biospin, Karlsruhe, Germany), using a micro 2.5 gradient system 
and 20 mm SAW volume head coil (M2M Imaging, Brisbane, Australia). To reduce 
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geometrical distortions, the mouse brain was initially shimmed globally using a standard 
free-induction decay (FID)-based first order and Z2 shimming procedure (Wu, D et al. 
2014). Secondly, a Bruker Mapshim protocol, which employs magnetic field-map 
information, was used to optimize the shimming of the whole head volume. Finally, a 
localized shim was performed on a rectangular voxel derived using the Point Resolved 
Spectroscopy (PRESS) method and placed in the centre of the brain to refine the first and 
second order shims (Harsan et al. 2010). 
 
3.3.3 DWI imaging sequences 
3.3.3.1 Segmented EPI-DWI 
The segmented EPI-DWI sequence consists of a single 90°excitation and a 180° 
refocusing pulse followed by alternating frequency and phase-encoding gradients 
(DeLaPaz 1994; Stehling, Turner & Mansfield 1991).  Diffusion gradient pulses are placed 
on either side of the 180o RF pulse (Basser, P. , Mattiello & LeBihan 1994). A schematic 
diagram of the segmented-DWI-EPI can be seen in Figure 3.2.  A Bruker Stejskal-Tanner 
pulse-field gradient spin-echo was interfaced with a segmented EPI read-out sequence to 
acquire the data with the following parameters: repetition time (TR) = 6000 ms, sampling 
bandwidth 500 KHz, a minimum echo time (TE) = 13.97 ms to accommodate the two 
identical diffusion gradients with δ/Δ = 2.4/6.4 ms and a b-value of 3000 s/mm2. Four 
dummy scans were employed to reach a steady state net magnetization. Sixty-four 
diffusion direction-encoding measurements were acquired within approximately 55 minutes 
(without respiratory triggering) and 2 hours (with respiratory triggering). Two excitation 
averages (NEX) were used to increase the SNR and to reduce the motion artefacts, whilst 
maintaining a reasonable experimental time frame of 2 hours.  
MRI data were acquired from 24 contiguous slices acquired at 0.6 mm thickness with FOV 
= 1.60×0.96 cm and matrix size = 128×64, resulting in an acquired resolution of         
125×150 µm2. Partial k-space data were acquired in the phase encoding direction with a 
combination of partial Fourier transform (FT) and zero-fill acceleration factor of 1.35 (FT 
overscans = 15). The encoding acceleration permits the truncation of full k-space 
acquisition by approximately 30% and consequently reduces the experiment time. 
Encoding acceleration in the frequency-encoding direction was not used, as it provides no 
reduction in the acquisition time. The encoding acceleration allowed the truncation of the 
echo train length (ETL) and consequently shortened the apparent echo time to avoid 
acquisition at the late stage of the T2 relaxation period (Figure 3.3).  
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Figure 3.2 Schematic diagram of segmented EPI-DWI.  
The segmentation of the echo train length is required to reduce off-resonance artefacts. The time between 
two 90° excitation pulses is the repetition time (TR) and the time from the first 90° excitation pulse to the 
central echo acquisition is the average echo time (TE). Δ is the separation time between the two applications 
of diffusion-encoding gradients and δ refers to the duration of the application of the diffusion gradients, RF 
refers to radiofrequency, Gz (slice gradient), Gy (phase gradient), Gx (readout gradient).  
 
	  
Figure 3.3 The method of zero-filling and partial Fourier transform.  
This diagram shows the combination of the zero filling and partial Fourier transforms and how they are 
applied to fill the k-space. Zero filling reduces the echo train length and consequently avoids acquisition at 
late echo period with significant signal decay. A partial Fourier transform reduces the experiment time by 
30%.  (Diagram is adopted from Burker Paravision 5.1 manual). 
 
The EPI echo train was segmented into 10, 8, 4 and 2 segments to assess the optimal 
level of segmentation with respect to acquisition time, sensitivity to motion artefacts and 
reduction of the echo time. Four segmentations were found to be optimal. A total of six 
naïve animals were imaged using the optimized segmented EPI-DWI sequence and the 
same imaging experiment was repeated twice in four animals. The optimized segmented 
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EPI-DWI protocol was then tested on 6 mice during acute stage (3 EAE and 3 sham mice), 
and 6 mice during chronic stage (3 EAE and 3 sham). However, this was done during the 
development process of the immunization protocol at the School of Pharmacy, before the 
dosage of administered components was standardized.   
Image processing and analysis: Prior to Fourier transform, the matrix was zero-filled to 
256×128, resulting in a final image in-plane resolution of 62.5×75µm2. To reduce motion 
artefacts, diffusion images were registered to a single b0 image (without application of 
diffusion gradients) using 2D translation only rigid body registration using the FSL FLIRT 
program. FA, MD, AD and RD maps were calculated using the MRtrix program (Tournier, 
Calamante & Connelly 2012). 
ROIs were drawn manually around the white matter (WM) structures on the FA map of 
each individual mouse using an ITK-snap (Yushkevich et al. 2006). The corpus callosum 
was divided into small segments, including forceps minor and major, rostral, middle and 
caudal. Other WM structures examined included the external capsule, right and left 
cerebral peduncles, optic tracts, internal capsule and optic nerve, segmented according to 
the histological atlas (Figure 3.4) (Paxinos 2004).  
3.3.3.2 Spin Echo (SE)-DWI 
For comparison with EPI-DWI, one spin-echo (SE)-DWI HARDI data set was acquired with 
16 contiguous slices, with 0.8 mm thickness, FOV = 1.60×0.96 cm and matrix size = 
128×64, resulting in an acquired in-plane resolution of 125×150µm2. Partial Fourier k-
space encoding acceleration was applied in both the phase- and frequency-encoding 
directions using an acceleration factor of 1.65 in the phase direction factor and FT 
overscans = 10. In the frequency direction, a zero fill factor of 1.35 was used. However, 
the calculated acquisition time was over 3 hours with respiratory triggering. Such a long 
imaging time was deemed to be intolerable for the animals, and thus only one sacrificed 
animal was imaged using this protocol. SE-DW images were processed, using the MRtrix 
program, in same manner as the segmented EPI DW images (Tournier, Calamante & 
Connelly 2012). 
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Figure 3.4 Schematic ROI representations for the measurement of DTI parameters acquired from 
segmented 2D EPI DWI in vivo.  
ROI were drawn manually on FA maps of each individual mouse. This image sequence represents rostral 
(top left) to caudal (bottom right) brain slices. The following structures were analyzed: Rt (green) and Lt 
(brown) optic nerve (ON), forceps minor corpus callosum (fmi) (navy), rostral corpus callosum (R-cc) (red), 
middle corpus callosum (M-cc) (green), external capsule (ec) (yellow), fimbria (fi) (dark blue), internal 
capsule (ic) (green), caudal corpus callosum (C-cc) (blue), Rt (navy) and Lt (pink) optic tract (opt), Rt (brown) 
and Lt (red) cerebral peduncle (cp) and forceps major corpus callosum  (fmj) (dark red). 
 
3.3.4 In vivo structural MRI  
In vivo T1, T2 and T2* weighted images (WI) were acquired to detect active EAE lesions in 
the mouse brain during the disease cycle. The imaging protocols for these sequences are 
summarized in Table 3-2. T1 and T2 weighted images were acquired using 2D multi-slice 
multiple echo (MSME) and T2* weighted images were acquired using 2D Fast low angle 
shot (FLASH) (Ahrens et al. 2002; Driehuys et al. 2008; Pohmann, Rolf, Shajan, G & Balla, 
DZ 2011; van de Ven et al. 2007).  
5mm 
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Table 3-2 imaging parameter of in vivo T1, T2 and T2* weighted imaging at 16.4T 
Parameters  T1 WI  T2 WI T2* WI 
Repetitions time (TR)  700ms 2000ms 420ms 
Echo time (TE) 8ms 14ms 4.1ms 
Flip angle (FA) 90° 90° 35° 
FOV 1.60×0.96 1.60×0.96 1.60×0.96 
Matrix size 128×64 128×64 128×100 
Slice thickness, 
slices number  
0.6 mm, 24 slices 0.6 mm, 24 slices 0.6 mm, 24 slices 
Resolution 125×150µm2 125×150µm2 125×96µm2 
Encoding 
acceleration factor 
1 1 1 
NEX 4 4 8 
Experiment time  2m 59s 2m 8s 3m 48s 
 
3.3.5 In vivo MRI of preliminary EAE mouse model 
Subsequent to optimizing the in vivo segmented EPI-DWI protocol, the method was 
applied to detect pathological changes in the RR-EAE mouse model. However in this first 
series, EAE induction used only low MOG and adjuvant doses. These tested animals were 
prepared using the dosage shown in Table 3-3. 
 
3.4 Ex vivo MRI studies at 16.4T 
In initial experiments, the optimized in vivo segmented EPI-DWI protocol was applied to 
detect pathological changes in the RR-EAE mouse model injected with high and low doses 
of MOG and adjuvant. Subsequently, ex vivo imaging studies were designed to acquire 
high-resolution images without being constrained by the experiment time, and using RR-
EAE model induced with the optimized, higher dose of MOG and adjuvant according to the 
animal behaviour during the EAE cycle. 
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Table 3-3 Summary of preliminary RR-EAE mice used for in vivo imaging 
Stage Group Dose Score 
Optimized chronic 
group  
1 sham 1X adjuvant 0 
1 EAE MOG (200 ng) + 1X 
adjuvant 
1.5 
Chronic (54-57 days 
post immunization)  
1 sham 3X adjuvant 0.5 
2 EAE MOG (200 ng) + 3X 
adjuvant 
1.5 
Acute (13-16 days 
post immunization) 
3 sham 3X adjuvant 0.5 
3 EAE  MOG (200 ng) + 3X 
adjuvant 
1.5 
1X adjuvant (15 µg Saponin) + pertussis (400ng), 3X adjuvants (45 µg Saponin) + 
pertussis (500ng) 
 
3.4.1 Sample preparation 
Ex vivo MRI samples were prepared using C57BL6 mice in the following groups: (i) non-
disease control animals (n=8); (ii) acute (day 13-16 post injection): 7 sham and 7 EAE, (iii) 
chronic (day 54-57 post injection): 7 sham and 9 EAE. Mice were anaesthetized and 
transcardially perfused with 0.1 M phosphate-buffered solution (PBS) followed by 
immersion of mouse heads in 4% (paraformaldehyde) PFA for 24 h. Following extraction, 
brain tissues were washed with PBS for 48h prior to MR imaging (Cahill et al. 2012; 
Calamante, Fernando et al. 2012). The brain samples were then immersed in Fomblin to 
preserve the sample during long imaging periods. The scanner room temperature was 
maintained at 22°C (Benveniste & Blackband 2002).  
3.4.2 DW MRI acquisition  
Ex vivo MRI experiments were carried out using polarized birdcage RF coil. 3D ex vivo 
HARDI data were acquired using the Stejskal-Tanner pulse-field gradient spin echo 
sequence (Calamante, Fernando et al. 2012), with 30 diffusion gradient directions at b = 
3000 s/mm2, δ/Δ = 2.4/6.4 ms, TR/TE = 400/14.5 ms, two b0, and at 100 µm3 isotropic 
resolution.  Two images were also acquired with identical parameters but with b = 0.  The 
total acquisition time was 14h 44m. DWI spin echoes were zero-filled by a factor of 1.5 
prior to a Fourier transform, resulting in 67µm3 3D isotropic resolution. Diffusion tensors 
imaging (DTI) parametric maps were calculated using the MRtrix program (Tournier, 
Calamante & Connelly 2012). 
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3.4.3 Ex vivo structural MRI  
Ex vivo structural images were acquired to correlate pathological changes detected with 
changes observed in DTI images. These include 3D Fast Low angle shot (FLASH) to 
produce T2* weighted images and 3D multiple gradient echo (MGE) to produce T2* 
weighted images which can be used to produce quantitative susceptibility weighted 
images (frequency maps) (Lee, J et al. 2012). 
T1 and T2 relaxation times were calculated from 2D RARE VTR (rapid acquisition with 
relaxation enhancement) acquired with variable TR and TE with RARE acceleration factor                 
was set to 1 (Bitar et al. 2006; Shah et al. 2011). In addition, 2D multiple gradient echo 
(MGE) was acquired to quantify the T2* relaxation time (Chavhan et al. 2008; Chavhan et 
al. 2009). Table 3-4and 3-5 summarized the imaging parameters of ex vivo structural MRI.  
 
Table 3-4 Imaging parameters for ex vivo 3D FLASH and 3D MGE 
Parameters 	   3D FLASH (T1 & T2* WI)	   3D MGE (T1 & T2* WI)	  
Repetitions time (TR)  20 ms 80 ms 
Echo time (TE) 10 ms 6, 15.50, 25, 34.50 and 44 ms 
Flip angle (FA) 20° 30° 
FOV 2.10×1.20×0.90 cm 2.10×1.20×0.90 cm 
Matrix size 420×240×180 420×240×180 
Resolution	   50 µm3 isotropic 	   50 µm3 isotropic  
Encoding acceleration factor Zero fill acceleration for 1st and 2nd 
phase encoding directions = 1.34;  
All set to 1  
NEX 4	   1	  
Experiment time 	   32m 38s 	   57m36s 
 
Table 3-5 Imaging parameters for 2D T1 and T2 measurements using RARE VTR and T2* measurement 
using MGE 
Parameters  2D T1 T2 measurement using 
RARE VTR sequence 
T2* measurement using MGE 
sequence 
Repetitions time (TR)  800, 1082.7, 1478, 2142, 5000ms	   2500ms 
Echo time (TE) 7.5, 15, 22.50, 30, 37.5, 45ms  4.50, 10.56, 16.62, 22.68, 28.74, 
34.81, 40.87, 46.93ms 
Flip angle (FA) 90° 30° 
FOV, 1.28×0.90cm 1.28×0.90cm 
Matrix size 128×128 256×128 
Slice thickness  0.6 mm 0.6 mm 
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Resolution 100×70 µm2 50×70 µm2 
Encoding acceleration factor 1, RARE factor=1 1 
NEX 1 4 
Experiment time  22m24s 21m20s 
 
3.5 Image registration  
3.5.1 Template generation 
For spatial normalization, a study-specific template was created from all controls, acute 
and chronic EAE and sham mice (n=10) using Advanced Normalization Tools (ANTs. 
V1.9.x, http://picsl.upenn.edu/ANTS/). A group-wise diffeomorphic normalization procedure 
(SyN, as implemented in the build template parallel.sh script V0.0.13) was employed on 
the realigned FA maps and b0 images of each mouse. A FA map and a b0 template            
(T1-weighted image) were created from all datasets (Avants, Tustison & Song 2009). The 
protocol for template generation using ANTS took approximately 72 hours using a 7-core 
Xeon Linux Workstation.  
Subsequent to the template generation, additional ex vivo data from all controls, acute and 
chronic EAE and sham mice (n=28) were acquired to increase statistical power. All 
individual data to template were registered using FMRIB's Linear and Non-Linear 
registration tools (FLIRT/FNIRT) to maintain the similarity of registration tool of dataset 
between pre- and post- template generation and with that employed by Tract Based 
Spatial Statistics (TBSS, refer to section 3.5.3). 
3.5.2 Linear registration  
FLIRT (FMRIB's Linear Image Registration Tool) is an FSL software tool used to perform 
linear (affine) registration of brain images and allow translation, rotation, 
expansion/shrinking and shearing to match one image to another (Jenkinson et al. 2002; 
Jenkinson & Smith 2001). All brain images were registered to the template using the 
FLIRT tool (Greve & Fischl 2009). The following parameters were used during linear 
registration: cost function = normalized correlation for intra model registration; full 
orientation and angular alignment search in X, Y and Z axes; degrees of freedom =12 to 
perform 3D affine registration of images with the same imaging modality; interpolation 
method = trilinear with nearest neighbour. The interpolation is part of the final 
transformation and not part of registration tool (Greve & Fischl 2009; Jenkinson et al. 
2002; Jenkinson & Smith 2001).  
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3.5.3 Non-linear registration  
FLIRT (FMRIB's Non-Linear Image Registration Tool) can be applied to perform global 
affine transformations of the images; whereas FNIRT is typically applied to perform local 
warps within the image, which can be either coarse or fine warps depending on the 
degrees of freedom selected (Smith, Kindlmann & Jbabdi 2014). The resolution of the 
template and the input images was 0.067mm isotropic. To avoid convergence to a false 
local minimum, the following parameters were used for FNIRT three-step registration: A) a 
gradual decrease of subsampling factors from 4 to 2, and then 1, so that registration is 
initially done at coarse resolution and at the last step images are registered at the full 
resolution. B) A gradual decrease in the level of image smoothing at 0.3, 0.15, and 0 mm 
for the input and reference images, where the final registration step is done without 
smoothing. C) Warp field resolutions of 1, 1, 1 mm which specify the position of the points 
of displacement fields. D) Bias field resolutions of 5, 5, 5 mm, which is used to control the 
sensitivity to image bias that can vary gradually over the space. It is suggested that the 
bias field resolution should be set to 5x the warp field resolution. E) Lambda smoothing of 
30, 15 and 4 for smoothing of the warp field to the reference image and controlling how 
much smoothing affects the input image. Lambda values have to be selected carefully to 
match the type of data. F) The number of iterations for each step was set to 5, 5, 5, to 
reach a compromise between the accuracy of the registration and the length of registration 
protocol. G) Intensity modelling was used for the two steps, and none in the final 
registration step. H) Masks were applied in both reference (template) and input image to 
help registration. The MD, AD and RD maps were then shadow registered to the mouse 
brain template using FSL applywarp command. The Jacobian (tissue displacement) map 
from each sample was produced during FNIRT registration of 3D ex vivo b0 DWI to the 
template image.  
  
3.6 Statistical data analysis 
After registering the FA maps of the brain samples to the FA template; the following data 
analysis methods were used: ROI based analysis (Cercignani 2010), voxel based 
morphometry analysis (VBM) (Whitwell 2009) and tract based spatial statistics (TBSS) 
(Smith et al. 2006; Smith et al. 2007). Figure 3.5 shows the image-processing pipeline of 
the DWI data using ROI and VBM based analysis. All b0 images were registered using the 
same methodology as used for FA maps (Section 3.5.1). Subsequently, using FSL’s 
applywarp command, the MD, AD and RD maps were shadow-registered to the template.    
 109 
 
Figure 3.5 Summary of the image-processing pipeline of the DWI data using ROI and VBM based 
analyses  
 
3.6.1 ROI based analysis 
3.6.1.1 3D ex vivo DTI 
ROI based analysis can be defined as a selection of a specific area in the examined 
images (Cercignani 2010). This analysis method is highly sensitive in detecting small 
changes specifically when the ROIs are drawn in small and specific areas in the brain 
(Cercignani 2010). However, the definition of the ROI should be based on the anatomical 
knowledge and requires clearly defined guidelines (Jones, D. K. & Cercignani 2010).  
ROI based analysis require prior hypothesis to determine the location of the pathology. In 
addition, it is a time-consuming method and operator dependent. Therefore it could be 
highly susceptible to a large inter-rate variability (Filippi et al. 1998; Mitchell et al. 1996; 
Rovaris, Marco et al. 1999). The ROI size controls and affects the measurement results. 
Increasing the ROI will dramatically reduce the standard deviation. But this will increase 
susceptibility to partial volume effects, for example, signal coming from different structures 
such as corpus callosum and anterior cingulate in the mouse brain. It is often difficult to 
define an ROI with homogenous properties due to the limitation of MRI resolution (Pajevic 
& Basser 2003).  
In our experiment, we selected white matter (WM) structures because they are well-
defined areas in the FA map and were thought to be susceptible to MS pathological 
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changes (Sun, S et al. 2007). To acquire reliable and reproducible ROI measurements, 
twelve regions of interest (ROIs) of various WM structures were drawn manually on the FA 
template using ITK-snap, and used to determine the values from each FA map of each 
brain sample (Figure 3.6) (Yushkevich et al. 2006).   
 
 
Figure 3.6 ROIs were drawn manually around the white matter (WM) structures on the FA map 
template using an ITK-snap.  
The corpus callosum (CC) was divided into small segments, including forceps minor (fmi) (light blue; top left) 
and major (fmj) (red; bottom right), rostral (R-cc) (red, middle top) middle (M-cc) (green; top right) and caudal 
(C-cc) (bottom; left). Other WM structures examined included the external capsule (ec) (yellow) fimbria (fi) 
(dark blue), right (Rt-cp) (light blue) and left (Lt-cp)  (light red) cerebral peduncles (bottom; middle and right), 
right (Rt-opt) (dark yellow) and left (Lt-opt)  (red) optic tracts (bottom; middle and right), internal capsule (ic) 
segmented according to the histological atlas.  
 
The ROIs were drawn on the template as this provides more reproducible measurements 
because it allows accurate definition of the ROI in each brain sample. Also, inverse warps 
of these ROIs to each individual brain sample were performed and no miss-registration 
errors were detected. In our experiment, the ROI of each WM structures was 
conservatively drawn in each sample. This is critical in a thin structure such as the external 
capsule and assists in producing a homogeneous ROI and avoiding edge effects, 
consequently reducing the standard deviation (SD), although on the other hand this 
approach may affect the measurement accuracy.   
1mm 
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3.6.1.2 2D ex vivo T1, T2 and T2* maps  
For 2D data, accurate registration is difficult to obtain due to thick slices and variability in 
slight positions. In this case, ROIs were drawn manually on single slices and matched up 
to the same anatomical structures in all mice groups (Figure 3.7).  
 
 
Figure 3.7 ROIs drawn on 2D RARE images for the quantification of T1 and T2 relaxation times.  
The same ROIs were copied onto T2* maps. 1 and 2 (Rt and Lt-cing): anterior cingulate right and left 
hemisphere, 3 and 4 (Rt and Lt M): primary and secondary motor area Rt and Lt hemisphere, 5 and 6 (Rt 
and Lt S): somatosensory area Rt and Lt hemisphere, 7: corpus callosum, 8 and 9: external capsule Rt and 
Lt hemisphere, 10 and 11 (Rt and Lt HC) Hippocampus Rt and Lt and 12 and 13 (Rt and Lt CP): caudate 
putamen Rt and Lt.  
	  
3.6.2 Voxel based morphometric (VBM) analysis  
VBM is a method of analysing quantitative images such as FA, MD, AD and RD maps, is 
fully automated and does not require prior hypothesis of the expected pathology location 
(Ashburner & Friston 2000). Pre-processing steps include linear (FLIRT) and non-linear 
FNIRT registrations and smoothing achieved by spatial filtering using a mostly 3D 
Gaussian kernel.   
Smoothing is an essential step for VBM analysis for several reasons. First, it increases 
SNR by averaging and it assists in removing the effect of imperfect registration due to 
misalignment of the anatomical structures. Further, it can increase the sensitivity of 
abnormal changes if the extent of smoothing matches the size of an effect of interest. 
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Finally, it improves the Gaussian distribution of the data, which is required for the statistical 
parametric test (Cercignani 2010; Smith, Kindlmann & Jbabdi 2014). An isotropic 
smoothing kernel of 5–10 times the smallest voxel dimension is recommended for most 
studies (Sawiak et al. 2013). Large smoothing may increase the detection power at the 
expense of the spatial localization (Sawiak et al. 2013), whereas inadequate smoothing 
may decrease the sensitivity of detection of abnormal changes (Smith, Kindlmann & 
Jbabdi 2014).  
As shown in Figure 3.8, we tested the influence of the smoothing factor by assessing the 
following values: 0.05, 0.15, 0.25, 0.33, 0.67, 0.85 and 1.2 mm. A medium Gaussian 
smoothing factor at 5x voxel size (= 0.33 mm) was chosen because it appears to provide 
enough detection power while maintaining the quality of spatial resolution of the smoothed 
images.  
 
 
Figure 3.8 The influence of changing the smoothing factor to VBM results.  
Smoothing factors (A) 0.05, (B) 0.15, (C) 0.25. (D) 0.33, (E) 0.67, (F) 0.85 and  (G) 1.2. The t-value is shown 
by the hot colour map. 
 
The statistical analysis is performed on voxel by voxel basis. This is applied by multiple 
regression or equivalent methods. The analysis test can be either parametric or non-
parametric methods. In this experiment, a t-test was used to identify significant correlations 
between control, acute and chronic groups. The final VBM analysis step is a correction for 
multiple comparisons, which is essential to reduce type Ι errors because large numbers of 
5mm 
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analysis tests are done over all the brain voxels. The correction methods can be Gaussian 
random fields (Worsley et al. 1992), false discovery rate (Genovese, Lazar & Nichols 
2002) or a permutation based approach (Nichols & Holmes 2002).     
The areas of significant difference in FA, MD, AD and RD maps were assessed by VBM 
analysis, which was performed on registered brain samples using MATLAB and the 
Statistical Parametric Mapping program (SPM 5). Two t-tests were carried out to identify 
areas of a significant increase of any DTI derived parameters (adjuvant/EAE > control) or a 
decrease (adjuvant/EAE < control) with False Discovery Rate correction and p-value<0.05. 
Using the same method, the Jacobian maps were analysed to determine the presence of 
brain atrophy. (Qin et al. 2013; Shu et al. 2013).  
 
3.6.3 Tract Based Spatial Statistics (TBSS) 
TBSS was developed to resolve the major limitations of VBM, which include the alignment 
issues and arbitrary smoothing selection (Smith et al. 2006; Smith et al. 2007). TBSS is 
fully automated and does not require assumption of the location of the tracts of interest. 
TBSS is a processing tool found in the FMRIB FSL software library 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS.  
The first step in TBSS is registering each subject FA image to the mouse brain template. 
This is achieved by linear and non-linear registration FLIRT/FNIRT. In order to 
accommodate mouse brain data into TBSS pipeline without changing the code 
extensively, the resolution specified in the mouse data header file was changed from 0.067 
to 1mm isotropic, and our generated mouse brain template was used to replace the human 
brain template in the FSL database. The target subject should have minimum mean 
deformation to minimize the required warping for all subjects (Smith, Kindlmann & Jbabdi 
2014).  
After co-registering all subject FA maps, they were averaged to produce a mean FA 
image. This represents the average of the white matter tract across all subjects, which was 
used to generate a skeleton across all subjects. The skeleton of each tract can be seen as 
a single line passing through the centre of the tract. The topology of the tract differs 
according to the anatomical structure; for example the corpus callosum is composed of a 
curved sheet of certain thickness and its skeleton should be a thin curved plane surface 
passing through the centre of the sheet. On the other hand, the tract can also be a curved 
tube, which is less common, but present in structures such as the cingulum bundle. The 
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cingulum skeleton should appear as a curved line passing through the centre of the tube 
(Figure 3.9) (Smith & Kindlmann 2009; Smith, Kindlmann & Jbabdi 2014).  
 
Figure 3.9 Skeleton shapes determined by the anatomical structure.   
The common topology is a “thick sheet” with thin surface (A) and a tube with centred line (B). Reproduced 
from (Smith, Kindlmann & Jbabdi 2014) 
 
To reconstruct the skeleton, the local surface orthogonal direction is estimated first and 
then, in the same direction, the search continued to find the highest FA value, which 
represents the centre of the tract. Once it is found, the parallel direction is changed slowly. 
The mean FA threshold is typically set to be greater than 0.2 - 0.3 to exclude grey matter 
and CSF. In addition, it is essential to prevent analysis in the areas of low FA value such 
as cortex (Sierra et al. 2011). In our experiment, the 3D ex vivo TBSS analysis of mouse 
brain, the mean FA threshold was set to greater than 0.2.  
Subsequently, the FA map from each subject was projected onto the mean FA Skeleton. 
This important step removes any residual misalignments that occurred between subjects 
during the initial non-linear registration. As computed in the previous steps, the maximum 
FA is determined in the orthogonal direction and this value is assigned to the skeleton 
voxel. This is an effective approach to determine fine alignment across subjects because 
FA changes significantly in perpendicular direction, whereas parallel to the tract FA 
generally only changes gradually. TBSS should be less susceptible to partial volume 
effects in assessing thick tract, because the FA skeleton is filled with FA values from the 
centre of the adjacent relevant tracts. However, in case of thin tracts, the partial volume 
effect increases because the centre of each FA tract skeleton reflects both the tract width 
and true peak FA (Smith et al. 2006; Smith et al. 2007).  
The last step is to perform voxel-wise statistics across two groups of subjects. The 
correction for multiple comparisons is carried out using permutation methods (Nichols & 
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Holmes 2002). 500 permutations were used to test for statistical significance p-value < 
0.05. The TBSS analyses of FA, MD and RD were carried out comparing control, acute 
and chronic EAE and acute and chronic adjuvant. Figure 3.10 summarizes the TBSS 
pipeline applied in the experimental analysis.   
 
Figure 3.10 (A) Summary of TBSS steps and (B) example of mean skeleton FA 
 
3.7 Validation of the MRI and DTI findings using BGII Myelin staining   
To increase the certainty of the pathological changes detected by MRI or DTI imaging, the 
findings should be cross-correlated with the ‘gold standard’ histology. There are several 
histological myelin staining techniques for investigating the integrity of myelin in the axonal 
structures, for example, luxol fast blue (LFB) (DeBoy et al. 2007; Klawiter et al. 2011), 
myelin basic protein (Budde et al. 2009) and Galley’s myelin stain  (Calamante, F. et al. 
2011; Pistorio, Hendry & Wang 2006).  
In this study, Black Gold II (BGΙΙ) myelin staining was used to visualize myelinated axons 
and to confirm the MRI observations. It offers several advantages; first and most 
importantly it provides high-resolution images of the myelinated fibres. BGII reagents can 
be prepared easily without extending heating and it produces a more uniform and 
consistent chemical concentration. It was shown to be less labour-intensive and more 
reliable when compared with LFB (Schmued et al. 2008; Schmued & Slikker Jr 1999).  
1mm 
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The brain samples of 3 controls, 2 EAE and 1 sham from the acute group, 3 EAE and 1 
sham from the chronic group were sectioned with a 50 µm slice thickness, using a Leica 
VT1000s vibrotome (Leica, Germany) and the sections were then stored at 4°C in 
phosphate buffer solution (PBS). Prior to the BG II myelin staining, the brain slices were 
mounted on the positive side of glass slides (Superfrost Plus, Menzel-Gläser, Germany) 
and left for 24 hours to air dry and adhere strongly to the slides.  
The materials required for BG II myelin staining (AG105 BlackGold II staining kit, Millipore, 
USA) are BG II powder, 0.9% sodium chloride (NaCl) (saline solution), deionized filtered 
water (MilliQ, Milipore, USA), sodium thiosulfate, xylene, 70%, 95%, 100 ethanol and 
sodium acetate. BG II powder was resuspended in the saline solution to a final 
concentration of 0.3% (150 mg of BG II powder was added to 50 ml 0.9% NaCl solution). 
Sodium thiosulfate solution (1% w/v) was prepared using MilliQ water prior to use.  
Several factors may affect the quality of BGII staining, such as the staining time; oven 
temperature, the freshness of staining solutions and the brain samples. Staining 
procedures steps include the following:  The mounted tissue sections were rehydrated in 
MilliQ water for 2 minutes, and transferred to BG II solution (0.3 % BG II, pre-warmed to 
60°C) to incubate for 12 to 30 minutes at 60°C. The slides were monitored at 2-5 minutes 
intervals until the finest fibres appeared dark red to black. Lavender background colour, 
indicating over-staining was avoided. After good stain density is reached, the slides were 
washed in MilliQ water (2 x 2 minutes), and transferred to 1% preheated sodium 
thiosulfate solution for 3 minutes at 60°C to stop the staining reaction. The slides were 
finally washed MilliQ water (3 x 2minutes).  
For post staining, the brain tissues sections in each slide were dehydrated sequentially 
with 70%, 95% and 100% ethanol for 2 minutes each. After that, they were then soaked in 
xylene for 2 minutes and coverslip was applied with DEPEX (Ajax Australia) mounting 
media. In our study, comparisons between the histology and the DTI findings were 
achieved by direct comparison of images of comparable slices between healthy and 
affected samples. Areas where FA changes were detected by VBM and TBSS analyses 
were compared with BG myelin stain images. Brightfield images were captured using Carl 
Zeiss microscope (Axio Imager Azure) with 5x magnification and they were stitched and 
processed using Zen 2012 software (www.zeis.com.au).  
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4 Results 
4.1 Comparison between in vivo SE-DWI and segmented EPI-DWI 
SE-DWI was tested for the ability to obtain diffusion measurements at 16.4T within a 
reasonable experiment time. Partial Fourier encoding accelerations in both the frequency 
and phase encoding directions were used to reduce both the total experiment time and the 
echo time to compensate for the shorter T2* and T2 relaxation times at 16.4T. However, 
even with the significant benefit of a partial Fourier acceleration, the total time for the SE-
DWI experiment was still excessive (3.5 hours) which is intolerable for in vivo mouse brain 
studies. Furthermore the SE-DWI suffers from a high specific absorption rate (SAR). One 
SE-DWI was acquired using a sacrificed mouse to enable comparison with the in vivo 
segmented EPI-DWI dataset (Figure 4.1). 
 
 
Figure 4.1 FA map (6 slices) reconstructed from in vivo SE-DWI.  
2D SE-DWI was acquired using a thick slice of 0.8 mm slices. The image appears to be free of 
inhomogeneity distortion but it took much longer time to acquire and with thicker slices compared to the 2D 
segmented EPI DWI sequence.  
 
In comparison to the FA image from the in vivo segmented EPI-DWI dataset (Figure 4.3C), 
the SE DWI data (Figure 4.1) showed less distortion and higher SNR in the SE DWI data. 
Although the two datasets have the same in-plane resolution, the SE-DWI has thicker 
slices (0.8mm) compared to the EPI-DWI (0.6 mm). In this case, the SE-DWI dataset 
contains a more significant partial volume effect. The absence of motion in the culled 
animal may have contributed to the higher SNR. A comparison of technical aspects of the 
SE-DWI and segmented-EPI-DWI is summarized in Table 4.1. 
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Despite efforts to minimize motion, the motion effects are sometimes seen in the mouse 
brain HARDI data (Figure 4.2). During the implementation of segmented EPI-DWI, a 
number of ETL segmentations were tested 10, 8 and 4 (Figure 4.3). Increase number of 
segments will cause the possibilities of misalignment of k-space lines due to motion 
artefacts without reduction of geometric distortion. Four-segmented ETL produced a good 
compromise between low image distortion, low sensitivity to motion and reasonable total 
acquisition time (Figure 4.3C).  
  
 
Figure 4.2 The effect of motion artefacts in an in vivo segmented DWI experiment, showing signal 
loss.  
(A) and (B) are DWI images of the same slice position but were acquired in the presence of minimal (A) and 
excessive motion (B). 
 
 
Figure 4.3 Optimization of ETL segmentation to reduce image artefacts.  
The FA map from 4-segment EPI-DWI(C) shows less susceptibility to motion artefacts and structure 
displacement compared the maps reconstructed from 10 and 8-segment ETL (A and B, respectively). Arrows 
in A and B images indicate the presence of artefacts in anatomical structures. Windowing was exaggerated 
to show the differences between the segmented images.   
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Table 4-1 Comparison between SE-DWI and Segmented EPI-DWI 
SE-DWI Segmented EPI-DWI 
Reduced sensitivity to magnetic susceptibility 
and geometric distortion artefacts  
Prone to distortion artefacts and 
increased demands on the gradient set  
Long experiment time 
 
Shorter acquisition time allows 
acquisition of more diffusion-encoding 
directions or more averaging 
Difficulties with acquiring thinner slices owing 
to low SNR  
Suitable image quality to study 
anatomical structures. Allows thinner 
slices with more averaging to reduce 
partial volume effects  
Unacceptable experiment due to long 
experiment times and high SAR at short TR 
values 
Provides reproducible results in a 
tolerable experiment time  
 
4.2 Diffusion tensor imaging of mouse brain white matter  
Two-dimensional segmented EPI at 16.4T, using HARDI for sensitizing diffusion, produced 
images with good resolution, low distortion and sufficient SNR, suitable for studying white 
matter structures of the whole brain. The majority of important WM structures can be easily 
identified, including the corpus callosum, external capsule, cerebral peduncles, optic 
tracts, optic nerve and fimbria. Representative DTI parametric maps acquired using in vivo 
2D EPI DWI sequence from this study are shown in Figures 4.4. Figure 4.5 shows 
example of the FA colour map of the mouse brain from rostral to caudal slices and the WM 
structures were clearly visualized according to their encoding directions. The quality of the 
images was satisfactory, even in regions that are difficult to image, such as the optic 
nerves (Figure 4.6).  
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Figure 4.4 Example of the DTI derived parameters of the level of the mid-brain structures from in vivo 
2D EPI DWI at 16.4 T. 
(A) Fractional anisotropy (FA) map, (B) apparent diffusion coefficient (MD) map, (C) axial diffusivity map and 
(D) radial diffusivity (RD) map 
 
	  
Figure 4.5 Example of FA colour map of mouse brain from in vivo 2D EPI DWI data. 
Left top to right bottom represent rostral to caudal brain anatomical level, the following directional colour 
encoding is used: red = medial-lateral, green = rostral-caudal, blue =dorsal-ventral. 
 
5mm 
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Figure 4.6  FA maps of the optic nerves from in vivo 2D EPI DWI data..  
Images were reproducible across six mice (M1-M6) and were less susceptible to motion artefacts with less 
partial volume effects in comparison to SE-DWI experiment. The ROI analysis used only 3-4 voxels in the 
centre of the nerve to reduce partial volume effects. 
  
DTI parameters (FA, MD, AD and RD) were analysed in a cohort of 6 wild-type C57BL/6 
adult mice (Figure 4.7). The rostral, middle, caudal and external capsule of the CC were 
found to have low FA compared to other WM structures, with an average FA of ~0.32. The 
cerebral peduncles had the highest FA of ~0.57. Other structures such as the optic tracts, 
the optic nerves, fimbria and the forceps major and minor of the CC had intermediate FA 
values between 0.4-0.5 (Figure 4.7A). 
MD values ranged between 4.9-6.2 x 10-4 mm2/s (Figure 4.7B). The rostral, middle and 
caudal part of the corpus callosum (CC) showed an interesting pattern of diffusivity, with 
an AD of 8.4, 7.5 and 7.0 x 10-4 mm2/s, respectively (Figure 4.7C), while the RD was 
similar for all CC segments (4.7-4.9 x 10-4 mm2/s; Figure 4.7D). For RD, the cerebral 
peduncle has the lowest value at 3 x 10-4 mm2/s, whereas other structures such as the 
optic tract, optic nerve, internal capsule, fimbria, and the forceps of the CC have 
intermediate RD in the range of 3.7-4.4 x 10-4 mm2/s. 
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Figure 4.7 ROI analysis of DTI parameters.  
(A) FA, (B) MD, (C) AD, and (D) RD calculated from 6 adult wild-type C57BL/6 male mice imaged using in 
vivo segmented 2D DWI-EPI. Data are presented as mean ± standard deviation. 
 
4.3 Preliminary test of in vivo 2D segmented EPI DWI for assessing RR-EAE mouse 
brain 
The results of in vivo MRI on preliminary RR-EAE mice (those only receiving low MOG and 
adjuvant dose) unfortunately showed no significant changes in DWI and DTI parametric 
maps that could be detected visually or quantitatively. Other conventional in vivo structural 
imaging protocols: T1, T2 and T2* WI also tested, but they also did not show any active 
EAE lesions. Figure 4.8 shows examples of the variability of the FA measurement in the 
white matter structure of the control mice compared with acute adjuvant, EAE and chronic 
adjuvant and EAE.  
In the beginning of this project, in vivo HARDI method was developed to provide both high 
angular diffusion resolution and reasonably high 2D in-plane spatial resolution to enable 
comprehensive assessment of the brain structures. However, these requirements made in 
vivo DWI experiment too long, where approximately two hours were required to acquire a 
24-slice 2D HARDI data with 30 angular diffusion-encoding directions. The mouse 
recovery was more than 20 mins, this prolonged anaesthesia, which may threaten the 
welfare of unhealthy EAE mice especially at the late chronic stage.  
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Figure 4.8 Quantification of FA values from in vivo 2D EPI DWI data. 
(A) Naïve control mice (n=10) compared with acute adjuvant (acute-adj, n=2) and chronic EAE mice (acute-
EAE, n=3). (B) Naïve control mice compared with a chronic adjuvant (ch-adj-01) and chronic EAE mice (ch-
EAE, n=2). These preliminary RR EAE test mice were immunized using the dose explained in Table 3-3, 
Section 3.3.4 and 3.3.5.  
 
Figure 4.9 shows an example of the FA maps of control mouse compared with acute 
adjuvant, acute EAE, chronic adjuvant and chronic EAE. No gross changes in the FA 
maps could be recognized visually or by ROI analyses. The absence of detectable findings 
 124 
may be due to low sensitivity of 2D in vivo imaging; or very mild pathological effect due to 
insufficient EAE induction given to these preliminary cohorts. It is also observed that there 
was variability in the other in vivo DTI derived parameters, including the MD, AD and RD, 
which could also be contributed by motion artefacts. 
These observations suggested 2D in vivo data provides a low sensitivity for studying 
changes of the brain anisotropy. Such characteristics would become drawbacks for 
assessing anisotropy changes in areas that exhibited lower anisotropy such as gray matter 
and cortex. Further studies in this project therefore were performed on mice with stronger 
EAE induction and using ex vivo imaging to obtain the highest sensitivity. 
 
 
Figure 4.9 FA map of control mouse compared with acute adjuvant, EAE and chronic adjuvant and 
EAE.  
  
5mm 
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4.4 Comparison between 2D in vivo and 3D ex vivo DTI derived parameters in 
control mice 
 
Figure 4.10 Examples of DTI derived parameters from ex vivo 3D DWI data. 
(A) Fractional anisotropy (FA) map, (B) mean diffusivity, (C) axial diffusivity (AD) and (D) radial diffusivity 
map.  
 
Ex vivo 3D DTI derived parametric maps calculated using MRTrix are shown in Figure 
4.10. Using ROI analysis, 2D in vivo and 3D ex vivo DTI derived parameters including FA, 
MD, AD and RD were compared in the control subjects (Tables 4-2, 4-3, 4-4 and 4-5). 
Table 4-2 summarizes the FA values differences between 2D in vivo and 3D ex vivo DWI 
experiment. All of the FA values of the white matter structure quantified from 2D in vivo 
DTI parametric values were lower compared to the values from 3D ex vivo data. e.g. the in 
vivo FA values of the corpus callosum segments (rostral, middle and caudal)  were 0.34, 
0.31 and 0.32 and they  were approximately half of the ex vivo FA values which equal to 
0.71, 0.56 and 0.58. Such low FA in the corpus callosum is unexpected as high anisotropy 
is present in this area (Aggarwal et al. 2010; Harsan et al. 2010). It is possible that the 
apparent low anisotropy observed in the 2D in vivo data is due to partial volume effect 
from thick slices (0.6 mm) compared to the relatively higher 0.1 mm in-plane resolution 
(Aggarwal et al. 2012). On the other hand, the in vivo FA values of the cerebral peduncles 
(0.59±0.07) were closer to the ex vivo FA values (0.69±0.01). It is worth noting that the in 
1mm 
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vivo FA data showed high variability in specific anatomical structures such as rostral 
(17%), forceps minor corpus callosum (16%) and internal capsule (17%).     
 
Table 4-2 Comparison of FA measurements of 2D in vivo and 3D ex vivo DWI 
WM	  
structure	  
Relative	   in	  vivo/	  
ex	  vivo	  FA	  
2D	  In	  vivo	  FA	   3D	  ex	  vivo	  FA	  	  
Mean	   STDEV	   STDEV/Mean	   Mean	   STDEV	   STDEV/Mean	  
R-­‐cc	   0.48	   0.34	   0.06	   17%	   0.71	   0.03	   4%	  
M-­‐cc	   0.55	   0.31	   0.03	   8%	   0.56	   0.04	   6%	  
C-­‐cc	   0.56	   0.32	   0.03	   9%	   0.58	   0.03	   4%	  
ec	  	   0.59	   0.31	   0.02	   6%	   0.54	   0.02	   4%	  
Rt-­‐cp	   0.85	   0.59	   0.07	   11%	   0.69	   0.01	   2%	  
Lt-­‐cp	   0.85	   0.59	   0.07	   11%	   0.69	   0.01	   2%	  
Rt-­‐opt	   0.65	   0.51	   0.04	   7%	   0.79	   0.03	   3%	  
Lt-­‐opt	   0.64	   0.51	   0.04	   7%	   0.79	   0.03	   4%	  
ic	   0.63	   0.40	   0.07	   17%	   0.64	   0.02	   2%	  
fmi	   0.64	   0.45	   0.07	   16%	   0.69	   0.03	   4%	  
fmj	   0.67	   0.51	   0.05	   10%	   0.76	   0.03	   4%	  
fi	   0.71	   0.55	   0.04	   7%	   0.77	   0.03	   4%	  
 
The MD values acquired from the 3D DWI were significantly lower compared to 2D in vivo 
DWI (Table 4-3). This can be observed in all of the white matter structures. It is also worth 
noting that the MD values quantified using 2D in vivo were less variable comparing with 3D 
ex vivo experiment among all the white matter structures. Table 4-3 summarizes the MD 
values acquired from 2D in vivo and 3D DWI experiment.   
 
Table 4-3 Comparison of MD measurements of 2D in vivo and 3D ex vivo DWI 
WM	  
structure	  
Relative	   in	  
vivo/	  ex	  vivo	  
MD	  
2D	  In	  vivo	  MD	  mm2/s	   3D	  ex	  vivo	  MD	  mm2/s	  
Mean	   STDEV	   STDEV/	  
Mean	  
Mean	   STDEV	   STDEV/Mean	  
R-­‐cc	   2.83	   6.08×10-­‐04	   2.49×10-­‐05	   4%	   2.15×10-­‐04	   2.56×10-­‐05	   12%	  
M-­‐cc	   2.42	   5.83×10-­‐04	   1.85×10-­‐05	   3%	   2.41×10-­‐04	   2.75×10-­‐05	   12%	  
C-­‐cc	   2.20	   5.48×10-­‐04	   2.11×10-­‐05	   4%	   2.49×10-­‐04	   2.67×10-­‐05	   11%	  
ec	  	   1.89	   5.66×10-­‐04	   1.39×10-­‐05	   2%	   2.99×10-­‐04	   2.48×10-­‐05	   8%	  
Rt-­‐cp	   1.65	   4.92×10-­‐04	   1.55×10-­‐05	   3%	   2.99×10-­‐04	   1.99×10-­‐05	   7%	  
Lt-­‐cp	   1.66	   4.92×10-­‐04	   1.76×10-­‐05	   4%	   2.99×10-­‐04	   2.43×10-­‐05	   8%	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Rt-­‐opt	   1.86	   5.49×10-­‐04	   2.44×10-­‐05	   4%	   2.95×10-­‐04	   2.12×10-­‐05	   7%	  
Lt-­‐opt	   1.84	   5.49×10-­‐04	   1.74×10-­‐05	   3%	   2.95×10-­‐04	   1.97×10-­‐05	   7%	  
ic	   1.73	   5.04×10-­‐04	   1.84×10-­‐05	   4%	   2.92×10-­‐04	   2.13×10-­‐05	   7%	  
fmi	   2.41	   6×10-­‐04	   3.33×10-­‐05	   6%	   2.49×10-­‐04	   2.73×10-­‐05	   11%	  
fmj	   1.88	   5.56×10-­‐04	   1.39×10-­‐05	   3%	   2.95×10-­‐04	   2.97×10-­‐05	   10%	  
fi	   2.47	   5.84×10-­‐04	   1.68×10-­‐05	   3%	   2.36×10-­‐04	   1.69×10-­‐05	   7%	  
 
The AD values of the white matter structures were generally lower in the 3D ex vivo 
compared with 2D in vivo DWI experiment. 2D in vivo DWI experiment has smaller 
variations in AD measurements compared with 3D ex vivo DWI. A similar tendency was 
observed for the RD values of the white matter structures, they were lower of the 3D ex 
vivo DWI experiment compared with 2D in vivo. The variability of RD values between in 
vivo and ex vivo studies, however, was less pronounced than the other DTI parameters. 
Table 4-4 and 4-5 summarize the AD and RD values acquired from 2D in vivo and 3D ex 
vivo DWI experiment, respectively.   
 
Table 4-4 Comparison of AD measurements of 2D in vivo and 3D ex vivo DWI 
WM	  
structure	  
Relative	  	  
in	   vivo/	   ex	  
vivo	  AD	  
2D	  In	  vivo	  AD	  mm2/s	   3D	  ex	  vivo	  AD	  mm2/s	  
Mean	  	   STDEV	   STDEV/	  
Mean	  
Mean	   STDEV	   STDEV/Mean	  
R-­‐cc	   1.96	   8.46×10-­‐04	   4.04×10-­‐05	   5%	   4.32×10-­‐04	   6.11×10-­‐05	   14%	  
M-­‐cc	   1.84	   7.63×10-­‐04	   2.80×10-­‐05	   4%	   4.15×10-­‐04	   5.32×10-­‐05	   13%	  
C-­‐cc	   1.64	   7.07×10-­‐04	   2.27×10-­‐05	   3%	   4.31×10-­‐04	   5.10×10-­‐05	   12%	  
ec	  	   2.52	   7.55×10-­‐04	   1.09×10-­‐05	   2%	   2.99×10-­‐04	   2.48×10-­‐05	   8%	  
Rt-­‐cp	   1.48	   8.72×10-­‐04	   2.49×10-­‐05	   3%	   5.89×10-­‐04	   3.96×10-­‐05	   7%	  
Lt-­‐cp	   1.50	   8.61×10-­‐04	   3.79×10-­‐05	   4%	   5.74×10-­‐04	   4.84×10-­‐05	   9%	  
Rt-­‐opt	   1.38	   8.99×10-­‐04	   4.55×10-­‐05	   5%	   6.50×10-­‐04	   4.87×10-­‐05	   8%	  
Lt-­‐opt	   1.35	   8.96×10-­‐04	   3.05×10-­‐05	   3%	   6.62×10-­‐04	   4.28×10-­‐05	   7%	  
ic	   1.36	   7.37×10-­‐04	   3.06×10-­‐05	   4%	   5.44×10-­‐04	   4.06×10-­‐05	   8%	  
fmi	   1.88	   9.23×10-­‐04	   4.34×10-­‐05	   5%	   4.91×10-­‐04	   6.88×10-­‐05	   14%	  
fmj	   1.47	   9.29E-­‐04	   2.80×10-­‐05	   3%	   6.32×10-­‐04	   7.32×10-­‐05	   12%	  
fi	   1.97	   1×10-­‐03	   3.39×10-­‐05	   3%	   5.08×10-­‐04	   4.36×10-­‐05	   9%	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Table 4-5 Comparison of RD measurements of 2D in vivo and 3D ex vivo DWI 
WM	  
structure	  
Relative	   in	   vivo/	  
ex	  vivo	  RD	  
2D	  In	  vivo	  RD	  mm2/s	   3D	  ex	  vivo	  RD	  mm2/s	  
Mean	  	   STDEV	   STDEV/M
ean	  
Average	  	   STDEV	   STDEV/Mean	  
R-­‐cc	   4.61	   4.90×10-­‐04	   3.78×10-­‐05	   8%	   1.06×10-­‐04	   1.23×10-­‐05	   12%	  
M-­‐cc	   3.22	   4.93×10-­‐04	   1.81×10-­‐05	   4%	   1.53×10-­‐04	   1.72×10-­‐05	   11%	  
C-­‐cc	   2.97	   4.68×10-­‐04	   2.54×10-­‐05	   5%	   1.58×10-­‐04	   1.62×10-­‐05	   10%	  
ec	  	   2.34	   4.71×10-­‐04	   1.76×10-­‐05	   4%	   2.02×10-­‐04	   1.59×10-­‐05	   8%	  
Rt-­‐cp	   1.96	   3.03×10-­‐04	   1.88×10-­‐05	   6%	   1.54×10-­‐04	   1.08×10-­‐05	   7%	  
Lt-­‐cp	   1.96	   3.07×10-­‐04	   3.39×10-­‐05	   11%	   1.57×10-­‐04	   1.30×10-­‐05	   8%	  
Rt-­‐opt	   3.28	   3.84×10-­‐04	   4.64×10-­‐05	   12%	   1.17×10-­‐04	   1.34×10-­‐05	   11%	  
Lt-­‐opt	   3.34	   3.87×10-­‐04	   5.08×10-­‐05	   13%	   1.16×10-­‐04	   1.63×10-­‐05	   14%	  
ic	   2.34	   3.87×10-­‐04	   2.56×10-­‐05	   7%	   1.66×10-­‐04	   1.29×10-­‐05	   8%	  
fmi	   3.43	   4.38×10-­‐04	   4.74×10-­‐05	   11%	   1.28×10-­‐04	   1.01×10-­‐05	   8%	  
fmj	   2.90	   3.69×10-­‐04	   2.26×10-­‐05	   6%	   1.27×10-­‐04	   1.48×10-­‐05	   12%	  
fi	   3.74	   3.74×10-­‐04	   1.88×10-­‐05	   5%	   9.99×10-­‐05	   1.04×10-­‐05	   10%	  
 
4.5 Comparison between control, sham-adjuvant and EAE (acute and chronic) 
groups using ex vivo 3D SE-DWI DTI derived parameters  
4.5.1 Analyses of FA  
4.5.1.1 ROI based analyses of FA  
Acute mice groups (13-15 days post immunization) and the chronic mice groups (55-60 
days post immunization) were sacrificed and the mice brain samples were imaged at 
defined time point as explained in the method section.  
In most cases of human patients or animal models, MS has been found to affect the white 
matter structures (Aharoni et al. 2013; Filippi, Charil, et al. 2014). Therefore, initially the 
ROI analysis was tailored to primarily assess the integrity of the white matter structures 
using FA, MD, AD and RD of DTI derived parameters. Especially, FA values had been 
found to be proportionally correlated to the amount of myelin in the examined structure 
(Rueda-Lopes et al. 2014).  
ROI based analyses of FA between control and all mouse groups with t-test revealed no 
significant differences. There was a very small trend of FA reduction of acute adjuvant 
group in the rostral (0.68± 0.04), middle (0.56 ±0.07) and caudal (0.54 ±0.06) corpus 
callosum areas and the external capsule (0.51±0.03), respectively and in the acute EAE 
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group in the same areas (0.71±0.05), (0.54±0.05), (0.56±0.08) and (0.52±0.05), 
respectively compared to the control mice ((0.71±0.03), (0.56±0.03), (0.58±0.03) and 
(0.54±0.02)) (Figure 4.11). This observation may reflect the complexity of our RR EAE 
model as the clinical score is fluctuating during the disease cycle: the variability of FA 
values can be detected in several white matter structures in acute EAE and acute adjuvant 
groups, but not in the control or chronic groups (Figure 4.11).  
As shown in Figure 4.11, there was also no significant difference detected in FA values of 
the cerebral peduncles, fimbria, optic tracts and internal capsule using ROI analysis. The 
FA values were relatively similar in the chronic EAE in these respective areas (0.69±0.06), 
(0.75±0.02) (0.81±0.03) and (0.63±0.01) compared to the chronic adjuvant groups 
((0.69±0.02), (0.76±0.02) (0.80±0.01) and (0.63±0.03)) and compared to controls 
((0.69±0.01), (0.77±0.03) (0.79±0.03) and (0.64±0.02)).  
 
Figure 4.11 Quantification of the FA values in the WM using ROI  
Rostral (A), middle (B), Caudal (C), forceps minor (D) forceps major (E) corpus callosum segments and (F) 
external capsule (EC). Quantification of the FA values in (G) the right cerebral peduncle, (H) left cerebral 
peduncle, (I) fimbria, (J) right optic tract, (K) left optic tract and (L) internal capsule 
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4.5.1.2 VBM analyses of FA  
Compared to naïve control mice, VBM analyses revealed significant reductions of FA in 
chronic EAE-mice in several GM brain areas including the primary and secondary motor 
areas, primary somatosensory area, anterior cingulate and rostral CA1 (cornu ammonis) 
hippocampal regions and external capsule and a small portion of the forceps minor corpus 
callosum (Figure 4.12). However, VBM comparison between naïve controls, acute 
adjuvants, acute EAE and chronic adjuvants revealed no significant change.  
Table 4-6 summarizes the FA values of the affected areas detected by the VBM analysis 
and compared among the all mice groups. The bellow table shows how the FA reduction is 
progressing with the disease cycle. However, the VBM analysis of the FA values is not 
sensitive to detect changes after the first relapsing event (acute stage post injection) but 
after three to five relapses (at the chronic stage), it can start to observe FA reduction.  
 
 
Figure 4.12 VBM analyses of FA map shows extensive FA reduction in the chronic EAE  
The hot colour map shows t-statistics and represents areas with significant FA reduction in the chronic EAE 
mice (p-value<0.05). 
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Table 4-6 FA values of the affected areas detected by VBM 
FA values of the 
affected areas  
Controls  Acute 
adjuvants  
Acute EAE Chronic 
adjuvants 
Chronic EAE 
Anterior cingulate  0.27 ± 0.07 0.26 ± 0.07 0.26 ± 0.07 0.23 ± 0.07 0.21 ± 0.07 
Primary and 
secondary motor 
areas 
0.25 ± 0.07 0.24 ± 0.06 0.24 ± 0.07 0.22 ± 0.06 0.21 ± 0.06 
Somatosensory 
area 
0.19 ± 0.06 0.19 ± 0.06 0.18 ± 0.06 0.17 ± 0.05 0.16 ± 0.05 
Hippocampus 0.24 ± 0.06 0.24 ± 0.06 0.23 ± 0.06 0.22 ± 0.06 0.21 ± 0.06 
Values are expressed as mean±SD 
 
This VBM result is different to what was observed in ROI based analysis, whereby in the 
ROI analysis only a trend of FA reduction were observed in the acute EAE group 
compared to controls. This difference may be caused ROI analyses would be successful to 
detect changes if the ROI contains well-defined boundary, homogeneous intensity and 
uniformly affected by the disease (Smith, Kindlmann & Jbabdi 2014). Otherwise, the 
statistical analysis done using ROI based analysis may have reduced sensitivity due to 
partial volume effects of areas experiencing non-uniform changes within the ROIs (Jones, 
D. K. & Cercignani 2010). 
4.5.1.3 TBSS analyses of FA  
TBSS analysis of the DTI data revealed a statistically significant decrease in FA in several 
brain regions in chronic EAE mice compared to the controls (Figure 4.13 and 4.14). These 
regions include the anterior cingulate, primary and secondary motor areas, forceps minor 
corpus callosum, external capsule and hippocampus. On the other hand, there were no 
significant changes detected using FA TBSS comparing controls with acute EAE or 
adjuvant as well comparing controls with chronic adjuvants. Also, TBSS shows the same 
pattern of changes in the anterior cingulate, which similarly detected by the VBM analysis. 
The anterior cingulate have higher anisotropy compared with other cortical areas such as 
primary and secondary motor area. These changes can be seen more obviously on the 
sagittal view (Figure 4.14). TBSS is not the typical technique to detect the FA changes in 
the cortical and gray matter area, which exhibit low anisotropy normally. This is because 
TBSS is more tailored for assessing the white matter structures and the minimum FA 
threshold used was 0.2. 
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Figure 4.13 Axial view TBSS analysis of FA maps of controls subjects versus chronic EAE mice  
The FA (WM) skeleton of the averaged template is shown in green. The hot colour map shows t-statistics 
and represents areas with significant FA reduction in the chronic EAE mice (p-value<0.05).  
 
Figure 4.14 Sagittal view of TBSS analysis of FA maps of controls subjects versus chronic EAE mice  
The FA (WM) skeletons are shown in green. The hot colour map shows t-statistics and represents areas with 
significant FA reduction in the chronic EAE mice (p-value<0.05). 
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4.5.2 Analyses of MD  
4.5.2.1 ROI based analyses of MD 
During the acute stage, there was a significant increase of the MD values in the white 
matter structures including rostral, middle, caudal, forceps minor and forceps major corpus 
callosum and external capsule. These MD changes have been detected using the ROI 
(Figure 4.15), VBM (Figure 4.16) and TBSS (Figure 4.17) analysis. This can be indicator of 
the existence of inflammation as early changes because it appeared after the first attack 
and was not observed during the late stage (Bakshi et al. 2005).  
 
Figure 4.15 Quantification of the MD values in WM using ROI 
Rostral (A), middle (B), Caudal (C), forceps minor (D) forceps major (E) corpus callosum segments and (F) 
external capsule (EC), (G) the right cerebral peduncle, (H) left cerebral peduncle, (I) fimbria, (J) right optic 
tract, (K) left optic tract and (L) internal capsule.  
 
MD refers to microscopic displacement of water molecules in a single voxel (Le Bihan 
2003, 2006). The role of MD is still debated because of existence of cytogenic or 
vasogenic edema may lead to MD variation (Tievsky, Ptak & Farkas 1999). In an active 
inflammatory lesions, the MD exhibited higher MD values, which has been postulated due 
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to vasogenic edema. Also, if there is axonal membrane breakdown due to demyelination 
and axonal loss; this may cause MD elevation. Therefore, MD may be not specific indices 
to determine active inflammation (Tourdias & Dousset 2013). During the chronic stage, 
there was a decrease in MD values and it was significant comparing with acute groups. 
This could be pseudo-normalization or hypoxic white matter damage (Balashov & Lindzen 
2012). On the other hand, low MD value has been observed previously in another study 
using a focal EAE model during the first days after lesion induction and has been 
correlated with cytokine concentration (Tourdias et al. 2011).   
There was no MD change detected in the Rt and Lt cerebral peduncles, Rt and Lt optic 
tracts and internal capsule (Figure 4.15). However, the MD values were significantly 
increased in the fimbria in the acute sham and EAE compared with chronic sham and 
EAE. These changes were not detected using the VBM analysis and TBSS. Comparison 
between control with acute groups and control with chronic groups, there were no 
significant differences detected using the ROI, VBM or TBSS analysis. This could reflect 
the variability of this EAE model as it affects each brain area differently. As observed in the 
ROI analysis graphs (Figure 4.15), the patterns of the MD changes are mostly similar. This 
could be evidence to what usually observed in MS patients which known as normal 
appearing white matter. In addition, acute adjuvants mice show significant increase of the 
MD values in some of the white matter areas such as middle, caudal forceps major corpus 
callosum and fimbria compared with chronic adjuvants mice.  
4.5.2.2 VBM and TBSS analyses of MD  
VBM analysis of the MD values (Figure 4.16) shows the areas of the MD elevation in the 
acute EAE compared with chronic EAE. There was significant changes detected in the 
forceps minor, major, rostral, middle and caudal corpus callosum. These changes extend 
toward the external capsule from middle to the caudal brain section. There were also small 
changes had been detected in the fimbria. In parallel, the TBSS (Figure 4.17) had detected 
a significant increase of the MD in the acute EAE in the same areas detected by the VBM. 
There were agreements between the VBM and TBSS results in the white matter areas but 
there were some dispersion changes, which can be related to the differences in 
methodology of each analysis method. For example, VBM detected larger MD changes in 
the anterior cingulate compared to TBSS. It appears that TBSS produced a more 
conservative result in comparison to VBM, with the exception that TBSS shows more 
changes in hippocampal commissure compared to VBM. Figures 4.16 and 4.17 show the 
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areas of MD elevation in the acute EAE mice compared with chronic EAE using VBM and 
TBSS respectively.  
 
Figure 4.16 VBM analyses of MD map shows extensive MD elevation in the acute EAE  
The hot colour map shows t-statistics and represents areas with significantly increased MD in the acute EAE 
mice compared with chronic EAE (p-value<0.05). 
 
Figure 4.17 Axial view TBSS analysis of MD maps of acute versus chronic EAE mice  
The WM skeleton is shown in green. The hot colour map shows t-statistics and represents areas with 
significant MD increase in the acute EAE mice comparing with chronic EAE (p-value< 0.05).   
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4.5.3 Analysis of AD 
Using ROI analysis of the AD values, there were significant AD reductions detected in the 
chronic EAE group compared with acute EAE group (Figure 4.18). The AD values were 
variable with a trend of increasing AD during the acute period and decreasing during the 
chronic period. Decreasing of the AD in the chronic EAE groups can be interpreted as 
indicator of demyelination, which was observed in the FA ROI analysis of the WM (Figure 
4.11). These were observed in the caudal, forceps minor corpus callosum. Also, strong AD 
reductions have been observed forceps major corpus callosum and external capsule 
(Figure 4.18). A significant AD reduction has been observed in the fimbria comparing 
acute with chronic EAE and comparing acute with chronic adjuvants using ROI analysis 
(Figure 4.18) but not detected using either VBM or TBSS. In addition, VBM and TBSS 
based analysis have been carried out to compare control subjects with acute adjuvants 
and EAE and comparing controls with chronic adjuvants and EAE, but there was no 
significant change detected. AD values, like MD, were increased in most of the WM 
structures in the acute EAE group. 
 
Figure 4.18 Quantification of the axial diffusivity (AD) values in WM using ROI  
Rostral (A), middle (B), Caudal (C), forceps minor (D) forceps major (E) corpus callosum segments and (F) 
external capsule (EC), (G) the right cerebral peduncle, (H) left cerebral peduncle, (I) fimbria, (J) right optic 
tract, (K) left optic tract and (L) internal capsule.  
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4.5.4 Analyses of RD  
4.5.4.1 ROI based analyses of RD 
RD values were increased in the acute mice compared to chronic groups. These changes 
were detected in several WM structures including rostral, middle, forceps minor and 
forceps major corpus callosum, Rt and Lt cerebral peduncles, Rt and Lt optic tracts and 
internal capsule (Figure 4.19). A stronger RD increase was detected in the caudal corpus 
callosum segment and the external capsule. There were no significant changes detected 
in the fimbria, which showed previously reduction of the AD values in the chronic EAE 
mice. This could reflect the heterogeneity of this RR-EAE model even within the WM 
structures and ascertain the importance of comprehensive MRI assessment. Figure 4.19 
shows that RD values have less variability in comparison to AD, which perhaps making it 
more sensitive in comparison to AD in term of tracing pathological changes in the 
relapsing remitting cycle.  
 
Figure 4.19 Quantification of the radial diffusivity (RD) values in WM using ROI  
Rostral (A), middle (B), Caudal (C), forceps minor (D) forceps major (E) corpus callosum segments and (F) 
external capsule (EC), (G) the right cerebral peduncle, (H) left cerebral peduncle, (I) fimbria, (J) right optic 
tract, (K) left optic tract and (L) internal capsule. 
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4.5.4.2 VBM and TBSS analyses of RD  
VBM analysis showed increase in the RD values in the acute EAE group compared with 
the chronic EAE group in the following brain areas: forceps minor and major, rostral, 
middle, caudal corpus callosum (Figure 4.20). The internal capsule and cerebral 
peduncles and optic tracts were also affected. The TBSS analysis had detected the same 
changes and more extensive changes in the anterior commissure and the internal capsule 
(Figure 4.21). Both VBM and TBSS analyses of the RD map showed similar pattern of 
changes in the acute EAE groups compared with chronic groups (Figures 4.20 and 4.21).  
 
Figure 4.20 VBM analyses of RD map shows extensive RD elevation in the acute EAE  
The hot colour map shows t-statistics and represents areas of significantly increased RD in the acute EAE 
mice compared with chronic EAE (p-value<0.05). 
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Figure 4.21 Axial view TBSS analysis of RD maps of acute versus chronic EAE mice 
The WM skeleton is shown in green. The hot colour map shows t-statistics and represents areas with 
significantly increased RD in the acute EAE mice comparing with chronic EAE (p-value< 0.05).  
4.5.5 Analyses of T1, T2 and T2* relaxation times 
Using ROI based analysis, T1, T2 and T2* relaxation times were measured in several brain 
areas including corpus callosum, external capsule, anterior cingulate cortex, primary and 
secondary motor areas and somatosensory areas, hippocampus and caudate putamen. 
Manual ROI based analyses instead of VBA was carried out due to difficulties of creating 
2D ex vivo template.   
T1 relaxation times were variable among the studied groups and there were no significant 
differences detected (Figure 4.22). The acute and chronic adjuvant mice, and acute and 
chronic EAE mice show small trend of increased T1 relaxation times compared with 
controls. This negative finding was confirmed with VBM analysis carried out using b0 (T1 
weighted) images acquired within the diffusion experiment (data not shown).  
On the other hand, T2 relaxation times were significantly increased in several brain areas 
of the chronic EAE mice compared with control subjects (Figure 4.23). This can be 
observed in cingulate cortex, primary and secondary motor areas somatosensory areas, 
hippocampus and caudate putamen.  Also, in some areas, there were significant increases 
of the T2 relaxation times when the chronic EAE group was compared to the acute EAE 
group. The decrease of FA appears to be inversely correlated with the increase in T2 
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relaxation times. However, these finding should be interpreted cautiously because the T2 
relaxation time analysis were done using manually ROIs on 2D images, which can be 
susceptible to partial volume effects.  
There was no significant difference of T2* relaxation times observed between the groups 
(Figure 4.24). There was only a trend towards higher T2* variability in grey matter motor 
and somatosensory areas in the acute and chronic EAE and chronic adjuvant groups 
(Figure 4.24C, D, E and F) compared to the controls and acute adjuvant groups. VBM 
analysis using Jacobian determinant of the unregistered 3D ex vivo b0 DWI and T2*-
weighted 3D FLASH image showed that there was no significant change detected using 
this modality (data not shown).   
Table 4-7 summarizes the agreement between the analysis methods: ROI, VBM and 
TBSS showing areas where significant changes have been detected. FA reductions in the 
cortex and gray matter areas were observed and can be correlated with the increase of T2 
relaxation time. The increases of MD and RD have been observed in several other white 
matter structures. In general, it can be observed that there is some significant reduction of 
FA and increase of T2 relaxation in the chronic EAE compared to control subjects and 
some significant increase of MD and RD in the acute EAE compared to chronic EAE.  
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Figure 4.22 Quantification 
of the T1 relaxation time 
(ms) in several brain 
structures using ROI 
(A) the Rt cingulate (cing-
01), (B) Lt cingulate (cing-
02), (C) Rt primary and 
secondary motor area (M1), 
(D) Lt primary and 
secondary motor area (M2), 
(E) Rt somatosensory area 
(S1) and (F) Lt 
somatosensory area (S2), 
(G) middle corpus 
callosum, (H) Rt external 
capsule, (I) Lt external 
capsule, (J) Rt 
hippocampus (HC-01), (K) 
Lt hippocampus (HC-02) (L) 
Rt caudate putamen and 
(M) Lt caudate putamen. 
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Figure 4.23 Quantification 
of the T2 relaxation time 
(ms) in several brain 
structures using ROI 
(A) the Rt cingulate (cing-
01), (B) Lt cingulate (cing-
02), (C) Rt primary and 
secondary motor area (M1), 
(D) Lt primary and secondary 
motor area (M2), (E) Rt 
somatosensory area (S1) 
and (F) Lt somatosensory 
area (S2), (G) middle corpus 
callosum, (H) Rt external 
capsule, (I) Lt external 
capsule, (J) Rt hippocampus 
(HC-01), (K) Lt hippocampus 
(HC-02) (L) Rt caudate 
putamen and (M) Lt caudate 
putamen.  
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Figure 4.24 Quantification 
of the T2* relaxation time 
(ms) in several brain 
structures using ROI 
(A) the Rt cingulate (cing-
01), (B) Lt cingulate (cing-
02), (C) Rt primary and 
secondary motor area (M1), 
(D) Lt primary and secondary 
motor area (M2), (E) Rt 
somatosensory area (S1) 
and (F) Lt somatosensory 
area (S2), (G) middle corpus 
callosum, (H) Rt external 
capsule, (I) Lt external 
capsule, (J) Rt hippocampus 
(HC-01), (K) Lt hippocampus 
(HC-02) (L) Rt caudate 
putamen and (M) Lt caudate 
putamen.  
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Table 4-7 Summary finding of ROI, VBM and TBSS in detection of EAE pathology 
Brain structure  ROI analysis VBM 
analysis 
TBSS analysis 
FA MD RD T2 FA MD RD FA MD RD 
Rostral-cc  ! !   ! !  ! ! 
Middle-cc  ! ! !  ! !  ! ! 
Caudal-cc  ! ! !  ! !  ! ! 
fmi  ! !   ! !  ! ! 
fmj  ! !   ! !    
ec  ! ! ! " ! ! " ! ! 
Rt-cp   !    !   ! 
Lt cp   !    !   ! 
Fimbria   !        ! 
Rt-opt   !    !    
Lt-opt   !    !    
Internal capsule   !       ! 
Rt cingulate "   ! "   " !  
Lt cingulate "   ! "   " !  
Rt M cortex  "   ! "   "   
Lt M cortex  "   ! "   "   
Rt S cortex "   ! "      
Lt S cortex "   ! "      
Rt Hippocampus "   ! "      
Lt Hippocampus "   ! "      
Rt caudate putamen    !       
Lt caudate putamen    !       
 
Arrows indicate the increase or decrease of parameters in chronic EAE compared to 
control animals. 
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4.6 Histological validation of DTI derived parameters using BGII Myelin staining  
As shown in Figures 4.25, 4.26 and 4.27, there were significant reductions in the 
coherence of myelin fibres of several cortical areas including the anterior cingulate cortex, 
somatosensory areas, and primary motor areas (more staining results are shown in 
Appendix 7.1-7.5). These histological changes can be correlated with FA reductions in 
these areas revealed using VBM and TBSS analysis (Figure 4.27). There were no 
significant reduction of myelin fibre coherence detected in the acute adjuvant, EAE and 
chronic adjuvant groups. It is most likely that the development of neurological disabilities 
(high clinical score) in the chronic EAE groups can be linked to extensive demyelination in 
the motor and sensory cortical areas.  
On the other hand, most of other white matter structures were not severely affected by 
demyelination as suggested by the MRI analyses. There is possibility of acute axonal 
damage in the WM as suggested by the increase of MD and RD during the acute stage of 
EAE cycle. However, these require other histological techniques to confirm these changes 
such as axonal neurofilament antibody staining (e.g. NF200).     
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Figure 4.25 Black and Gold myelin stain of mouse brain samples.  
(A) Mouse brain mid structures, zoomed in the anterior cingulate cortex of (B) control subject, (C) acute-
adjuvant, (D) chronic-adjuvant, (E) acute-EAE and (F) chronic-EAE (the yellow arrows point out the areas of 
loss coherence in myelin fibres.  
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Figure 4.26 Comparision between control (A) and chronic-EAE subject using BG myelin stain.  
Zoomed regions (red boxes) of the hippocampus in control subject (C) and (D) chronic-EAE showing 
extensive reduction of myelin stain intensity in this area. Zoomed regions (blue boxes) of the somatosensory 
areas of the control (E) and chronic-EAE (F) respectively, red arrows indicate area of extensive reduction in 
myelin fibre staining. 
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Figure 4.27 Correlation between VBM, TBSS analysis of FA values and BG Myelin stain.  
(A) VBM analysis, (B) and (C) axial and transverse plane of TBSS analysis, (D) control subject, (E) and (F) 
two chronic EAE mice. The box region show zoomed regions of anterior cingulate cortex and primary motor 
area from the control (G) and (F) chronic EAE mice. There are less myelin stained fibres in the two chronic 
EAE mice compared to the control. This difference is more obvious in the zoomed image (H). The red and 
yellow arrows show changes in the anterior cingulate and somatosensory cortex, respectively.   
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5 Discussion  
MS is a heterogeneous disease with several pathological processes, including 
demyelination, inflammation and axonal injury (Dutta & Trapp 2014; Lassmann, H. 2013; 
Metz, I et al. 2014). Detection of demyelination using in vivo human imaging in the cortical 
areas is still difficult to attain (Daams, Geurts & Barkhof 2013; Filippi, M et al. 2013; 
Schmierer et al. 2010), such that these pathological changes were mostly reported only in 
post-mortem studies (Bo, L 2009; Bo, L. et al. 2007; Kutzelnigg, A et al. 2007; Kutzelnigg, 
A. et al. 2005). Establishing an animal model of MS with such pathology would contribute 
immensely to the understanding of the progression of cortical demyelination in MS 
patients, especially in the early RR stage (Khan, Woodruff & Smith 2014).  
In this project, various MRI modalities, especially DTI parameters, were investigated to 
determine their sensitivity as imaging biomarkers to measure RR EAE mice disease 
progression. Initially, 2D in vivo segmented EPI-DWI at 16.4T was optimized to detect 
changes in mouse brain structures. However, the acquired in vivo DTI derived parameters 
were unable to detect pathological changes possibly due to a combination of sub-optimal 
immunization dosage, low number of test animals and insufficient resolution. 
Subsequently, ex vivo 3D DWI experiments were used to study the EAE brain pathological 
changes in much higher resolution and free from imaging artifacts. DTI-derived parameters 
were analysed using ROI, VBM and TBSS analyses, in addition to conventional MRI 
relaxation parameters, to measure changes in the brain. Ex-vivo DTI data revealed 
specific areas of WM demyelination in the chronic EAE animals, which were observed as 
low anisotropy in the anterior cingulate, motor and somatosensory cortex. These 
observations were confirmed with high-resolution myelin histology showing extensive 
reductions in myelinated fibres detected in these areas. Together, this study has 
elucidated that the increased clinical scores observed in chronically developing RR EAE 
could be clearly linked to demyelination in the somatosensory and motor cortex.  
 
5.1 Considerations for mouse brain in-vivo DWI at ultra-high magnetic field   
Most animal MRI scanners operate in the range of 4.7 T to 16.4 T, whereas standard MRI 
clinical scanners operate in the range of 0.5 T to 3 T. Scanning animals in such a high 
magnetic field is required due to the necessity of an increase in image resolution of a 
factor of 8000 times as compared to human brain imaging (~0.1x0.1x0.1 mm3 resolution 
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for mouse brain and ~2x2x2 mm3 resolution for human brain), as the entire mouse brain is 
approximately equal to only the size of the caudate nucleus in the human brain. To acquire 
images in a reasonable time, either the spatial resolution or the SNR must be lowered. It is 
therefore essential to optimize MRI acquisition parameters to achieve a high imaging 
quality (Aggarwal, Zhang & Mori 2012; Marzola, Osculati & Sbarbati 2003; Pautler 2004). 
Therefore high field MRI would be advantageous for providing a high SNR and spatial 
resolution and can be exploited to acquire the data in a short time (Maronpot, Sills & 
Johnson 2004).  
At ultra-high field 16.4T, significant alterations in the relaxation times are observed (T1, T2 
and T2*); both the TR and TE must be optimized accordingly. This is essential for 
maintaining a desirable SNR and a well-defined contrast between the anatomical 
structures (Pohmann, Rolf, Shajan, G & Balla, DZ 2011). A comparison study of in vivo T1 
relaxation between  9.4T and 17.6T (van de Ven et al. 2007) showed an increase in T1 
values in several anatomical structures in the mouse brain, for example, T1 of the corpus 
callosum increased from 1750± 50 msec at 9.4T to 1830±90 ms at 17.6T.  
The T1 relaxation times for rat brain at 16.4T was found to be considerably long cortex 
(2272± 113 ms for the cortex and 2073±97 ms for the white matter), while the T2 values 
were found to be short (25±2 ms the cortex and 20±1 ms for the white matter) (Pohmann, 
R., Shajan, G. & Balla, DZ 2011). During the initial process of setting up in vivo DWI of the 
mouse brain at 16.4T, T1 and T2 relaxation times were measured for the cortex, 2350±90 
and 28±4ms, respectively, and for the corpus callosum, 2120±140ms and 23±3ms, 
respectively, similar to the previous finding.      
In addition to lengthening of T1 and shortening of T2 relaxation times, magnetic 
homogeneity is a significant concern at high magnetic field strength, with the increase in 
magnetic susceptibility artifact especially with gradient echo (GE) and echo planar imaging 
(EPI) sequences. Therefore, conventional MRI spin echo sequences are preferred 
because of the ability of the 180° refocusing pulse to refocus the loss of net magnetization 
due to dephasing from magnetic susceptibility. SE-DWI was tested but soon it became 
obvious that this sequence was not an appropriate choice. SE-DWI sequence is slow in 
acquiring MRI data (Song et al. 2003; Sun, S et al. 2007; Xie et al. 2010) and difficult to 
apply for HARDI in vivo acquisition due to the requirement of a large number of applied 
diffusion gradients (Zhang, J, Aggarwal & Mori 2012). Increasing the number of averages 
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for compensating inherently relatively low SNR (due to diffusion gradient signal 
attenuation) was also problematic due to acquisition time constraints.  
5.2 In vivo segmented EPI-DWI for mouse brain imaging at 16.4T 
In the beginning of the project, the protocol for mouse brain in vivo imaging at 16.4T was 
optimized using segmented 2D EPI-DWI. Choosing the options for DWI parameter 
optimisation was not straightforward. It is still intensely debated if the optimization of in 
vivo DWI acquisition could be achieved by increasing either the angular directions or the 
spatial resolution (Mori 2014; Tournier, Mori & Leemans 2011). Improving both imaging 
parameters simultaneously would be difficult because it increases the experiment time 
dramatically (Basser, P. & Özarslan 2014). For in vivo DW imaging of mouse brain, the 
dependency of the quality of the analysis upon angular resolution or in-plane resolution is 
still unclear (Wu, D et al. 2014; Wu, D et al. 2013).  Therefore, our optimization was aimed 
to obtain the highest spatial resolution while maintaining reasonable SNR and acquisition 
time. The DW images were acquired with a large number of applied diffusion gradient 
directions (64) and high b-values (3000 s/mm2) for increased sensitivity of measuring 
diffusion (Le Bihan 2014; Miller, KL 2014).  
The resulting images were obtained with sufficient quality for analysing the diffusion 
properties of the brain WM structures. The processed DTI parameters were sensitive 
enough to detect distinct normal variations of diffusivities in various regions of the corpus 
callosum (cc). The forceps major and forceps minor regions were found to have higher FA 
compared to the rostral, middle and caudal cc segments. Additionally, a gradual decline in 
AD and MD values were detected in these segments. The variations of the axonal 
diameter of the corpus callosum segments were previously observed (Barazany, Basser & 
Assaf 2009), where the axonal diameter of the rostral-cc was found to be approximately 
20% larger compared to the caudal-cc. Such sensitivity is important in studying rodent 
models of neurological diseases especially those involving the cc, which is the largest 
white matter structure in the mammalian brain connecting the right and left hemispheres. 
The corpus callosum has been shown to be highly susceptible to multiple sclerosis, and it 
is often characterized as the primary site for the pathological demyelination process (Wu, 
QZ et al. 2007; Xie et al. 2010). 
Our data showed that the FA, AD and RD of the cerebral peduncles, optic tracts and 
fimbria are similar to the previously published study using 3D DWI acquisition (Aggarwal et 
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al. 2010). Aggarwal reported that the FA values of these respective structures were 
0.54±0.1, 0.57±0.1 and 0.62±0.09 respectively (data was acquired at 9.4T, 3D acquired 
resolution was 117×125×375µm3, using b-value 1000 s/mm2). In comparison, the FA 
values for these structures (from data obtained at 16.4T, at 125×125 µm2 in-plane 
resolution and 600µm slice thickness using b-value 3000 s/mm2) were 0.59±0.07, 
0.51±0.04 and 0.55±0.04, respectively. It is possible that these anatomical structures are 
less prone to partial volume effect of 2D slice acquisition as the fibre direction of these 
tracts run in a rostro-caudal direction, similar to the direction of the stacks of the 2D slices.  
For regions within the corpus callosum and external capsule, the FA values determined in 
our studies were lower compared to that obtained from the Aggarwal study. This is thought 
to relate to the differences in the segmentation of the cc. In our experiment, the corpus 
callosum was segmented into four regions: rostral, middle, caudal, forceps minor and 
forceps major and the FA values were 0.34±0.06, 0.31±0.03, 0.32±0.03, 0.45±0.07 and 
0.51±0.05 respectively, whereas in the Aggarwal study, the corpus callosum was divided 
into three segments; rostral, middle and caudal and the FA values were 0.62±0.11, 
0.51±0.09 and 0.59±0.10 (Aggarwal et al. 2010).  
The optimized in vivo segmented EPI-DWI method also produced surprisingly exceptional 
image quality of the optic nerve. This structure is difficult to image because the diameter of 
the optic nerve in rodents is only 0.3–0.4 mm. As a result it can be severely affected by 
imaging artefacts such as motion and magnetic susceptibility due to the proximity to the 
skull and nose air pockets (Xu et al. 2008). In vivo assessment of the optic nerve was 
shown to be valuable for exploring the pathological changes of several neurological 
diseases (Xu et al. 2008) such as retinal ischemia (Sun, S, Liang, HF, et al. 2006) and 
multiple sclerosis (Sun, S et al. 2007). Recent studies of the optic nerve using DTI 
demonstrated that axonal injury was strongly correlated with a decrease in axial diffusivity 
(Sun, S, Liang, H, et al. 2006), and the demyelination was related to the increase in radial 
diffusivity (Sun, S et al. 2007).  
The main disadvantage of our optimized in vivo DWI EPI experiment was that the slice 
thickness (600µm) was significantly larger than the in-plane resolution. This limitation is 
due to the constraints of available SNR and experiment time (approx. 2 hours). Therefore, 
the acquired images remained susceptible to partial volume effects in some anatomical 
structures, which result in difficulties of delineating complex white matter e.g. thinning of 
the external capsule, or gray matter structures e.g. anterior cingulate cortex (Aggarwal, 
  
153 
Zhang & Mori 2012; Wu, D et al. 2013). Due to the limitation from SNR and anisotropic 
image resolution, our in vivo DWI imaging study only permitted the assessment of high 
anisotropy WM structures, but not suitable to accurately study the cortical GM areas. In 
this case, ROI based analysis was used to measure DTI derived parameters. Fibre 
tracking was tested using this in vivo data but the results were unsatisfactory due to the 
noise, motion and insufficient resolution. 
2D MRI data with relatively large slice thickness is not commonly used in automated image 
registration for statistical analyses. This may be due to possible error in slice positioning 
for group comparison. If the data were interpolated to isotropic 3D resolution, significant 
interpolation in the slice direction could affect the accuracy of the analyses (Wu, D et al. 
2013). A 3D in vivo acquisition requires a significantly longer experiment time, and at the 
time this experiment was undertaken, there was no suitable sequence developed to 
address this. 
 
5.3 Alternative approaches for in vivo DWI acquisitions  
Segmented EPI with a partial Fourier transformation has been previously used at 9.4 T to 
acquire a 2D DWI dataset with 30 diffusion gradient directions with spatial resolution of 
156×156×500 µm3 (Harsan et al. 2010). In our experiment, we increased the angular 
resolution to 64 applied diffusion gradients and with native spatial resolution of 
125×150×600 µm3. These parameters were preferred because they provide a lower partial 
volume effect, and a greater diffusion angular resolution for improving the accuracy of the 
DTI-derived parameters with the ability to resolve crossing-fibres (Tournier, Calamante & 
Connelly 2012; Zhang, J 2010; Zhang, J, Aggarwal & Mori 2012).  
An alternative imaging approach for in vivo DWI acquisition is using a stimulated echo 
diffusion-weighted imaging (STE-DWI) sequence. STE-DWI useful for imaging samples 
with short T2 relaxation times (Frahm et al. 1985). Single-shot STE-DWI has been 
incorporated with half-partial Fourier transforms (Finsterbusch & Frahm 2002). This 
method was not tested because it still suffered from low SNR and limited number of slices 
that can be acquired in a reasonable time to cover the whole brain structures. STE-DWI 
has been used in a recent study at 9.4 T for specific imaging of the corpus callosum 
(Boretius, S. et al. 2012), as compared to our requirement for imaging of the whole brain.  
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5.4 Recent novel developments for improving in vivo DWI acquisition 
5.4.1 3D isotropic gradient and spin echo (GRASE) sequence  
Most of 3D DWI experiments have been acquired from ex vivo brain samples (Aggarwal et 
al. 2010; Jiang & Johnson 2010; Zhang, J et al. 2003). However, there are now new 
studies showing the application of 3D DWI on live mouse brain imaging. A gradient and 
spin echo (GRASE) sequence has been developed to acquire 3D diffusion-weighted 
imaging of the mouse brain in a high magnetic field such as 9.4T and 11.7T (Aggarwal et 
al. 2010; Wu, D et al. 2014; Wu, D et al. 2013).  
GRASE is a combination of EPI and fast spin echo (FSE), and therefore provides two 
potential advantages. First, it provides a higher immunity to magnetic susceptibility 
artefacts because the pulse sequence consists of multiple 180° refocusing pulses 
(Feinberg & Oshio 1991). Second, it can acquire three-dimensional data in a reasonable 
time, because of the alternating polarity of the readout gradients (Aggarwal et al. 2010). 
This sequence requires a specific design to eliminate phase errors caused by gradient 
instability and off-resonance effects, with the incorporation of twin navigator echoes to 
reduce motion artefacts (Aggarwal et al. 2010; Kober, Gruetter & Krueger 2012). An in vivo 
3D GRASE DWI of the mouse brain has been acquired at 9.4T using a head coil with a 
native resolution of 117×125×375µm3. This method has provided a higher spatial 
resolution, but is still limited in terms of the angular diffusion resolution (only six applied 
DW gradient directions) (Aggarwal et al. 2010).  
5.4.2 Cryogenic probe 
The cryocoil is a promising tool for application to the DWI experiment (Baltes et al. 2009; 
Ratering et al. 2008). It has been utilized in a combination of 2D multi-slice acquisition and 
resulted in SNR improvement up to a factor of three (Muller et al. 2012). As a recent study 
shows the feasibility of acquiring DW images at 11.7T without respiratory triggering within 
30 minutes. The data were acquired with 30 applied diffusion gradients and b-value= 1000 
s/mm2. It also allowed smaller voxel size 156×156m2 with high slice resolution 250µm, 
critical for accurate fibre tracking, and increasing the accuracy of FA maps (Muller et al. 
2012). However, motion artifacts still affected the quality of the acquired images. The 
application of the cryocoil at ultra-high field scanners should improve the quality of the 
acquired DTI derived parameters (Aggarwal, Zhang & Mori 2012; Muller et al. 2012).  
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5.4.3 Combination of GRASE and cryogenic probe 
A recent study (Wu, D et al. 2013) applied a modified GRASE with a 11.7T vertical bore to 
acquire a 3D DWI experiment using a cryocoil. This has assisted in the acquisition of a 
high spatial isotropic resolution of 125µm3 and better angular resolution (12 applied DW 
gradient directions) within an experiment time of 2 to 2.5 hours (Wu, D et al. 2013).  
This development was followed by the application of GRASE DWI in mouse brain to 
acquire high spatial (0.1 mm) and angular resolution (30 diffusion encoding directions) and 
b-value= 2335 s/mm2 within 1 hour (Wu, D et al. 2014). Reducing the field of view and 
using spatially selective radiofrequency pulses allowed the focus on target brain structures 
such as hippocampus, motor and sensory cortex (Wu, D et al. 2014). However, whole 
brain DWI using the same parameter setting would take approximately 10h (Wu, D et al. 
2013). This localized DWI experiment can be beneficial to study animal model with known-
area with expected anatomical structural change such as traumatic brain injury (Mac 
Donald et al. 2007), stroke (Wang, S et al. 2008) and demyelination/ remyelination models 
(Wu, QZ et al. 2007). For a whole brain exploratory study, which is the scope of our study 
using a new RR-EAE mouse model, this ultra-high spatial resolution using reduced FOV 
method would not be initially suitable. However, now that it is known which specific areas 
affected, it would be tremendous opportunity to study these areas in higher detail using 
this newly developed method.      
5.5 Comparison of RR-EAE model with other MS models  
The majority of models current relapsing remitting EAE do not accurately mimic the MS 
clinical course because they invoke relapsing and remitting cycles and continued 
progression of MS symptoms without distinct recovery (Baker & Amor 2014; Skundric 
2005). This pattern of relapsing remitting cycle has been observed in several MS model 
including (Kuerten & Angelov 2008): RR-EAE models using B6×SJL (F1) immunized with 
proteolipid protein (PLP) 139-151 (Aharoni et al. 2013), C57BL6 mice immunized with 
MOG35-55 (Berard et al. 2010), and SJL mice immunized with PLP13-151 (Skundric 2005).  
Our RR EAE mice exhibit relatively milder symptoms with partial recovery. This model is 
developed to provide a better depiction of the early stage of MS development, where 
during this early relapsing remitting stage patients often show recovery (Dutta & Trapp 
2014). This model is potentially significant in understanding the immuno- and 
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neuropathological mechanisms which regulate the RR stage of MS if it is induced in 
certain knockout and transgenic animals (Lassmann, H. 2008; Libbey & Fujinami 2011).    
The major difference in our immunization protocol compared with other protocols in the 
literature is the inclusion of Quil adjuvant (A) (Juedes et al. 2000; Nicolson et al. 2002). 
EAE is known to be driven by T cell pathogenesis (Rao & Segal 2012), and Quil A acts by 
inducing the proliferation of B cells and preferential T cell expansion (Constantinescu, C & 
Hilliard 2005; Peiris et al. 2007). Using this immunization protocol, it was observed that 
Quil A produced a milder immune response compared to Complete Freud’s adjuvant 
(FCA) while it still induced T cells and cytotoxic T cell response (CTL) essential to initiate 
the first EAE relapsing peak (Rajput et al. 2007). Quil A appears to facilitate the entrance 
of antigens into the lymphocyte but does not induce RR-EAE alone (Khan, Woodruff & 
Smith 2014; Peiris et al. 2007). Therefore, by itself, Quil A is not associated with 
neuroinflammation in the CNS because there was no evidence of gliosis and lymphocyte 
infiltration as evidenced by the Quil adjuvant group (Khan, Woodruff & Smith 2014), which 
were used as the sham control in our experiments. This group clinical score ranged 
between 0-0.5 and they did not experience the actual relapsing-remitting cycle nor 
developed neuropathic pain.   
FCA induces a chronic form of MS in C57BLS mice (Aharoni et al. 2013; Gold, Hartung & 
Toyka 2000). FCA also causes several side effects which includes swelling, intense 
inflammation and formation of granulomatous lesions (Berard et al. 2010; Slavin et al. 
1998). Therefore, it is difficult to differentiate between neuroinflammation caused by EAE 
itself or FCA (Sun, H, Xie & Ye 2009). Our model is more specific because Quil adjuvant is 
only highly active at the point of immunization and consequently the disease is induced 
primarily by MOG35-55, which reacts with T cells. Quil A also did not produce side effect 
reactions in the injection sites and more importantly, and it help to produce more 
consistent results (Khan, Woodruff & Smith 2014; Peiris et al. 2007).  
In other models, the relapsing peaks are observed with high clinical scores, between 3-4, 
which can be characterized by multiple limb paralysis (Aharoni et al. 2013). During the 
remission period the clinical score improved to 1, which can be characterized by poor gait 
(Berard et al. 2010). Therefore, relapsing models of EAE with high clinical scores are not 
likely to exhibit full recovery (Kuerten & Angelov 2008; Skundric 2005; Zhang, G et al. 
2004), but instead it will result in severe motor deficits (Lisi et al. 2012; Yuan, Shi & Tang 
  
157 
2012). In our model, the development of mild symptoms is necessary to allow the mice to 
recover during the disease cycle, whereby the clinical score does not exceed 1.5 as 
characterized by limp tail and hind limb weakness (Khan, Woodruff & Smith 2014; Peiris et 
al. 2007).  
The first recovery observed in our model occurred approximately 15-20 days post 
immunization with clinical score <1 and the second recovery was observed 30-33 days 
post immunization. The final recovery was observed at approximately day 50. This 
predictable disease progression is advantageous because the offset of the timing can be 
potentially useful as the marker for the evaluation of interventional treatments. Peiris et al 
have shown that administering pioglitazone to these mice reduces the severity of the 
relapses (Khan, Woodruff & Smith 2014; Peiris et al. 2007).  
In parallel with our imaging study, Khan et al showed that the optimized RR-EAE model 
has the following neuro and immunopathological features: glial cell activation, marked 
activation of microglial/ macrophages and astrocyte, T-cell infiltration and most importantly, 
demyelination. All of which were evident in the brain and lumbar spinal cord of chronic 
EAE mice (Khan, Woodruff & Smith 2014). Their findings confirmed our DTI parameter 
analyses and detection of demyelination in the anterior cingulate cortex, primary motor and 
somatosensory areas using BG myelin staining (see section 5.6.3 below). 
 
5.6 Assessment of RR EAE mouse brains using 3D ex vivo DWI 
5.6.1 MS normal appearing white matter (NAWM)  
During the acute stage (13-17 days post immunization), there were significant increases of 
MD and RD in many of the WM structures of the acute EAE groups compared to the 
chronic EAE groups. As the MRI data was acquired early after the first relapsing period, 
this may be an indicator of inflammation rather than atrophy or tissue loss. BG myelin 
staining showed that there was no significant demyelination in the white and gray matter or 
cortical areas of the acute adjuvant and EAE mice. This histology results confirmed the 
negative finding of the ROI, VBM, and TBSS analyses, which showed no difference in FA 
between control subjects and acute EAE and adjuvants. Furthermore, there was no MRI 
lesion detected in our model, suggesting that only mild changes to neurological structure 
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was present. However, it is still possible that there is some axonal injury developed in the 
WM structures, which could drive NAWM damage. 
It appears that our RR-EAE model represents what is known in the clinical MS patient as 
normal appearing white matter, where a subtle balance existed between inflammation and 
neuroprotection (Ceccarelli, Bakshi & Neema 2012; Zeis et al. 2008). Such a condition has 
been previously shown in combined histopathological and MRI studies. The presence of 
injured axons could be detected in NAWM, which is thought to drive microglial activation 
resulting in pathology of the cortex (Mistry et al. 2011; Moll et al. 2011). Other pathological 
processes may also exist in NAWM such as such as myelin and/or axonal loss and gliosis 
(Natarajan et al. 2013; Poloni et al. 2011).  
In clinical MS patients, increasing MD values were observed in the NAWM during the 
clinical isolated syndrome (CIS) stage and become more prevalent during the secondary 
progressive MS stage (Roosendaal et al. 2009). This has also been observed in the 
relapsing remitting stage but differ in the degree of the damage according to the patient’s 
clinical symptoms (Tortorella et al. 2006; Vrenken et al. 2006).  
Another study reported that a steady and moderate increase of the MD in NAWM might 
happen before development of new MS lesion (Filippi, Charil, et al. 2014; Werring et al. 
2000). The MD increases rapidly during the period when gadolinium enhancement is 
detected and returning to normal after the cessation of Gd enhancement. The mild 
increase in MD is suggested to arise from secondary degeneration of axons transected 
within MS lesions (Werring et al. 2000), and such changes is thought to reflect MD 
sensitivity in assessing the evolution of abnormal tissues (Inglese, M & Bester 2010).  
Increasing MD and decreasing FA of WM structures were observed mostly in the SPMS 
(secondary progressive multiple sclerosis) patients compared to RRMS and PPMS 
(primary progressive multiple sclerosis) patients (Tortorella et al. 2006). In our experiment, 
the increase of MD and RD values appeared to be a transient phenomenon because it 
was not observed in the chronic EAE groups at the end of relapsing remitting cycle. It 
appears that the MD and RD values recovered or pseudo-normalized. This is in agreement 
with PLP induced RR-EAE models, where substantial remyelination was observed from 
the recovery of MTR and myelin basic protein staining at the end of the relapsing remitting 
cycle (Aharoni et al. 2011).   
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5.6.2 Gray matter and cortical demyelination 
Most studies of animal models of MS have focused on the pathology of the brain major 
white matter structures (Boretius, S. et al. 2012; Sun, S et al. 2007; Wu, QZ et al. 2007). 
However, MS is a whole brain disease and could also affect the gray and cortical brain 
areas (Filippi, Charil, et al. 2014). Recent studies have established there are correlation 
between gray matter lesion burden and clinical disability in MS patients (Honce 2013). The 
number of intracortical lesions increases in late MS stages with 36% was detected in CIS 
patients, 64 % in RRMS and 73% in SPMS (Calabrese, Massimiliano et al. 2007).  
The decrease of FA was suggested to be a strong indicator of demyelination in these 
areas because FA values are proportionally correlated to the amount of myelin in 
neurological tissue (Arnold et al. 2013). Our data shows that FA values were significantly 
decreased in large areas of cortical gray matter and several brain white matter structures 
in the chronic EAE groups compared with control mice. The reduction in FA was extensive 
in cortical areas including the three layers: leukocortical (type Ι), intracortical (type ΙΙ) and 
subpial (type ΙΙΙ) which mimic the pattern of cortical demyelination in human. Our animal 
model, which produces cortical demyelination during the relapsing remitting cycle, would 
be potentially useful in developing the understanding the pathological mechanisms and 
approaches to treatment (Geurts, JJ & Barkhof 2008; Merkler et al. 2006).   
MS patients’ cortical lesions are typically difficult to detect using MRI, but they have been 
extensively observed in several post-mortem studies (Kutzelnigg, A et al. 2007; 
Kutzelnigg, A. et al. 2005). The development of the double inversion recovery (DIR) 
sequence for clinical imaging has enabled detection of cortical and gray matter lesions, 
and attracted great interest since these lesions appear to be a sensitive indicator of 
progression of neurological disabilities in MS patients (Geurts, JJG, Pouwels, et al. 2005; 
Nelson, F et al. 2008; Pitt et al. 2010).  
In MS patients, cortical demyelinating may occur during the early relapsing remitting stage 
(Lucchinetti et al. 2011). In rare cases, this may occur before developing focal WM lesions 
(Popescu et al. 2011). As these lesions accumulate over time, the chance of detecting 
cortical lesions will increase dramatically (Kutzelnigg, A. et al. 2005). In some very extreme 
cases of SPMS, cortical lesions may affect 68% of the cortical area volume (Geurts, JJ & 
Barkhof 2008; Kutzelnigg, A. et al. 2005).  
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Cortical demyelination has also been observed in focal EAE induced in rats. The pathology 
resolved relatively rapidly, reflecting the capability of cortical regions to remyelinate 
(Merkler et al. 2006). Cortical demyelination in the chronic EAE model presented the 
following pathological features: demyelination, microglial activation and apoptotic cells 
(Mangiardi et al. 2011).    
Gray matter (GM) lesions are different to WM lesions, in which the lymphocyte infiltration is 
absent (with exception of some activated ramified microglia) and BBB disruption level is 
low (Bo, Lars et al. 2003; Peterson et al. 2001; Stadelmann et al. 2008). GM lesions are 
usually characterized by a low degree of inflammation, demyelination and neuronal and 
glial synaptic loss, axonal loss and microglial proliferation (Geurts, JJ & Barkhof 2008). It 
was suggested that FA decrease may be related to the local activation of the microglial 
cells (Davalos et al. 2005; Nimmerjahn, Kirchhoff & Helmchen 2005).  
A three-year follow up case study found that FA values were increased in cortical lesions 
and normal appearing gray matter in RRMS patients compared with control subjects 
(Calabrese, M. et al. 2011). However, a more recent DTI study showed a decrease in FA 
values in cortical lesions and the normal appearing cortex of MS patients. These variations 
in FA characteristics are thought to be useful to distinguish MS phenotypes: benign MS, 
RRMS and SPMS (Filippi, M et al. 2013).  
In our model, extensive FA reductions were observed in cortical areas, and validated with 
BG myelin staining as areas with extensive demyelination. The major differences between 
our experiment and the Calabrese et al study highlights the complexity of MS in humans 
because the disease can originate from various spontaneous processes such as axonal 
injury and breaking the blood brain barrier, whereas EAE induced in mice is caused by 
immunoreaction to brain tissue antigens. In humans, the cortical areas are highly 
prominent and occupy a larger volume compared with rodent brains (Bo, L 2009; 
Kutzelnigg, A. et al. 2005; Stadelmann et al. 2008).  
Our model has been initially designed to understand pain mechanisms in MS (Khan, 
Woodruff & Smith 2014). In our experimental model, we have observed significant 
reduction of FA values in the anterior cingulate (acc) areas. This area is functionally 
heterogeneous. In rodent brain, it is correlated with several cognitive tasks, which include 
attention (Carter, Botvinick & Cohen 1999; Miller, EK 2000), motor (e.g. preparation and 
execution of movement) (Paus & sbreve 2001) and sensory (e.g. pain) (Price 2000; Zhuo 
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2005). A recent study (Teixeira et al. 2006) also revealed the role of acc in remote spatial 
or non-spatial memory. The presence of demyelinated axons in this area is thought to 
cause functional disruption and the development of neuropathic pain (Khan, Woodruff & 
Smith 2014).  
5.6.3 Biological factors contributing to DTI derived parameters for the assessment 
of axon and myelin pathology  
DTI derived parameters are a widely used tool for assessing axonal and myelin 
architectures (Aliotta et al. 2014; Aung, Mar & Benzinger 2013; Ceccarelli, Bakshi & 
Neema 2012). However, DTI has the drawback that it cannot produce accurate 
representations of the pathological changes as the contrast mechanism of the diffusion 
MRI signals are not fully understood (Le Bihan 2014). CNS contains complex 
arrangements of neuronal cell architecture which consequently influence the overall MRI 
signal, and it will become even more complex in the presence of pathology (Zhang, 
Yunyan et al. 2013).  
In neuronal tissues, the myelin sheath and axonal membrane are tightly coupled in terms 
of structural and functional properties. Both neuronal structures act as barriers to water 
diffusion along the perpendicular axis of the axon (Beaulieu 2002). It is difficult to 
distinguish between axonal and myelin sheath injuries using diffusion tensor MRI because 
damage of one leads to damage of the other (Zhang, J 2010; Zhang, J, Aggarwal & Mori 
2012). The cytoskeletal architecture inside the axon would also contribute to water 
diffusion parallel or perpendicular in the axon (Beaulieu 2002).  
DWI experiments typically measured diffusion of water from both the intracellular (inside 
the axonal environment) and extracellular components (among axons) (Le Bihan 2014; 
Tournier, Mori & Leemans 2011). All these technical and structural factors could contribute 
significantly to the sensitivity of DTI derived parameters as surrogate biomarkers in 
detecting pathological changes. In addition, there is no simple animal model that can 
produce pure axonal or myelin pathologies (Beaulieu 2002; Zhang, J, Aggarwal & Mori 
2012).  
To interpret the conventional DTI derived parameters, it can be assumed that WM signals 
contain signal contributions from normal or abnormal tissues without considering fibre 
crossing (Figure 5.1). There are several scenarios that could be used to describe changes 
in the DTI derived parameters:  
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1) Decreasing AD and increasing RD can be correlated with significant axonal injuries and 
demyelination. This correlation was established previously in CNS injury rodent models 
(Figure 5.1b) (Budde et al. 2008; Budde et al. 2009; Xie et al. 2010).    
2) When inflammation is present due to axon and myelin injury, cell proliferation (increased 
presence of oligodendrocytes, astrocytosis, microgliosis, or other immune cells) between 
the axon fibres (Figure 5.1c) will produce a stronger inhibition of axial diffusion of water. 
This situation would result in a large decrease in AD and a smaller decrease in RD. In this 
scenario, the DTI parameters may underestimate the extent of demyelination and 
overestimate the extent of axonal injury. The increase of cellularity will increase the 
presence of highly restricted intracellular diffusion (shown with small circular ellipsoids) 
(Song et al. 2005; Sun, SW et al. 2006; Xie et al. 2010).  
 
 
Figure 5.1 schematic diagram explain the complex relationship between neuropathology and axial 
and radial diffusivity.  
(a) Normal myelinated axon and the corresponding axial and radial diffusivity. (b and c) injured axon and 
myelin sheath with and without infiltrating cells respectively. (d and e) injured axon and myelin sheath with 
axonal loss with and without infiltrating cells respectively. Reproduced from (Zhang, J, Aggarwal & Mori 
2012).  
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Our chronic RR EAE model appeared to correlate with this scenario, in which both 
decreased AD and RD were observed. However, it could also be a pseudo-normalization 
process due to the fluctuation of the disease cycle. To better validate this scenario, 
additional histology data would be required, such as axon neurofilament staining and 
microglia staining, in addition to the data available for the validation of demyelination using 
BG myelin staining.  
3) Major axonal loss is usually observed in the chronic MS disease stage, which leads to 
the increase in RD but AD remained unchanged due to the increase in isotropic diffusion 
components (Figure 5.1d) (Kim, JH et al. 2006).  
4) The interpretation of DTI derived parameters becomes complicated if there is 
coexistence of cellular infiltration, demyelination, significant axonal loss and axonal injury 
(Figure 5.1e) (Wang, Y et al. 2011; Zhang, J, Aggarwal & Mori 2012).  
In our experiment, we have observed an increase in RD in most of the WM structures in 
acute EAE compared with chronic EAE. The AD values of the acute groups did not 
decrease which could be interpreted as the presence of inflammation without 
demyelination after the first relapsing cycle.  
   
5.7 Comparison between in vivo and ex vivo DTI study 
In vivo DTI investigation is preferred as it allows longitudinal observation of pathological 
changes in the same animal (Aharoni et al. 2013; Boretius, S. et al. 2012). However, live 
animal imaging is susceptible to motion artefacts and has limitations in term of spatial and 
angular resolution. To acquire higher resolution comparable to histology images, ex vivo 
MRI is required. The major uncertainty in ex vivo experiments is that the results from brain 
post-mortem may not be an accurate representation of the tissue structures in live animals 
due to the effect of fixation procedures. This may cause alteration in the tissue 
microstructures and consequently result in a variation of the intracellular and extracellular 
membrane permeability (Cahill et al. 2012; Zhang, J et al. 2012).  
In our experiment, we have observed significant differences of the values of FA, MD, AD 
and RD obtained from 2D in vivo and 3D ex vivo DWI experiments. The FA values were 
significantly higher in the 3D ex vivo DWI compared with 2D in vivo DWI, although the 
results of our 3D ex vivo FA values are similar to previous 3D in vivo studies (Aggarwal et 
al. 2010). Our data indicated that within the corpus callosum, the rostral segment has the 
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highest anisotropy (FA=0.71±0.033) compared to the middle (0.56±0.035) and caudal 
segments (0.58±0.025) and the external capsule (0.54±0.020). Aggarwal et al reported the 
in vivo 3D FA measurements of the rostral (0.62±0.11), middle (0.51±0.09), caudal 
(0.59±0.1) segments of the corpus callosum and external capsule (0.51±0.09) (Aggarwal 
et al. 2010). These comparisons between ex vivo and in vivo experiments confirmed 
previous findings that FA values were not significantly affected by post fixation procedures 
(Song et al. 2003; Sun, S et al. 2005; Zhang, J et al. 2012). On the other hand, most of 
MD, AD and RD values for the WM structures ex vivo were significantly lower compared to 
the values obtained from 2D in vivo DWI (result section, tables: 4-4, 4-5 and 4-6). These 
changes are thought to be due to the effect of the post fixation procedures.  
    
5.8 VBM and TBSS analyses showed significant changes in the GM cortical areas 
and major WM structures in RR EAE mouse brains 
In our analysis, ROIs were drawn in WM structures on the template image and the same 
ROI were then back transformed to the individual mouse brain image. This was less time 
consuming and allowed improved reproducibility of the FA measurement and minimizing 
operator bias. In addition to ROI analysis, both VBM (Schwarz et al. 2014) and TBSS 
(Aliotta et al. 2014) analyses provided global brain assessment of FA, MD, AD and RD. 
Gross pathological changes were found in crossing fibre areas such as the anterior 
cingulate cortex, which are difficult to define using tractography (Bodini et al. 2009). We 
attempted to perform tract density imaging (TDI) (Calamante, Fernando et al. 2012) 
analyses but no changes were observed in the affected areas. Recent papers showed that 
a TDI analysis is less quantitative and further development is required for more reliable 
quantitative measurement (Willats et al. 2014). 
VBM analysis method is fully automated, allowing investigation of the whole brain and 
does not require pre-determined or hypothesis for the regions of interest. However, the 
major problem with VBM is alignment inaccuracies and arbitrary smoothing, which may 
lead to misinterpretation of results (Abe et al. 2010; Jones, Derek K et al. 2005; Whitwell 
2009). Alternatively, TBSS has been introduced to solve these problems for whole brain 
analysis and dose not require previous knowledge of tracts of interest. The basis of TBSS 
is the projection of neighbouring voxel information onto skeletonized WM tracts to reduce 
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the partial volume effect, improving the accuracy of registration and boosting statistical 
power from dimensionality reduction (Smith et al. 2006; Smith, Kindlmann & Jbabdi 2014).     
The major limitation of the TBSS is the intrinsic bias in the process of tract skeletonization 
because it relies on identification of the maximum FA values in the direction perpendicular 
to the direction of the tract (Cercignani 2010). This process is followed by a thresholding 
step to exclude voxels with low FA values (Smith, Kindlmann & Jbabdi 2014). If there are 
WM abnormalities, which may cause local significant reduction in the FA values e.g. focal 
MS lesions, these pathological changes may be difficult to detect using TBSS and 
therefore disease affected areas should be assessed carefully (Cercignani 2010; Smith et 
al. 2006). Another technical challenge of TBSS is its dependence on registration target to 
achieve maximum sensitivity. To solve this problem, Keihaninejad et al suggested the use 
of a group-wise template as the target for registration (Keihaninejad et al. 2012).         
In our study, it appears that VBM is more sensitive in detecting FA reduction in the cortical 
and gray matter areas. This can be observed in Figure 4.12, 4.13 and 4.14 (results 
section) which shows extensive FA changes in the primary and secondary motor, 
somatosensory areas. These FA changes were not detected using TBSS. The major 
reason for this is that the cortical and gray matter areas have low anisotropy (≤0.2) and 
TBSS does not produce skeletonized tracts in these cortical areas due to FA thresholding 
applied.                   
For the anterior cingulate cortex area, which has higher anisotropy compared with other 
cortical areas; VBM and TBSS detected the same pattern of FA change. In the majority of 
white matter areas, TBSS results appeared to be more conserved in the detection of FA 
changes compared with VBM. There are more agreements between VBM and TBSS in 
detecting the increase of MD and RD of the acute EAE compared with chronic EAE group 
in the most of the WM areas. These changes were also observed using ROI based 
analysis. Our data showed that TBSS was more sensitive and anatomically conservative in 
depicting FA changes compared with VBM in thin WM areas like external capsule.  
An alternative approach to VBM and TBSS methods is information sampling by 
tractography, which is based on measurement of FA of the voxels that traverse through 
the tractography streamlines (Behrens, Timothy E. J., Sotiropoulos & Jbabdi 2014). This 
technique is initiated by hand drawn ROIs to seed the beginning of a tract streamline, 
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defining constraints of how the fibres are passing through the tracts and choosing the 
optimum tractography parameters (Girard et al. 2014). This requires defining ROI of each 
individual brain sample in the native space to identify and compare each tract in each 
group. This can be a disadvantage in routine clinical studies, as it requires assessment of 
each individual tract and the registration of different spatially oriented DW images. (Smith, 
Kindlmann & Jbabdi 2014).  
 
5.9 Relaxation time analyses confirmed the presence of EAE lesions indicated by 
DTI parameters, but no brain atrophy was detected 
ROI based analysis was used to measure changes in the T1, T2 and T2* relaxation times of 
the brain tissues. There were significant increases in the T2 relaxation time of chronic EAE 
groups compared with control subjects in the following areas: the anterior cingulate cortex, 
primary and secondary motor and somatosensory area. Compared to T1 and T2*, T2 
relaxation appeared to be more sensitive in measuring the pathological changes and 
provided similar information to that detected in FA maps. A previous study used the 
Cuprizone model and showed a correlation between increasing T2 relaxation and 
demyelination as depicted by luxol fast blue myelin staining. It was suggested that 
inflammatory cellular infiltration may have contributed to T2 signal abnormalities (Wu, QZ 
et al. 2007).  
The major limitations of our quantitative relaxometry measurement are the use of thick 2D 
slices and manual definition of the ROI. Therefore, if there were any abnormalities in other 
than the selected areas, they may be easily missed. 3D T1 weighted images (WI) obtained 
from non-diffusion weighted images (b0) of the ex-vivo 3D HARDI data were also used for 
VBM and Jacobian analyses to compare between control, acute and chronic EAE groups. 
However, no abnormalities were detected. This observation suggested that T1 WI have the 
lowest sensitivity of the relaxation parameters in detecting changes in our RR EAE model. 
The absence of Jacobian abnormalities also excluded the existence of regional brain 
atrophy in the white or gray matter.  
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5.10 Translation of MS animal model studies to clinical trials 
MS is a unique human disease and does not occur in animals spontaneously (Lassmann, 
H. 2013; Trapp & Nave 2008). There are no single animal models that can produce all 
aspects of MS (Lassmann, H. 2008). However, experimental animal models have assisted 
in gaining a better understanding of neuroinflammation, exploring links between 
demyelination, axonal injury and the progression of neurological disability (Baker & Amor 
2014). Therefore, preclinical studies have significantly contributed to acquiring basic 
knowledge but have not provided direct translation to clinical studies (Pachner, A 2012; 
Ransohoff 2012).   
There are several challenges in the translation of the outcomes of studies performed in 
animal model MS into clinical trials (Altmann & Boyton 2004; Denic, Johnson, et al. 2011). 
Firstly, the causes of MS are still not yet resolved (Hauser, Stephen L, Chan & Oksenberg 
2013). The two major MS animal models, EAE and TMEV, are based on the hypothesis 
that MS results from autoimmune reaction and viral infection (Robinson et al. 2014). 
However, in the current literature there is no strong evidence to confirm these hypotheses 
(Venkatesan & Johnson 2014). Secondly, MS is a complex disease which involves several 
pathological aspects such as demyelination, inflammation, and excessive immunoglobulin 
production within the CNS (Lubetzki & Stankoff 2014). Animal models of MS cannot 
produce the whole MS spectrum but they can focus on targeted aspects of MS (Steinman 
& Zamvil 2006).  
It is often difficult to compare EAE studies carried out in various centers due to differences 
in the experimental conditions such as selection of the animal species, strain, and sex. 
Most importantly there are differences in the immunization protocols: the induction dose, 
timing, and frequency of the given treatment (Constantinescu, CS et al. 2011; Gold, 
Linington & Lassmann 2006). Most rodent EAE experimental studies were carried out in 
genetically identical groups of animals. This is an important methodological step to reduce 
experimental variability. However, this may lead to some bias in rodent studies compared 
to humans, whose genetic variation exists (Robinson et al. 2014). For direct comparison, 
all experimental animals should have an identical environment. However, this may not be 
easily controlled in some cases, for example, the degree of colonization of the gut and the 
type of commensal flora is difficult to control in different laboratory, and this was shown to 
lead to a great degree of variability in the susceptibility to EAE (Yokote et al. 2008). 
Despite all these issues, MS animal models remain an integral part of MS research, with 
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increasing pressure to translate preclinical treatment approaches into clinical environment 
(Nathoo, N, Yong, V  & Dunn, J 2014).  
MS may affect each patient differently and different regions of the CNS may be affected 
more extensively in some patients than others (Kornek & Lassmann 2003; Pittock & 
Lucchinetti 2007). For example, some patients may experience sensory and motor 
disability due to lesions in the spinal cord. However, other patients may have cognitive 
impairment due to extensive cortical lesions (Filippi et al. 2002; Molyneux et al. 2000). 
Establishing animal models which affect or target specific areas could be advantageous for 
a better understanding of MS development in these regions (Mangiardi et al. 2011). Also, 
this may assist in the discovery of neuroprotective treatment for specific CNS regions 
because each region is known to vary in response to neurotrophic factors, receptor 
expression and sensitivity to excitotoxic-induced cell death (Iihara et al. 2001). In our 
experimental MS model, cortical areas are extensively affected. Therefore, a treatment 
may be tailored to target these CNS regions specifically (Mangiardi et al. 2011).  
EAE model can be used for developing and testing symptomatic treatments in MS patients 
(Constantinescu, CS et al. 2011; Kubajewska & Constantinescu 2010). Cannabinoids have 
a significant role in controlling spasticity and tremor in EAE mice (Baker et al. 2000). 
Bladder dysfunction in EAE model has been exploited to develop drugs to treat neurogenic 
symptoms in the bladder of MS patients (Al-Izki et al. 2009; Altuntas et al. 2008). In our 
model, Khan et al established a correlation between cortical and gray matter demyelination 
and neuropathic pain by temporal development of mechanical allodynia in bilateral hind 
paws of the chronic EAE mice and is now being used to test the efficacy of several potent 
analgesic agents (Khan, Woodruff & Smith 2014).  
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6 Conclusion 
6.1 Summary  
In summary, a mild RR-EAE mouse model of MS (Khan, Woodruff & Smith 2014; Peiris et 
al. 2007) was induced in C57BL/6 mice using MOG35–55 and Quil A adjuvant. This induction 
results in a clinical course where relapses are followed by recovery periods (during which 
clinical symptoms are resolved) before another relapse occurs. This model produces small 
pathological changes, which are reflected in mild clinical scores, and can be utilized to 
elucidate early MS biomarkers. Our model is not appropriate for examining severe EAE 
symptoms which involve paralysis (Khan, Woodruff & Smith 2014; Peiris et al. 2007).  We 
have produced a comprehensive imaging study of this model using in vivo and ex vivo 
diffusion weighted MRI at 16.4T, which allows better interpretation of pathological changes 
during the relapsing remitting cycle.  
Longitudinal MRI imaging of rodent models of MS facilitated investigation of temporal 
changes in the brain during progression from the acute to the chronic stages of MS 
disease. In this project, the optimized 2D in vivo DWI imaging data was acquired in 
approximately 2h and investigated for its feasibility to study RR-EAE model. The WM 
structures were assessed using ROI based analysis of the FA, MD, AD and RD, but 
unable to find significant pathological changes. This may reflect the inability of the 
acquired resolution to explore the pathological changes due to significant partial volume 
effect even in highly anisotropic areas like the corpus callosum.  
Subsequently, 3D ex vivo DWI was tested as a way to boost spatial image resolution, 
resulting in better assessment of fine anatomical structures. FA reductions were observed 
in the cortical areas in the chronic phase of the relapsing remitting cycle. Specific areas 
with FA reductions were observed in the anterior cingulate cortex, somatosensory and 
primary motor areas. With BG myelin staining, these areas were confirmed to suffer from 
extensive demyelination. Our observation is in agreement with a recent in vivo human DTI 
study, which also indicated that FA reductions in the cortical lesions could be used as the 
marker for distinguishing MS phenotypes (Filippi, M et al. 2013; Llufriu et al. 2014). MD 
and RD of similar regions were found to be increased during the acute stage, but were not 
observed during the chronic stage, indicating that these changes may be caused by a 
transient inflammation.  
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We have used two analysis methodologies: VBM and TBSS, which are commonly used in 
clinical research. Our data showed agreement between these two techniques in highly 
anisotropic WM areas. However, VBM outperformed TBSS in detecting changes in low 
anisotropy areas such as anterior cingulate cortex. BG myelin stain staining demonstrated 
strong correlation between FA changes highlighted in the WM and GM structures and 
demyelination. 
   
6.2 Future Perspective 
Clinical diagnosis and pre-clinical research in MS has the potential to benefit from further 
development and optimization of MRI technology at high field strengths. The increased 
signal to noise and improved RF coil technology, including the emergence of 
transmit/receive phased arrays, is providing better sensitivity and imaging at higher spatial 
resolution with reduced partial volume effects, which will lead to improved detection and 
characterisation of small lesions in normal appearing white/grey matter. For human MRI, 
3T scanners are becoming more widely available in clinics, while 7T scanners are 
increasingly used in research and >9.4T dedicated human brain MRI scanners for cutting-
edge research have appeared (Filippi, Evangelou, et al. 2014; Tourdias & Dousset 2013). 
For pre-clinical and basic research, 9.4T mouse brain cryogenic coils for in vivo imaging 
and ultra-high field >11.7T scanners for ex-vivo imaging will improve characterisation of 
novel animal models of MS (Wu, D et al. 2014).  
New generation MRI scanners are equipped with multi-channel transmit/receive coils for 
faster acquisition and stronger gradients to allow diffusion imaging at higher b-values as 
well as demanding applications such as oscillating diffusion gradient imaging (Van, 
Holdsworth & Bammer 2014). New analysis methods in diffusion MRI including diffusion 
kurtosis (Cheung et al. 2009), neurite orientation dispersion and density imaging (NODDI) 
(Zhang, H et al. 2012), and axon diameter and density measurements (Alexander, DC et 
al. 2010), informed by new data from the human CONNECTOME project (Van Essen et al. 
2012) and high-resolution mouse brain (Ullmann et al. 2013) and spinal cord (Harrison et 
al. 2013) atlases will allow enhanced characterisation of changes in nervous tissue 
components and observation of cell infiltration into nervous tissues.  
Recent development of multi-modal MRI/PET scanners for human and animal imaging 
(Cho et al. 2013; Maramraju et al. 2011) allows simultaneous MRI and PET signal 
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detection of MRI markers and radioligands. This emerging technology holds great potential 
in the examination of specific aspects of inflammation, axonal degeneration or repair and 
changes in neuro-metabolism for enhanced characterization of MS and testing of potential 
intervention therapies. Translation of these new imaging modalities to the clinic remains a 
goal for the next decade.  
 
6.3 Recommendation  
Current optimization of in vivo segmented EPI-DWI did not provide sufficient resolution 
and sensitivity in detecting complex brain structures such as the cortex. Further study may 
involve high-resolution DWI images in these areas using localized FOV as developed in a 
recent study by Wu et al (Wu, D et al. 2014). To avoid deleterious susceptibility and 
geometric distortion artefacts at 16.4T, future experiments may utilize lower field scanners 
(9.4T or 11.7T) equipped with cryoprobe to increase the signal-to-noise by 2-3 fold but with 
less magnetic susceptibility artefacts. Further, it would be beneficial to explore the 
response of the RR-EAE model to a cognitive task using somatosensory (Tona et al. 2014) 
and/or resting state functional MRI (Barkhof, Haller & Rombouts 2014; Filippi, Massimo et 
al. 2013), to study the demyelinated cortical areas and the effect of potential treatments.  
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7 Appendices 
7.1 Appendix-1 Black and Gold myelin stain study of all mice groups  
 
Figure 7.1 BG myelin study of all mice groups.  
Column (A) control, (B) acute EAE, (C) chronic EAE, (D) acute sham, (E) chronic sham group. Scale bar is 
1mm. 
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7.2 Appendix-2 Detection of extensive demyelination in the rostral cortical brain 
structures 
 
Figure 7.2 Comparison between all mice groups for rostral cortical demyelination.  
The zoomed ROI includes anterior cingulate cortex (A-cing), rostral corpus callosum (R-cc), external capsule 
(ec), primary motor (M1) and somatosensory (S1) areas, (A) control, (B) acute EAE, (C) chronic EAE, (D) 
acute sham, and (E) chronic sham. Yellow arrows points at areas of extensive demyelination presented in 
(C) chronic EAE groups.  Scale bar is 1 mm. 
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7.3 Appendix-3 Detection of extensive demyelination in the somatosensory areas  
 
Figure 7.3 Detection of extensive demyelination in the somatosensory areas 
BG myelin stain reveals areas of extensive demyelination as pointed by yellow arrows in the chronic EAE 
groups (C) compared with other groups: (A) control, (B) acute EAE, (D) acute sham and (E) chronic sham. 
Scale bar is 1 mm 
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7.4 Appendix-4 Detection of extensive demyelination in the middle brain structures 
 
Figure 7.4 BG myelin stains of the middle brain structures 
BG myelin stains reveals extensive demyelination anterior cingulate (A-cing), primary motor (M1) and 
somatosensory (S1) areas, as pointed by yellow arrows in the chronic EAE (C) compared with (A) control, 
(B) acute EAE, (D) acute sham and (E) chronic sham. Scale bar is 1 mm   
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7.5 Appendix-5 Detection of extensive demyelination in the hippocampus and 
somatosensory areas 
 
 
Figure 7.5 Detection of extensive demyelination in the hippocampus and somatosensory areas 
BG myelin staining shows demyelination in the hippocampus (HC), anterior cingulate cortex (A-cing), primary 
motor (M1) and somatosensory (S1 and S2) areas of the chronic EAE (C) compared with (A) control, (B) 
acute EAE, acute sham (D) and (E) chronic sham. Scale bar is 1 mm. 
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7.6 Appendix-6 Black and Gold myelin stain of control mouse 
   
 
Figure 7.6 Mouse brain mid structures of control mouse, zoomed in the anterior cingulate cortex  
  
178 
7.7 Appendix-7 Black and Gold myelin stain of acute-adjuvant mouse 
                                                                       
 
Figure 7.7 Mouse brain mid structures of acute-adjuvant mouse, zoomed in the anterior cingulate cortex 
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7.8 Appendix-8 Black and Gold myelin stain of chronic-adjuvant mouse 
    
 
Figure 7.8 Mouse brain mid structures of chronic-adjuvant mouse, zoomed in the anterior cingulate cortex 
  
180 
7.9 Appendix-9 Black and Gold myelin stain of acute-EAE mouse 
                                                                   
 
Figure 7.9 Mouse brain mid structures of acute-EAE mouse, zoomed in the anterior cingulate cortex 
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7.10 Appendix-10 Black and Gold myelin stain of chronic-EAE mouse 
                                                                         
 
Figure 7.10 Mouse brain mid structures of acute-EAE mouse, zoomed in the anterior cingulate cortex 
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